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ABSTRACT
Introduction: Self-management plays a central role in the treatment chronic obstructive
pulmonary disease (COPD). However, the patient characteristics necessary for effective selfmanagement are not understood. The skills, confidence, and knowledge to engage in chronic
disease self-care, known as patient activation, may play a key role in the capacity of people to
self-manage COPD. How the complex, systemic nature of COPD influences patient activation
has not been explored. Therefore, the purpose of this study was to examine the relationships
among patient characteristics and health outcomes as determinants of patient activation among
community-dwelling adults in the U.S. with COPD. The Revised Wilson Cleary Model (Ferrans,
Zerwic, Wilbur & Larson, 2005) was adapted to examine a continuum of integrated variables
integral to the experience of COPD for this descriptive correlational survey study.
Methods: A random sample of 64 community-dwelling adults with COPD completed a selfreport postal survey. The questionnaire was comprised of demographic questions and the
Positive Affect Negative Affect Schedule, to measure individual and environmental patient
characteristics, and the Quality of Life Index Pulmonary Version III, Pulmonary Functional
Status and Dyspnea Questionnaire-Modified, a single question to assess general perception of
health, and the Patient Activation Measure-13 (PAM) to assess health outcomes. Additionally,
spirometry data was abstracted from participants’ medical records. Descriptive and univariate
statistics were utilized to describe and examine the unadjusted associations between patient
characteristics, health outcomes and patient activation scores. Variables significantly (p < .25)
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associated with patient activation were entered into stepwise multivariate regression models to
identify independent predictors of patient activation in the sample.
Results: The participants in the study were mostly men and women in their 70s with moderate to
severe COPD, having lived with the disease for over four years. The patient activation scores
were high among the sample (M = 66, SD = 16), with over 70% of the sample activated at PAM
Level 3 and 4 (n = 47, 73%). Univariate analyses revealed significant relationships between
several patient characteristics (gender, positive affect, lower Body Mass Index, education level,
time since diagnosis of COPD, smoking pack years, urban residence) and patient activation.
Health outcome domains, such as low fatigue, good or very good general perception of health,
and better perceived overall quality of life) were directly related to patient activation in the
sample. The resulting statistically significant regression model (R2 = .488, Adj.R2 = .454, p <
.001) contained four independent predictors explaining 45% of the variation in patient activation
in the sample. Positive affect β = .457 contributed most to the model, followed by smoking pack
years β = .345, overall quality of life β = .264, and female gender β = -.192.
Conclusions: Several patient characteristics and complex health outcomes underlie selfmanagement capacity in COPD. This study revealed novel determinants of patient activation that
have implications for COPD self-management science and nursing practice. Nurses are in a
pivotal position to apply knowledge of patient activation to the individualized assessment and
care interventions of people living with COPD. Further research is needed to explicate the
unique psychosocial factors that contribute to capacity to self-manage for targeted intervention
design in this population.
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CHAPTER I
INTRODUCTION
More than 15 million Americans have chronic obstructive pulmonary disease (COPD),
the fourth leading cause of chronic morbidity and preventable death in the United States (CDC,
2017). COPD is defined as “a preventable and treatable disease state characterized by airflow
limitation that is not fully reversible…the airflow limitation is usually progressive and associated
with a chronic inflammatory response of the lungs to noxious particles or gases” (Celli et al.,
2015, p. e5). Often referred to as an umbrella diagnosis, COPD encompasses a spectrum of
chronic lung diseases, including chronic bronchitis and emphysema (GOLD, 2018). These
diseases are thought to be caused by long-term exposure to airway irritants, most commonly
cigarette smoking, and are characterized by air flow obstruction causing debilitating shortness of
breath, coughing, and fatigue (ALA, 2017; CDC, 2017). Exacerbations and development of
comorbid conditions are typical in the progression of COPD and contribute to overall disease
severity and mortality (Halding and Grov, 2017). The incidence of COPD is roughly equal
between the genders, though in the last decade women exceed men in the numbers of both newly
diagnosed and those dying from the condition (ALA, 2017; Celli et al., 2015; Pruitt, 2014).
COPD treatment plans are multifaceted with self-management intensive (Titova et al.,
2017; Disler, Gallagher & Davidson, 2012). The plans require patients to monitor and manage
their symptoms and mood, avoid respiratory triggers, stop smoking, adhere to medication
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regimens, engage in regular physical activity, and actively maintain supportive relationships
(Celli et al., 2015; Disler et al., 2012; Kaptein, Fischer & Scharloo, 2014). As COPD cannot be
cured, the goals of treatment are to slow disease progression, and maintain function and quality
of life (Kruis et al., 2013).
Research Problem
Evidence suggests vigilant self-management is directly associated with reduced hospital
admissions, decreased perception of shortness of breath, and improved quality of life in people
with COPD (Andenaes, Bentsen, Hvinden, Fagermoen & Lerdal 2014; Zwerink et al., 2014).
Studies have also shown that less than one-half of patients with COPD demonstrate adherence to
recommended self-management activities prescribed in their treatment plans (Bischoff et al.,
2012; Bucknall et al., 2012). Further, randomized clinical trials investigating approaches to
effectively teach and support patients with COPD to self-manage have yielded controversial
results, including adverse events (Kaptein et al., 2014; Nici, Bontly, ZuWallack & Gross, 2014).
Though the burden of COPD has been implicated with poor adherence to treatment
plans, it is highly debated in the field why self-management interventions succeed for some
patients and fail for others (Bender, 2014; Titova et al., 2017). To address the disparate results of
intervention trials and low treatment adherence among adults with COPD, the research
community have begun to question what patient characteristics are necessary to become
motivated and effectively engage in self-management behaviors (Nici et al., 2014). As clinicians
and researchers call for individualized approaches to care tailored to the unique characteristics
and strengths of individuals with COPD, knowledge of these factors is needed.
The patient’s capability to self-manage this chronic disease has gained the attention of
health care providers and researchers. Patient activation has emerged as a primary mechanism in
2

self-management processes (Moore et al., 2016) and a reliable measure of self-management
capacity in chronic disease (Hibbard, Greene, Shi, Mittler & Scanlon, 2015). Patient activation
reflects individual’s beliefs that they have an important role to play in their health and is
demonstrated through the knowledge, skills, and confidence to maintain function, respond to
changes in health, and access appropriate care for their health needs (Hibbard, Stockard,
Mahoney & Tusler, 2004). The Patient Activation Measure (PAM) objectively characterizes an
individual’s activation level on a developmental spectrum of the passive care receiver with
limited self-management capacity (Level 1) to the confident, capable, and engaged self-manager
(Level 4) (Hibbard et al., 2004). The higher the level of patient activation an individual has, the
more likely he or she will have a sense of responsibility for their health, carry out self-care
activities to maintain wellness, engage with the health care system, and achieve treatment goals,
(Dixon, Hibbard & Tusler, 2009; Greene, Hibbard, Sacks, Overton & Parrotta, 2015; Mosen et
al., 2007).
Despite the growing body of evidence that suggests patient activation is the most
reliable indicator of a patient’s ability to manage his or her chronic disease (Coventry, Fisher,
Kenning, Been & Bower, 2014; Green et al., 2015; Halding & Grov, 2017), determinants and
mediators of patient activation are still relatively unknown (Hibbard et al., 2015). Understanding
the impact of chronic disease and healthcare practices on patient activation level has recently
emerged as a focus of nursing inquiry. Several studies have attempted to identify determinants of
patient activation in adults with a variety of chronic diseases. The results of these studies are
broad and contrasting, preventing any consensus of the factors that may predict patient activation
(Graffigna, Barello & Bonanomi, 2017). Further, most were conducted without a theoretical or
conceptual framework to explain variable choice or results in a meaningful way for translation or
3

application in clinical practice (Bos-Touwen et al., 2015; Hibbard et al., 2015; Korpershoek et
al., 2016).
The concept of patient activation has relevance in the treatment of COPD where the
onus of treatment success lies in the capacity of the patient to engage in treatment plans is
dependent upon self-management behaviors. Knowledge about how the complex, systemic
nature of COPD affects patient activation development is lacking in the literature (Evans &
Morgan, 2014; Korpershoek, 2015; Titova et al., 2017). In addition, the underlying patient
characteristics supporting patient activation in the individual with COPD have not been
explicated (Case et al., 2017). Nurses are pivotal in delivery of self-management education and
support to people with COPD, thus knowledge of ways to promote patient activation is important
to nursing practice. Examining how individual patient and disease-specific factors affect patient
activation level, through the lens of an organizing conceptual framework, would inform a gap in
the patient activation and COPD self-management evidence bases.
Evidence of patient activation as a predictor of chronic disease outcomes carries health
policy implications for COPD care. Health care utilization rates and costs for people with a
primary diagnosis of COPD are approximately twice that of age and sex-matched controls
(Green et al., 2015). Preventing readmission to the hospital through self-management is a
national priority for COPD care, as one in five people hospitalized for an exacerbation of COPD
will require re-hospitalization within 30 days (Charlot et al., 2017; National Quality Measures
Clearinghouse, 2017). Patient activation has been shown to mediate collaborative selfmanagement programming and hospitalization rates in people with COPD, thus, patient
activation may be a modifiable target in practice and policy planning efforts to reduce
hospitalization and readmission for people with COPD (Charlot et al., 2017). Established
4

evidence shows adults with higher patient activation levels are more likely to participate in
symptom monitoring and medication adherence (Hibbard & Greene, 2013, 2014; Hibbard et al.,
2015), two key self-management behaviors strongly associated with decreased hospitalization
and re-hospitalization for acute exacerbation of COPD (Roberts et al., 2016; Zwerink et al.,
2014). Because COPD is a resource-intensive disease process imparting costly healthcare
utilization burden on patients, providers, and payers (Dhamane et al., 2015), an examination of
the influencing factors for patient activation in this population is warranted.
Conceptual Framework
Patient activation is a multidimensional concept yet to be examined or tested within a
conceptual or theoretical framework. Therefore, a robust conceptual model that examines patient
activation in the bio-behavioral context of COPD is needed to guide this study. The widely used
Revised Wilson Cleary Model of Health-Related Quality of Life (Ferrans, Zerwic, Wilbur &
Larson, 2005) was chosen to guide the description and examination of relationships among
patient characteristics, health outcomes, and patient activation among adults with COPD.
In 1995 Wilson and Cleary (1995) proposed a model to help clinicians and researchers
conceptualize and test potential relationships among health outcomes and their collective impact
on overall quality of life in the setting of chronic disease. The Wilson Cleary Model of Healthrelated Quality of Life (Wilson & Cleary, 1995) integrated the biomedical and sociological
scientific views of quality of life and proposed taxonomy of health outcome measures organized
by dominant causal relationships. Five outcome levels of health in chronic disease were proposed
in the model: (a) biological/physiological variables, (b) symptoms status, (c) functional status,
(d) general health perceptions, and (e) overall quality of life (Wilson & Cleary, 1995). The
authors proposed that these health outcomes could be linearly or reciprocally related to each
5

other, and may be influenced by the individual and environmental characteristics of the person
living with a chronic disease (Wilson & Cleary, 1995).
In 2005 Ferrans, Zerwic, Wilbur, and Larson revised the Wilson Cleary Model (Wilson &
Cleary, 1995) to explicate the conceptual definitions of individual and environmental
characteristics and theoretically ground their relationships with each of the five health outcome
levels of the model. Ferrans et al. (2005) asserted that the characteristics of individuals and their
environment were significant and influenced all the health outcomes within the model. See
Figure 1. In addition, the authors expanded the definitions of each of the health outcome levels,
providing real-life examples of the outcomes and their relationships with other factors in the
model in the context of nursing care situations. Their primary goal of the revision was to increase
utility of this comprehensive health outcome model for guiding nursing research in chronic
disease (Ferrans et al., 2005). Both versions of the model have been widely utilized in COPD
health outcomes research, including examinations of general perceptions of health and overall
quality of life (Guyatt et al., 2007).

6

Figure 1. The Revised Wilson Cleary Model of Health-related Quality of Life. Adapted from
“Conceptual model of health‐related quality of life,” by C.E. Ferrans, J. Zerwic, J. Wilbur, and J.
Larson, 2005, Journal of Nursing Scholarship, 37(4), 336-342. Copyright by C.E. Ferrans.
The Revised Wilson Cleary Model of Overall Quality of Life (Ferrans et al., 2005)
organizes categories of health outcomes in chronic disease on a continuum of increasing
complexity and integration. Though dominant causal associations between individual and
environmental characteristics and the continuum of health outcomes are proposed, reciprocal,
mediated, or integrated relationships may exist (Ferrans et al., 2005). Consistent with Wilson and
Cleary (1995), Ferrans et al. (2005) assert that the model is intended to be fluid enough for
guiding health outcomes inquiry as well as testing relationships among the concepts described in
the model domains.
The Revised Wilson Cleary Model (Ferrans et al., 2005) afforded a fitting frame to
examine potential relationships among patient characteristics, COPD-specific health outcomes,
and patient activation. Patient activation and overall quality of life are modifiable, subjective,
and fluid health outcomes shaped by life circumstances and health status (Ferrans, 1996; Ferrans
et al., 2005; Guyatt, Feeny & Patrick, 1993; Hibbard & Green, 2013; Wilson & Cleary, 1995).
Both concepts have been identified as causal influences, mediators, and predictors of health
behaviors and patient outcomes in COPD (Guyatt et al., 2007; Hibbard et al., 2015; Kaptein et
al., 2014). The levels of patient activation reflect a continuum of developmental capacity to
apply necessary knowledge, skill, and confidence to self-manage one’s health in the setting of
chronic disease (Hibbard & Mahoney, 2010). This is consistent with Wilson and Cleary’s view
that measures of health can be categorized as existing on a continuum of increasing biophysical,
social, and psychological complexity (Wilson & Cleary, 1995).

7

This study adapts the Revised Wilson Cleary Model (Ferrans et al., 2005) to include
patient activation adjacent to overall quality of life on the far right of the model. Wilson and
Cleary (1995) originally depicted quality of life as an end-point in the model because of the
integrative complexity of the concept. Patient activation shares similar integrated
biopsychosocial complexity (Hibbard & Mahoney, 2010). Based on the congruency of these
conceptual descriptions, patient activation was purposefully integrated as an end point in the
model. Figure 2 illustrates the theoretical continuum and adaptation of the model.

Figure 2. Revised Wilson Cleary Model of Health-relate Quality of Life Adapted to Include
Patient Activation. Adapted from “Conceptual model of health‐related quality of life,” by C.E.
Ferrans, J. Zerwic, J. Wilbur, and J. Larson, 2005, Journal of Nursing Scholarship, 37(4), 336342. Copyright by C.E. Ferrans. Model adapted with permission from C.E. Ferrans.
An additional adaptation of the model was a change in the visual representation of the
relationships among the health outcome domains. The model provided a framework for
examination and description of relationships among relevant individual, environmental, and
health outcome factors and patient activation, not testing of the model for fit. Thus, the
directionality of the lines was kept consistent with the original model, reflecting the proposed
8

unidirectional flow of health outcomes toward the end points of overall quality of life and patient
activation. Unlike the original model, the lines were depicted in a dotted format, representing a
tentative relationship, to be explored in the aims of this study. The visual change is congruent
with Ferrans et al. (2005) and Wilson and Cleary (1995), whose research reveals it is conceivable
and probable that any arrow between the health outcomes could point in an opposite direction or
both directions, reflecting the complexity of interactions between and among them.
Purpose Statement
The purpose of this study was to describe and examine the relationships among patient
characteristics and health outcome factors, as conceptualized in the Revised Wilson Cleary
Model (Ferrans et al., 2005) as determinants of patient activation in adults with COPD.
Specific Aims and Research Questions
The specific aims and research questions that guided this cross-sectional, quantitative
study include:
1. Describe the patient characteristics (individual and environmental), health outcome factors
(biological function, symptoms, functional status, general perception of health, and overall
quality of life), and patient activation experienced by a cross-sectional sample of adults in the
United States with COPD.
Q1. What are the patient characteristics of the sample?
Q2. What are the health outcome factors experienced by the sample?
Q3. What is the patient activation level of the sample?
2. Examine the unadjusted associations that patient characteristics and health outcome factors
have with patient activation in the sample.
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Q4. What are the presence, strength, and direction of the relationships among the patient
characteristics, health outcome factors, and patient activation level in the sample?
3. Identify the independent predictors of patient activation in the sample.
Q5. Which patient characteristics and/or health outcome factors explain the greatest
percentage of the variance in patient activation within the sample?
Definition of Terms
Several key terms were presented in the research questions underpinning this study.
COPD, patient activation, and the domains presented within the Revised Wilson Cleary Model
(Ferrans et al., 2005) are conceptually defined in Table 1 to provide clarity of intent within the
context of this study. Objective measures and empirical tools, congruent conceptually and
operationally with of each of the study variables, are described in greater detail in Chapter III.
Table 1. Definition of Terms.
Term

Definition

Adults with COPD

People with a clinical diagnosis of COPD, chronic bronchitis, or
emphysema. Though chronic asthma of adulthood, bronchiectasis, and
alpha-1 antitrypsin deficiency are also included under the umbrella of
COPD (GOLD, 2018), for the purposes of this study only the initial
three diagnoses were included.

Biological function

The molecular, cellular, and whole organ system processes that support
life (Ferrans et al., 2005). Operationally, biological function is defined
as the measures used to assess and diagnose organ function (Wilson &
Cleary, 1995). For this study, severity of COPD quantified by
spirometric measure of lung function (forced expiratory volume in one
second, or FEV1), reflected biological function.

Characteristics of
the environment

The social or physical factors influencing health of the individual
within their living setting (Ferrans et al., 2005). Friends, family, and
caregivers represent the interpersonal and social influences of health
within one’s environment. The setting in which one lives, works, and
engages socially also influences health outcomes (Ferrans et al., 2005).
Operationally, three representative variables determine this domain: (a)
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category of residence (rural or urban), (b) marital status (single,
married/committed relationship, separated/divorced, or widowed), and
(c) living status (alone or with others).
Characteristics of
the individual

The demographic, psychological, developmental, and biological factors
that collectively influence health outcomes (Ferrans et al., 2005). For
this study, the characteristics of the individual were determined
through self-report of the following variables: (a) demographic
measures (age, gender, race, ethnicity, formal education, earned
income level, working status), (b) psychological measures (positive
and negative affect as measured by the Positive Affect Negative Affect
Schedule), and (c) biological measures (height and weight to calculate
Body Mass Index).

Determinants

Influencing factors that decisively affect the nature or experience of a
health outcome in chronic disease (Dictionary.com, 2016).
Operationally, a determinant reflected an independent variable
reflecting a significant relationship with the dependent variable through
multivariate regression statistical analysis.

Dyspnea

The perception of labored, uncomfortable breathing (Tel, Bilgic &
Zorlu, 2012). Dyspnea is a medical term synonymous with shortness of
breath.

Fatigue

A multidimensional sensation of tiredness perceived as deterring one’s
capacity to function normally in the setting of COPD (Kapella, Larson,
Patel, Covey & Berry, 2006).

Functional status

A person’s ability to perform tasks in multiple domains reflecting
adequate physical, social, role and emotional capacity (Ferrans et al.,
2005). Functional status is operationalized as the total score of the
Pulmonary Functional Status and Dyspnea Questionnaire-Modified
(Lareau, Meek & Roos, 1998).

General health
perceptions

A person’s subjective perception of overall health status (Ferrans et al.,
2005). Wilson and Cleary (1995) asserted that self-rated health was
synonymous with general health perception, thus the single question
from the Medical Outcomes Study SF-36 (Ware & Sherbourne, 1992)
asking, “How would you rate your health? Excellent, very good, good,
fair, or poor?” was utilized to operationalize this health outcome.

Health outcomes

Umbrella term referring to all patient health outcome levels (Ferrans et
al., 2005) or domains (Wilson & Cleary, 1995) presented in the
Revised Wilson Cleary Model of Overall Quality of Life and the
original Wilson and Cleary Model of Health-related Quality of Life. In
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this study, health outcomes include biological function, symptoms,
functional status, general health perception, and overall quality of life,
as named by Ferrans et al. (2005).
Overall quality of
life

The subjective, multidimensional measure of well being and
satisfaction of one’s life with chronic disease (Ferrans et al., 2005).
For this study overall quality of life was operationalized by the total
score from the Quality of Life Index Pulmonary Version III (Ferrans &
Powers, 1985).

Patient activation

An individual’s belief she or he has an important role to play in their
health, demonstrated through the knowledge, skills, and confidence to
maintain function, respond to health changes, and access appropriate
care for their health needs (Hibbard, et al., 2004). Patient activation
was operationalized by the Patient Activation Measure-13 (Hibbard,
Mahoney, Stockard & Tusler, 2005).

Patient
characteristics

Umbrella term referring to both the characteristics of the individual and
characteristics of the environment, as presented in the Revised Wilson
Cleary Model of Overall Quality of Life (Ferrans et al., 2005) and the
original Wilson and Cleary Model of Health-related Quality of Life
(Wilson &Cleary, 1995).

Self-management

The medical, emotional, and role management tasks or behaviors to
manage health and maintain wellness in the setting of chronic disease
(Grady & Gough, 2014; Lorig & Holman, 2003).

Symptoms

Person’s perception of an abnormal physical, emotional, or cognitive
state (Ferrans et al., 2005). Dyspnea and fatigue are the key physical
symptoms relevant to COPD. Dyspnea was operationalized by the
Dyspnea component subscale from the Pulmonary Functional Status
and Dyspnea Questionnaire-Modified (Lareau, Meek & Roos, 1998).
Fatigue was operationalized by the Fatigue component subscale from
the Pulmonary Functional Status and Dyspnea Questionnaire-Modified
(Lareau, et al., 1998).

Significance
Within chronic disease and self-management science, patient activation has emerged as
an integral concept in providing patient-centered, individualized care (Bos-Touwen et al., 2015).
This descriptive correlational study expands the limited scientific knowledge of determinants of
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patient activation of adults living with COPD in the United States. The identified determinants of
patient activation from this study will: (a) inform the nursing care of adults with COPD, (b)
expand the knowledge of patient characteristics associated with capacity to engage in necessary
self-management behaviors central to COPD care outcomes, and (c) contribute objective targets
to apply toward novel intervention design for future COPD self-management research.
The use of theory to guide research has been a long-standing tradition in the advancement
of nursing science (Alligood, 2011). Existing conceptual frameworks from nursing, social
sciences, or medicine may provide guidance for the exploration and interpretation of emerging
health concepts impacting health and wellbeing (Tappen, 2016). In this study, a widely used biobehavioral model from the social sciences was used to examine a new health outcome concept
originally explicated by health economists, with significant relevance to nursing science. Thus,
this study demonstrates the importance of sharing among scientific disciplines to expand health
knowledge (Waltz, Strickland, & Lenz, 2010). The application of a conceptual model of patient
outcomes in chronic disease organized the study of predominant health, individual, and
environmental factors, influencing patient activation in this population.
Nurse scientists have been early adopters of patient activation as both a predictor and
core outcome measure in chronic disease and self-management research (Hibbard et al., 2015;
Moore et al., 2016). Patient activation is a complex, yet modifiable, health behavior that directly
reflects self-management efficacy and capacity (Hibbard & Mahoney, 2010). Thus, the
determinants that influence patient activation development must be understood just as clearly as
the self-management outcomes the concept predicts. Therefore, this study contributes to the
National Institute of Nursing Research’s strategic research priority to define the mechanisms of
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complex health behaviors that underlie self-management efficacy in chronic illness (Grady &
Gough, 2014).
The findings from this study have important implications for nursing practice, research,
education, and policy. First, for nurses in direct care roles, understanding what patient activation
is and how disease and personal factors influence it will have meaningful impact on the
assessment, care planning, and educational resources provided to patients and families affected
by COPD. Knowledge of the personal and health factors associated with low activation will help
nurses to identify those patients at greatest risk for limited self-management capacity and engage
them in appropriate care coordination services (Hibbard & Greene, 2013; Naylor, Hirschman,
O’Connor, Barg & Pauly, 2013). Second, identification of the determinants of patient activation
addresses a gap in knowledge related to patient characteristics necessary for self-management.
This research has the potential to advance self-management science research in COPD. Third,
understanding the relationships among health outcome factors and patient activation will
enhance academic nursing education relative to chronic disease and self-management. Fourth,
this study further supports current health policy effort focused on patient engagement in self-care
when diagnosed with COPD to decrease the demand for health care resources by this high
healthcare utilization group (Evans & Morgan, 2014; Hibbard, Greene, Sacks, Overton &
Parrotta, 2016).
Delimitations
The following delimitations provided the boundaries in which this study was conducted.
•

The domains of the Revised Wilson Cleary Model (Ferrans et al., 2005) framed the
selection of variables to examine as potential determinants of patient activation level in
the study population. The domains were validated and specific variable measures
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identified from the empirical self-management literature examining people living with
from COPD, and published examinations of determinants of patient activation.
•

Patient activation has been linked to and overlapped conceptually with other behavioral
characteristics in the literature, such as self-efficacy, patient empowerment, and patient
engagement (Fumagalli, Radaelli, Littieri, Bertele & Masella, 2015). For this study, the
conceptual definition and singular tool to assess the concept developed by Hibbard,
Stockard et al. (2004) and Hibbard, Mahoney et al. (2005) was used to define the scope
of meaning. See Table 1 Definition of Terms in this chapter and Measurement Tools in
Chapter III.

•

This study includes adults who were diagnosed with COPD, chronic bronchitis, and/or
emphysema. Adults with chronic asthma, bronchiectasis, and alpha 1 anti-trypsin
deficiency were not included in the sample, as the causes, trajectory, and treatment plans
of these obstructive, chronic lung diseases differ from those of chronic bronchitis and
emphysema (GOLD, 2018). Chronic bronchitis and emphysema constitute the majority
of COPD diagnoses in the United States (CDC, 2017).

•

To achieve a sample reflective of people with COPD in the United States, the study
sample was drawn from the electronic medical records of a large, national healthcare
organization.

•

Because of the nature of the survey study design, the ability to write and read the English
language was required for participation.

•

As most people were at least 40 years of age when breathing symptoms associated with
COPD emerged (ALA, 2017), the age of 40 years established the lower threshold for
inclusion in the study. No upper limit of age was set for eligibility to participate in the
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study. COPD is a chronic, incurable pulmonary condition; thus, people will live with the
disease for the remainder of their lives.
•

The comprehensive survey tool provided to study participants was comprised of
demographic questions and validated, health outcome measures with high reliability in
the COPD population. Further detail of the survey tool is provided in Measurement
within Chapter III.

•

Data was included for analysis from completed survey tools returned from study
participants who provided informed consent.

•

The Dillman Total Design Method (Dillman, Smyth & Christian, 2014) of survey
research provided the procedure for participant recruitment, survey distribution, and data
collection. Data collection took eight weeks from the time of initial study mailing to
completion of survey collection. The procedure and methodology of this approach is
described in Chapter III.
Assumptions
Assumptions from the extant theoretical and research literature underpinned the

methods used in this study. First, quality of life and patient activation are complex,
multidimensional health constructs that are impacted by health status and unique life
circumstances. Second, unobservable health outcome constructs, such as patient activation,
functional status, and quality of life, can be objectively measured and understood through use of
survey tools and statistical analysis. Finally, study participants were truthful in their self-reported
responses to the questions posed in the study survey tool, which comprised the primary data
source for this research.
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Organization of Remaining Dissertation Chapters
The study is organized into five chapters and associated appendices and references.
Chapter I presents an introduction to the research problem, study purpose, research questions
guided by a conceptual framework, and the significance of this work to the field of nursing.
Chapter II provides a comprehensive review of the theoretical and empirical research literature
related to self-management of COPD and patient activation. Chapter III offers a detailed
description of the study design and methodology implemented for this study along with a
description of the statistical analysis to be conducted. The analysis of the data is detailed in
Chapter IV. Finally, Chapter V provides a discussion of the results, conclusions, and
recommendations for nursing practice, education, and research.
Summary
Patient activation is an emerging construct predictive of health outcomes in chronic
disease (Hibbard & Green, 2014). The personal characteristics and health outcomes that
influence the development and maintenance of patient activation in the setting of chronic disease,
and specifically COPD, are minimally understood. Adequate patient activation is vital for an
individual to self-manage (Hibbard et al., 2015), thus understanding patient activation
determinants is imperative for optimal planning and implementation of self-management
interventions for people living with chronic disease (Grady & Gough, 2014). Knowledge gained
from this quantitative study may expand the limited scientific knowledge of determinants of
patient activation in people living with COPD in the United States. Furthermore, this knowledge
may directly contribute to clinical care of people with COPD through informed and
individualized treatment decision-making by clinicians, nurses, and pulmonary rehabilitation
professionals.
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CHAPTER II
REVIEW OF LITERATURE
This chapter presents a review of the literature describing the state of the science of selfmanagement in chronic obstructive pulmonary disease (COPD) and patient activation. The
review discusses previous research relative to the significance of patient activation on selfmanagement and health outcomes in chronic disease. Additionally, associations among known
factors influencing outcomes in COPD and patient activation are identified and organized within
the domains of the guiding conceptual model. Lastly, gaps in the empirical and theoretical
literature are presented with discussion of how this study was designed to address them.
As introduced in the previous chapter, the objective of this study is to describe and
examine the relationships among patient characteristics and health outcome factors, as
conceptualized in the Revised Wilson Cleary Model (Ferrans et al., 2005), and to identify the
determinants of patient activation among adults living with COPD. The specific aims of this
descriptive correlational study are to:
1. Describe the patient characteristics (individual and environmental), health outcome
factors (biological function, symptoms, functional status, general perception of health,
and overall quality of life), and patient activation experienced by a cross-sectional sample
of adults with COPD living in the United States.
2. Examine the unadjusted associations that patient characteristics and health outcome
factors have with patient activation in the sample.
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3. Identify the independent predictors of patient activation in the sample.
Search Process
The literature reviewed was identified through several databases, including Cumulative
Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, ProQuest, PubMed,
PsycINFO, and Scopus. Key search terms included chronic obstructive pulmonary disease (or
chronic lung disease), self-care (or self-management), symptoms, functional status, general
perception of health, health-related quality of life, and patient-reported outcomes. The search
timeframe was limited to 2006-2016, though earlier landmark works related to self-management
were included.
Key terms to identify literature-examining determinants of patient activation included
patient activation (or Patient Activation Measure), determinants, correlates, and predictors. The
terms were also combined with chronic disease and chronic obstructive pulmonary disease.
Papers were included if the mean age of the study sample was 40 years of age or older,
congruent with the typical age in which symptoms of COPD were present and diagnoses were
made (ALA, 2017), and the identified sample had at least one or more chronic diseases. The
literature search was framed between 2004-2018, to include the seminal paper introducing the
Patient Activation Measure (PAM) by Hibbard et al. (2004). Patient activation is frequently used
interchangeably in the literature with other terms, such as patient engagement and selfmanagement capacity (Fumagalli et al., 2015), so care was taken to include only literature that
provided a definition of patient activation consistent with that of Hibbard et al. (2004).
Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease with no
known cure (ALA, 2017). Beyond causing significant debility and requiring frequent health care
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utilization (Celli et al., 2015), COPD causes considerable mortality as the third leading cause of
preventable death in the United States (ALA, 2017; CDC, 2017). The goals of COPD treatment
are to slow lung function decline, limit symptom impact, prevent exacerbations, improve
exercise tolerance, maintain function, and improve overall quality of life (Qaseem et al., 2011).
Treatment of COPD consists largely of medications and behavior change support (GOLD, 2018).
Multiagent medication regimens are prescribed based on the individual’s symptom profile,
exacerbation history, and severity of airway obstruction (Balkissoon, Lommatzsch, Carolan &
Make, 2011; Mannino et al, 2014). Lifestyle and behavior changes target maintaining pulmonary
function and limiting disease progression through avoidance of airway irritants (primarily
smoking cessation), prompt response to symptom change and physical activity (GOLD, 2018;
Rice, Bourbeau, MacDonald & Wilt, 2014). Primary care providers, pulmonologists, and
pulmonary rehabilitation providers direct COPD treatment, though nurses provide most of the
hands-on education, counseling, and support to patients (Park & Larson, 2016).
State of the Self-Management Science in COPD
Evidence suggests self-management is significantly associated with reduced hospital
admissions, improved shortness of breath, and improving quality of life in people living with
COPD (Andenaes et al., 2014; Trappenburg et al., 2013; Zwerink et al., 2014). Self-management
behaviors associated with optimal health outcomes in COPD include daily monitoring and
response to symptoms, smoking cessation, adherence to the medication regimen, engagement in
physical activity, monitoring of mood, and maintenance of relationships (Balkissoon, 2016;
Effing et al., 2016; Nici et al., 2014; Rice et al., 2014). People with COPD have complex medical
and emotional needs, making self-management particularly challenging. Thus, collaboration
among all members of the COPD care team, including providers, patients, and their families, is
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necessary for successful self-management and achieving shared goals of care (Rice et al., 2014).
The “team-based” approach to self-management, known as collaborative self-management
(Bourbeau & van der Palen, 2009) is integral to the multicomponent care approach for COPD
(Halding & Grov, 2017). Interventions to improve engagement in self-management by those with
COPD have been a research priority in the past decade, reflected in the qualitative and
quantitative literature (Effing et al., 2016; Jonkman et al., 2016).
Systematic reviews and meta-analyses. Five systematic reviews and meta-analyses
were analyzed in this literature review. Most revealed positive effects of collaborative selfmanagement interventions on dyspnea control, decreased healthcare utilization (hospital
admissions and total hospital days for respiratory causes), and improved perception of health
(Harrison, Janaudis-Ferreira, Brooks, Desveaux & Goldstein, 2015; Jonkman et al., 2016; Kruis
et al., 2013). However, authors found it difficult to draw any tangible conclusions for clinical
practice from the randomized control trials examined (Harrison et al., 2015; Jonkman et al.,
2016; Kruis et al., 2013; Zwerink et al., 2014). The same authors reported high heterogeneity
within the self-management interventions delivered and among the outcome measures. These
factors and inadequate statistical power prevented pooling of data for analysis to determine the
most effective approaches for collaborative self-management of COPD (Harrison et al., 2015;
Jonkman et al., 2016; Kruis et al., 2013; Zwerink et al., 2014). Furthermore, the authors
concluded that insufficient evidence existed to explain the characteristics of responders from
non-responders across studies reviewed (Zwerink et al., 2014; Kruis et al., 2013). Authors called
for greater description of the characteristics of study participants to identify factors associated
with likelihood of response to treatment (Harrison et al., 2015; Jonkman et al., 2016; Kruis et al.,
2013).
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Randomized control intervention trials. Numerous randomized control trials of
collaborative self-management interventions have been conducted. Unfortunately, health
outcome results have been highly variable (Benzo et al., 2012; Bucknall et al., 2012; Rice et al.,
2010; Titova et al., 2017), including adverse events (Fan et al., 2012). As discussed in the
published meta-analyses and systematic reviews, randomized control trials have been
inconclusive in identifying and validating effective means to affect self-management behaviors
necessary to improve COPD health outcomes (Bucknall et al., 2012; Fan et al., 2012). However,
some were successful in improving health outcomes that matter most to patients, namely dyspnea
control, mastery of the disease, and quality of life (Benzo et al., 2012, Rice et al., 2010).
Unfortunately, these studies were viewed as negative because they did not achieve their primary
aims of improved exercise capacity or decreased all-cause mortality. While no single cause of
negative results or adverse events were identified, authors of some of the studies posited that
some participants with COPD might simply not have been capable to self-manage (Bucknall et
al., 2012; Fan et al., 2012). The mixed results of these studies may suggest that the
heterogeneous, complex nature of COPD might undermine any intervention that is not
effectively tailored to the capabilities of the individual.
Self-management engagement. Several qualitative studies have examined the factors
people with COPD attribute to their engagement in self-management behaviors (Benzo,
Wetzstein, Neuenfeldt & McEvoy, 2015; Chen, Chen, Lee, Cho & Weng, 2008; Disler et al.,
2012; Sohanpal, Seale & Taylor, 2012). Less than one-half of people with COPD engage in the
recommended self-management practices (Bender, 2014; Nici et al., 2014). Those who do selfmanage prioritize what they do based upon the most significant burdens the disease places on
them at any given time (Bender, 2014; Bischoff et al., 2012; Bucknall et al., 2012).
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Chen et al. (2008) conducted a qualitative study to describe the self-management
behaviors people with COPD found most important to integrate into their daily lives. In their
sample the self-management behaviors that carried the most meaning were symptom
management (primarily dyspnea and fatigue), being physically active to support regular daily
activities, making healthy lifestyle choices (e.g., smoking cessation, good nutrition), keeping
emotions in check, and controlling their environment (avoiding cold). Sohanpal et al. (2012)
sought to understand the reasons people with COPD either regularly attended or skipped
collaborative self-management programs. They found that people who were more motivated and
had prior COPD knowledge were most engaged in attending group-based, peer led programs.
Participants acknowledged that programs tailored to their strengths and supported their
capabilities kept them wanting to come back and be engaged (Sohanpal et al., 2012). This view
from the participants is not surprising, as individualized strengths-based approaches to selfmanagement optimize an individual’s patient activation level for self-care (Hibbard & Greene,
2014). When people are offered self-management education and support matched to their current
capabilities they are more likely to be adherent to recommended self-management behaviors
(Jonkman et al., 2016).
Sohanpal et al. (2012) found feeling too ill was the primary deterrent for patients to
attend self-management programs following hospitalization for COPD exacerbations.
Alternatively, people who felt too well following hospital discharge indicated their quick
recovery as a motivational barrier to attendance. Other barriers included logistical factors
(distance and travel challenges), physical limitations (weakness and portable oxygen burden),
and emotional struggles (Sohanpal et al., 2012). In 2015 Benzo et al. found similar barriers to
participation in post-COPD exacerbation self-management programming. Thematic coding
23

revealed prevailing factors patients provided for not wanting to attend a pulmonary rehabilitation
program, such as lack of interest, feeling too ill or frail, being “too busy” to attend, travel
difficulties, and lack of social support (Benzo et al., 2015). These qualitative studies illuminated
the diverse challenges to self-management engagement perceived by people living with the
disease. The breadth of barriers is congruent with the multifactorial, holistic impact of COPD
(Jerant, van Friederichs-Fitzwater & Moore, 2005). Unfortunately, this heterogeneity prevents
identification of tangible intervention targets to circumvent lack of self-management engagement
by people with COPD (Kaptein et al., 2014). However, the results of these studies speak to the
need of examining factors that contribute to engagement and activation to self-manage in a
conceptually organized manner to achieve understanding of the findings for practice and research
advancement.
Self-management in COPD. Over the past two decades systematic reviews and metaanalyses provided a lens to view the large literature base of self-management science in COPD.
Self-management is integral to the treatment of COPD and successful engagement is associated
with better function and quality of life of those with the disease. The high heterogeneity found in
COPD self-management trial intervention designs, outcomes measured, and study results
undermine the ability to draw conclusions and establish an evidence base for practice (GOLD,
2018; Nici et al., 2014; Rice et al., 2014). However, it is important to acknowledge that the selfmanagement interventions studied were necessarily multicomponent to address the
multidimensional approach required to treat COPD. Moreover, the heterogeneity of outcomes
chosen to measure intervention effectiveness is a common problem in self-management science
(Grady & Daley, 2014), not just in COPD research.
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The state of the science reflects poor understanding of the unique patient characteristics
associated with self-management success and risk for failure (Nici et al., 2014; Titova et al.,
2017). What is known from review of the literature is passive education to acquire disease
knowledge and action plans for self-treatment of exacerbations are not sufficient to support
COPD patients to self-manage (Bodenheimer, Lorig, Holman & Grumbach, 2002; Jonkman et
al., 2016; Kaptein et al., 2014; Trappenburg et al., 2013). Collaborative self-management plans
must be designed to engage people at a level appropriate to their functional, psychosocial, and
cognitive/behavioral capability (Grady & Gough, 2014). Active, individualized interventions that
include bio-physiological management and the role of cognition and emotions are needed
(Kaptein et al., 2014). Some authors concluded that cognitive-behavioral influences might be at
the heart of self-management capacity for those with COPD (Kaptein et al., 2014; Korpershoek
et al., 2016). Thus, studies that examine behavioral constructs associated with self-management
capacity, such as engagement, motivation, and patient activation, are needed to advance patientcentered COPD self-management interventions (Korpershoek et al., 2016). Recently, patient
activation was included as an outcome measure in a COPD self-management intervention trial
(Titova et al., 2017). Adoption of patient activation as a core outcome measure in this population
has yet to be reported in the COPD literature.
Patient Activation
Patient activation emerged as a conceptual focus of health care consumerism and
engagement research to examine factors influencing self-management outcomes in the growing
population of people with chronic diseases (Hibbard et al., 2016). In 2004 Hibbard, Stockard,
Mahoney, and Tusler examined the concept of patient activation using the Delphi technique to
establish an operational definition and create a psychometrically sound measure patient
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activation for use in clinical and research settings. The authors credit theoretical influences from
Bandura’s (1991) social cognitive theory, Di Clemente et al.’s (1991) Transtheoretical Model of
Change, and Wallston, Stein and Smith’s (1994) health locus of control as shaping the item pool
used in their Delphi approach. They conceptualized and operationalized an individual’s capacity
to engage in self-care behaviors in chronic disease as patient activation. Patient activation is
defined as a measure of self-management capacity, reflecting the skills, knowledge, and
confidence to actively engage as a self-manager (Hibbard et al., 2004).
Though Hibbard’s (2004) work is considered seminal in introducing the concept of
patient activation in the chronic disease literature, the term first appeared in 1982. Morisky,
Bowler, and Finlay (1982) described increased patient activation, subsumed as being comprised
of locus of control, knowledge, and compliance, as the outcome of a cognitive-behavioral
intervention to increase patient engagement in hypertension self-management activities. Though
pre-dating Hibbard et al. (2004), Morisky et al.’s (1982) description of patient activation quite
similarly includes knowledge, skills—demonstrated by compliance to carry out actions to
manage and confidence to take control over their disease management. Interestingly, Hibbard et
al., (2004) did not include Morisky et al.’s (1982) work as a reference in their paper. The term
appears again in 1998 in Wagner’s Chronic Care Model (Wagner, 1998). Here, the informed
activated patient is an integral element of the coordinated process of delivering chronic disease
care to achieve optimal health outcomes (Wagner, 1998).
Since the inception of the first 22-item Patient Activation Measure in 2004, more than
200 peer-reviewed research papers have been published examining patient activation as: (a) a
valid assessment tool for self-management capacity; (b) a framework for designing and
implementing behavioral change interventions for adoption of self-management behaviors; and,
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(c) a valid and reliable outcome measure and predictor of health outcomes across multiple
chronic conditions, age, and sociodemographic groups (Hibbard et al., 2015; Moore et al., 2016;
Skolasky et al., 2011). The growing evidence base suggests that people with higher patient
activation levels have better health outcomes in the context of chronic illness; however, the
factors that determine or mediate patient activation within individuals are still relatively
unknown (Hibbard et al 2015; Schmaderer, Zimmerman, Hertzog, Pozehl & Paulman, 2016).
Patient activation and self-management. Several relationships exist among selfmanagement behaviors by people with chronic disease and patient activation. Symptom
monitoring and medication adherence were associated with higher patient activation (Dixon et
al., 2009; Graffingna et al., 2017; Hibbard & Tusler, 2007). Maintaining a healthy weight,
following exercise regimens, and attending healthcare appointments were also associated with
higher patient activation (Bolen et al, 2014; Hibbard et al., 2007; Wong, Peterson, & Black,
2011).
Four studies discussed self-management activities related to chronic lung diseases and
patient activation. Hibbard and Tusler (2007) explored adult asthma, self-management behaviors,
and relationships among these with patient activation. They found that knowledge of how to
respond to an asthma attack and use of stress management skills in the setting of symptom
change were significantly related to higher patient activation levels in their sample. Two studies
in this review found the degree of medication adherence to control shortness of breath and
wheezing was directly related to patient activation levels (Mosen et al., 2007; Skolasky et al.,
2010). Among a cohort of working adults with COPD, Fowles et al. (2009) identified a strong
association between patient activation level and reported self-management activities focused on
maintaining physical and role functions.
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Intervention studies have emerged examining the effects self-management support
programs tailored to the level of patient activation on chronic disease health outcomes. Selfmanagement studies utilizing patient activation-tailored interventions in heart failure, diabetes,
and multimorbidity found statistically significant improvements in patient activation level,
engagement in self-management behaviors, and health outcomes (Bolen et al., 2014; Deen, Lu,
Rothstein, Santana & Gold, 2010; Hibbard et al., 2007; Hibbard, Greene & Tusler, 2009;
Ryvicker, Feldman, Chiu & Gerber, 2013; Shively et al., 2013; Van Do, Young, Barnason &
Tran, 2015). The utility of patient activation in these studies was demonstrated two-fold. First,
interventions were tailored to the current patient activation level of the participants. A step-wise
approach to delivering the intervention aimed to build confidence in patients to self-manage was
consistent with the theoretical influences underpinning the conceptual definition of patient
activation (Shively et al., 2013). Second, the sensitivity of the PAM allowed for determining
correlations among patient activation change and health outcome change in the samples studied.
Most patient activation-tailored intervention studies showed positive relationships among selfmanagement interventions and improved outcomes—health and patient activation level (Deen et
al., 2010; Hibbard et al., 2009; Shively et al., 2013), but others showed no change in patient
outcomes (Bolen et al., 2014; Ryvicker et al., 2013; Titova et al., 2017).
The mixed findings of patient activation-tailored self-management trials are congruent
with the crux seen in the COPD self-management intervention literature. It is unclear why some
patient activation-tailored self-management interventions were not effective in changing
behavior. Knowledge that patient activation level is modifiable (Hibbard & Greene, 2013) and
responsive to strengths-based approaches to self-management support (Hibbard & Mahoney,
2010), suggests that complex and multidimensional factors are at play in the development of
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patient activation within people who have chronic disease. Interest in understanding the
complexity underpinning patient activation development in individuals has led to several studies
examining the determinants of patient activation level in people with chronic diseases.
Determinants of Patient Activation in Chronic Disease
Examining the impact of demographic, psychosocial, and disease-specific factors
influencing the development of patient activation among people with chronic disease has become
a recent focus of nursing inquiry. Several studies have examined a variety of patient-centered
factors as correlating to or predictors of patient activation level (Bos-Touwen et al., 2015; Chen,
Chen, Lee, Cho & Weng, 2014; Chubak et al., 2012; Goodworth et al., 2014; Korpershoek et al.,
2016; Mazanec, Sattar, Delaney & Daly, 2016; Schmaderer et al., 2016). Secondary goals of
these studies were to understand the potential risk factors for limited self-management capacity
and, thus, illuminate modifiable targets for individualized approaches to self-management
interventions.
Some studies identified a theoretical framework as underpinning variable choice, study
design, or framing the results (Chen et al., 2014; Chubak et al., 2012; Goodworth et al., 2014).
The Andersen Behavioral Model (Chen et al., 2014) and Chronic Care Model (Chubak et al.,
2012) have healthcare delivery systems and environments at their core. Thus, the studies were
limited to examining environmental factors influencing patient activation level, not including the
impact of chronic disease on individuals. Similarly, the internal, cognitive processes of SelfEfficacy Theory limited the study of determinants by Goodworth et al. (2012) to inclusion of
individual characteristics and disease-specific health outcomes. Other studies examined variables
found to be relevant to health outcomes in the disease-specific literature of their populations of
interest in lieu of using a guiding model or framework (Bos-Touwen et al., 2015; Korpershoek et
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al., 2016; Mazanec et al., 2016; Schmaderer et al., 2016). Both approaches to the study of
determinants of patient activation yielded a diverse array of variables for examination.
Disease-specific determinants. Determinants of patient activation within specific
chronic diseases have been studied. Chen and colleagues (2014) examined a national sample of
people with depression to identify contextual factors associated with mental healthcare
utilization. These factors formed the basis of a framework for explaining determinants of patient
activation level in this population. Through multivariate regression, characteristics of the
environment in which people lived and site of usual health care (local primary care clinic) were
significant in predicting higher levels of patient activation, explaining 15% of the variance in
patient activation scores. Goodworth et al. (2014) based their cross-sectional study of persons
with multiple sclerosis on Bandura’s self-efficacy theory, noting Hibbard and Mahoney’s (2010)
assertion that efficacy is necessary to establish one’s concept as a self-manager in chronic
disease. They examined mood, self-efficacy in multiple sclerosis, quality of life, and
sociodemographic factors through hierarchical regression modeling. Self-efficacy and
educational level were positively related to patient activation level, while depression was
negatively related to patient activation level. These variables explained 35% of the variance in
patient activation level in their sample. O’Malley and colleagues (2017) examined patient
characteristics and clinical factors as determinants of patient activation among prostate and
breast cancer survivors. Results from their cross-sectional survey indicated race, marital and
employment status, income, and ease of access to their healthcare providers were significantly
positively associated with patient activation level among prostate cancer survivors, but only
provider access and time spent with them were positive predictors among breast cancer
survivors. Associations among patient characteristics and patient activation were identified by
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analysis of variance, however, the assertions of these factors as predictors of patient activation
are unsubstantiated by the lack of linear regression used in the statistical analysis.
In these studies the variables examined and shown to predict patient activation among
community-dwelling adults are congruent with Ferrans et al.’s (2005) definitions of
characteristics of the individual and the environment and their assertion that these characteristics
can directly influence health outcomes in chronic disease. Thus, these disease-specific studies
suggest that characteristics of the individual (Goodworth et al., 2014; O’Malley et al., 2017) and
their environment (Chen et. al., 2014; O’Malley et al., 2017) are important factors to consider in
examining determinants of patient activation among people with COPD.
Disease transcending determinants. Other studies used cross-sectional design to
investigate disease-transcending determinants of patient activation across multiple chronic
conditions (Bos-Touwen et al., 2015; Schmaderer et al., 2016). Bos-Touwen et al. (2015)
examined 19 clinical, demographic, and psychosocial determinants of activation in a crosssectional survey study of patients with chronic renal, heart, pulmonary, or endocrine diseases.
Through multivariate regression analyses, the authors found that disease severity, health-illness
perceptions, mood, social support, sociodemographic factors, and co-morbidity impact explained
16% of the variance in activation levels across chronic disease sub-groups (Bos-Touwen et al.,
2015). Schmaderer et al. (2016) explored demographic, psychosocial, and clinical factors as
determinants of patient activation level among people with multimorbidity. The authors included
commonly used patient-reported outcomes tools (i.e., PACIC, PROMIS-29, EuroQOL 5) to
survey patients just prior to discharge for hospitalizations resulting from exacerbation of one of
more chronic conditions. Multivariate regression yielded three factors explaining 26% of the
variance in patient activation scores in the sample. These factors were health literacy, satisfaction
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with one’s social role, and level of involvement in chronic illness care team (Schmaderer et al.,
2016). These two studies examined highly heterogeneous factors across multiple disease states as
possible determinants influencing patient activation in chronic disease. The independent
variables examined in these studies aligned with each of the domains described in the Revised
Wilson Cleary Model (Ferrans et al., 2005), adapted to guide this study. Interestingly, the
predictors identified were reflected in each of the domains of the Revised Wilson Cleary Model
(Ferrans et al., 2005), except symptoms and overall quality of life. The results offer that complex
and highly integrated factors influence patient activation level among people living with
multimorbidity. The disease-transcending determinants of patient activation were relevant to the
design of this study, as most people with COPD have at least two other co-morbid chronic
conditions (Benzo et al., 2010; Celli et al., 2015).
Longitudinal studies of determinants. Building on the frequently used, cross-sectional
approach, longitudinal studies were conducted to examine disease-transcending determinants of
patient activation. Chubak et al., (2012) followed older adults with diabetes and heart disease
over one year as part of an integrated health delivery system. Self-rated health, serious adverse
events from chronic disease (e.g., ED visits, hospitalizations), satisfaction with chronic disease
care, patient activation, and measures of disease impact was collected via a survey during
Medicare enrollment visits. Though many of the variables were correlated, only older age and
worse self-rated health (i.e., Fair or Poor) were independent predictors of decreased patient
activation level from baseline to one year (Chubak et al., 2012). Hibbard et al. (2015) published a
report examining patient activation level as a predictor of health outcomes over time. Participants
were reexamined four years after first response to a national panel survey of people with diverse
chronic conditions, and the authors found that consistent self-management practices, increased
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function, and decreased costly health care use were enduring outcomes of high patient activation
at baseline (Hibbard et al., 2015). When patient activation changed over the four-year period, it
did so with health outcomes moving in the same direction (e.g., activation increased, positive
outcomes occurred; activation decreased, negative outcomes occurred). Congruent with Chubak
et al.’s (2012) findings, older age and poorer general perception of health were strongly
associated with lower patient activation scores (Hibbard et al., 2015). Recently, Mazanec and
colleagues (2016) studied relationships among symptoms, mood, physical and role function, and
patient activation before and four months after surgery among colorectal cancer survivors.
Interestingly, they found patient activation to be high (Level 3) and stable across time in this
population. In linear mixed effects models, negative emotions were significantly associated with
low patient activation (Levels 1 and 2) across all time points. Their finding is congruent with
Hibbard and Mahoney’s (2010) cross-sectional study that indicated patient activation is strongly
linked to the experience of positive and negative emotion in daily life. All the identified
predictors of patient activation that endure over time among people with chronic conditions align
with domains of the Revised Wilson Cleary Model (Ferrans et al., 2005), further supporting the
use of the model in the current study.
State of the Science for Determinants of Patient Activation
The growing body of literature described several determinants of patient activation in
the setting of community dwelling adults with one or more chronic diseases. Of these,
demographic and socioeconomic characteristics, mood, role status, social support, perceived
health status, and the impact of one or more chronic disease were shown in one or more studies
to predict patient activation level. This evidence provided further support for using the Revised
Wilson Cleary Model to study determinants of patient activation among adults with COPD in
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this dissertation research. Though correlations could not be drawn across the studies, as each
examined different variables of interest, age, general perception of health, negative mood states,
and socioeconomic status appeared most frequent as determinants in multiple studies. Therefore,
inclusion of these factors was imperative in the study of patient activation predictors in the
setting of COPD.
Patient Activation and COPD
Little is known about how the complex, systemic nature of COPD affects patient
activation (Evans & Morgan, 2014; Korpershoek, 2015). Although patient activation can be
objectively measured with the PAM (2004), it is not typically assessed in COPD clinical visits
(Korpershoek et al., 2016). Evidence of patient activation as a predictor of chronic disease
outcomes is particularly relevant in the domain of COPD care. COPD is a resource-intensive
disease process, imparting high self-care burden on patients and costly health care utilization
(Celli et al., 2015). Health care utilization rates, including 30-day hospital readmission, and
health care costs of people with COPD are approximately twice that of healthy age and sexmatched controls (Green et al., 2015; Mitchell et al., 2014; Roberts et al., 2000). Selfmanagement has been associated with decreased incidence of hospitalization for acute
exacerbation of COPD (Zwerink et al., 2014), which is the leading driver of COPD-related costs
worldwide (Dhamane et al., 2015). Adults with higher activation were more likely to participate
in recommended activities associated with collaborative self-management treatment plans for
COPD (Dixon, Hibbard & Tusler, 2009). Charlot and colleagues (2017) found patient activation
mediated the effect of self-management education on hospitalization rates among urban,
Caucasian adults. One standard deviation increase in PAM score was associated with 18%
reduced odds of being hospitalized with a COPD-related diagnosis, supporting patient activation
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as a modifiable target to address readmission rates in this population (Charlot et al., 2017).
Examining how patient activation is influenced in this population is warranted.
Determinants of patient activation in COPD. To date, only one Dutch study explored
determinants of self-management capacity, operationally defined as patient activation, among
people living with COPD. The work by Korpershoek et al. (2016) utilized a cross-sectional
survey design with electronic medical data abstraction to identify COPD-specific determinants of
self-management capacity. The sample (N = 296) included adults with COPD living in the
community and in skilled nursing facilities. Fifteen independent variables were chosen from the
extant COPD literature (Korpershoek et al., 2016), which reflected a diverse examination of
biological, behavioral, and psychosocial factors influencing self-management capacity.
Multivariate logistical regression analyses revealed six determinants explaining 17% of the
variance in self-management capacity; these included anxiety, illness perception, Body Mass
Index, COPD severity, comorbidities, and age (Korpershoek et al., 2016). It is important to note
that Korpershoek’s study cohort was included in the previously described multi-chronic disease
study of Bos-Touwen et al. (2015).
Korpershoek et al.’s (2016) work provides seminal insight to the individual patient
characteristics associated with patient activation among people with COPD. Several of these
predictors were included in the current study. Though Korpershoek et al.’s (2016) sample was
large, inclusion of participants living in skilled care environments who were not independently
responsible for managing their treatment plan raised questions to the meaning of the results. Selfmanagement of chronic disease is a phenomenon of community dwelling persons, not typically
associated with skilled care settings (Bodenheimer et al., 2002; Lorig & Holman, 2003).
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Therefore, this study of determinants of self-management capacity focused on people with
COPD who were independent in their health management.
Outcomes of COPD and Patient Activation Via the Revised Wilson Cleary Model
Patient activation is a multidimensional, patient-reported health outcome in chronic
disease. Though theoretically influenced by several behavioral frameworks (Hibbard et al.,
2004), a conceptual or theoretical framework describing the process of patient activation in
individuals and populations with chronic disease has yet to be reported in the literature. Thus,
adaptation of existing theoretical and conceptual frames would be needed to examine the concept
in the context of specific diseases. The Revised Wilson Cleary Model (Ferrans et al., 2005) is a
descriptive, explanatory framework that categorizes personal and health phenomena and
proposes relationships between and among these phenomena (Tappen, 2016). The model and the
original work by Wilson and Cleary (1995) were described in detail in Chapter I. The existing
evidence of relationships among health outcomes, characteristics of people with COPD, and
shared associations with patient activation, will be organized within the domains of the Revised
Wilson Cleary Model (Ferrans et al., 2005). Further, evidence of the application and adaption of
the conceptual framework in similar empirical research is presented.
Characteristics of the Individual
Characteristics of the individual are the demographic, developmental, psychological, and
biological factors that influence health outcomes in chronic disease (Ferrans et al., 2005). These
characteristics impact all antecedents of quality of life in the Revised Wilson Cleary Model
(Ferrans et al., 2005), and may moderate relationships among the health outcomes as well. In this
study, specific demographic, psychological, and biological factors were selected as important
characteristics of the individual with COPD, which could impact patient activation level.
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Demographic factors. Age is negatively associated with COPD health outcomes
(Croft, et al., 2018) and patient activation level (Dunlay, Griffin, Redfield & Roger, 2017;
Hibbard et al., 2015; Korpershoek et al., 2016). Evidence offers several gender differences in
expression of symptoms, disease progression, and exacerbation trajectories, favoring greater
morbidity and mortality for women with COPD (Balkissoon, 2011; Pruitt, 2014; Jenkins et al.,
2017). Inconsistent relationships between gender and patient activation level have been
identified. Several studies suggested women are more activated than men (Fowles et al., 2009;
Hibbard, Mahoney et al., 2005; Hibbard, Greene et al., 2015; Young et al., 2017), although
Lubetkin, Lu, and Gold (2010) found the opposite to be true. Authors recommended the role of
gender and patient activation should be considered cautiously, as many published patient
activation studies had disproportionately large numbers of women in their samples (Fowles et al.,
2009; Goodworth et al., 2016; Hibbard et al., 2005, 2007, 2015, 2016).
Race and ethnicity associations with health outcomes in COPD are thought to be largely
a component of socioeconomic status (GOLD, 2018; Mannino et al., 2014), as COPD is most
prevalent among white, non-Hispanics in America (Croft et al., 2018; Tilert et al., 2013). Low
socioeconomic status has been associated with limited functional status and poorer lung function,
thus, imposing risk for increased COPD severity and acute exacerbations (Dhamane et al., 2015;
Eisner et al., 2011). Racial and ethnic minorities have demonstrated lower levels of patient
activation than their Caucasian counterparts (Alexander, Hearld, Mittler & Harvey, 2012;
Hibbard et al., 2007; Hibbard & Cunningham, 2008; Lubetkin et al., 2010). Like the health
outcomes in COPD, more recent literature argued that socioeconomic status better explains the
variance in patient activation level among these groups (Hibbard et al., 2015; O’Malley et al.,
2018).
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Educational level (GOLD, 2018; Eisner et al., 2011), increased health literacy,
(Ryvicker et al., 2013; Smith, Curtis, Wardle, von Wagner & Wolf, 2013), and greater selfmanagement engagement (Lorig & Holman, 2003; Trappenburg et al., 2013) were positively
correlated with better health outcomes in COPD and patient activation levels (Bos-Touwen et al.,
2015; Fowles et al., 2009; Hibbard et al., 2007, 2015; Marshall et al., 2013). Limited education
attainment and income were independently related to greater risk of acute COPD exacerbation
when controlling for race and ethnicity (Eisner et al., 2011).
Employment has also been positively correlated with patient activation levels, selfmanagement engagement, and positive health outcomes in COPD (Eisner et al., 2011; Fowles et
al., 2009; Grodner et al., 1996; Smith et al., 2000). Among older adults with COPD, participating
in paid work was associated with greater perception of physical health and quality of life
(Andenæs, Bentsen, Hvinden, Fagermoen & Lerdal, 2014). Earned income, a measure of
socioeconomic status resulting from employment, has been correlated with engagement in health
care activities (e.g. seeing a health care provider, following treatment plans, compliance with
medication regimens) and self-reported health among adults with COPD (Eisner et al., 2011;
Fowles et al., 2009; Steer, Gibson, & Bourke, 2010).
Psychological factors. Positive and negative affect are inextricably linked to comorbid
mood disorders and health outcomes in COPD and patient activation. Anxiety, a negative affect
state (Cohen & Pressman, 2006), can be both comorbidity and symptom of COPD (Yohannes &
Alexopoulos, 2014), directly influencing the symptom of dyspnea (Carrieri-Kohlman et al.,
2010). Clinical depression and depressive symptoms are also associated with negative affect or
mood (Cohen & Pressman, 2006). Comorbid depression and anxiety often appear together in
people with COPD, with prevalence rates as high as 42% (Yohannes & Alexopoulos, 2014).
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Negative affective arousal induces sympathetic responses of increased breathing and heart rate,
exacerbating the sensation of dyspnea and feelings of fear in people with COPD (Cohen &
Rodriguez, 1995). In turn, strong negative emotional responses to dyspnea provoke increased
attention to breathing, inducing further anxiety, and yielding avoidance behaviors. The resulting
vicious negative cycle erodes functional performance (DiNicola, Julian, Gregorich, Blanc &
Katz, 2013; Nguyen, Donesky-Cuenco & Carrieri-Kohlman, 2008) and quality of life among
people with COPD (Carrieri-Kohlman et al., 2010; Norweg & Collins, 2013). Benzo, AbascalBolado and Dulohery (2016) found positive affect, manifested as feelings of optimism and
happiness, to be independently associated with quality of life and mediated the relationship
between self-management ability and quality of life among adults with COPD.
Positive affect has been associated with higher patient activation levels and engagement
in self-management behaviors by people with chronic disease (Charlson et al., 2014; Hibbard &
Mahoney, 2010; Graffigna et al., 2017). Several studies have shown that negative affect states,
such as anxiety and depression, are prevalent among people reporting lower activation scores
(Gerber et al., 2011; Hibbard & Cunningham, 2008; Hibbard & Mahoney, 2010; Smith et al.,
2013). Further, researchers have found that people with negative affect and concomitant low
patient activation scores were more likely to have been hospitalized or visited an emergency
department, than those with positive affect states (Greene & Hibbard, 2012; Hibbard et al.,
2015).
Biological factors. Increased Body Mass Index is a biological factor associated with
negative health outcomes (Eisner et al., 2011; Steer et al., 2010) and decreased patient activation
levels of people with COPD (Korpershoek et al., 2016; Liu et al., 2014). The length of time
people live with a COPD diagnosis is positively correlated with negative health outcomes (Steer
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et al., 2010) and increased COPD-related morbidity (GOLD, 2018). Similarly, the length of time
with chronic disease is associated with fluctuations in patient activation level (Chubak et al.,
2012; Hibbard et al., 2015; Skolasky et al., 2011). The longer people live with COPD, the greater
the incidence of exacerbations, diminished function, and reports of negative quality of life
(Andenæs et al., 2014; Balkissoon, 2016; Benzo et al., 2010). Disease burden and exposure to
care providers, rehabilitation services, and disease-specific education, over time are factors that
may influence patient activation level of people living with COPD (Hibbard et al., 2007).
Characteristics of the Environment
Characteristics of the environment are the social interactions and physical surroundings,
which influence the individual’s perception of quality of life in the context of chronic disease
(Ferrans et al., 2005). Friends, family, and caregivers represent the interpersonal and social
influences of health within one’s environment. The physical setting in which one lives, works,
and engages socially influences health outcomes (Ferrans et al., 2005). Previous studies in COPD
self-management and patient activation proposed that where people live (rural or urban) and
whom they live with (alone or with significant others) are relevant characteristics of the
environment influencing health outcomes.
Limited access to care providers and COPD resources (i.e., pulmonary rehabilitation or
Better Breathers Groups) in rural areas have been implicated as causal factors for increased risk
of COPD exacerbations and exacerbation-related mortality (Croft et al., 2018; NQMC, 2017).
Older adults living in rural settings report low patient activation scores (Young et al., 2017).
Relationships with physicians (Alexander et al., 2012; Wong et al., 2011), satisfaction with
overall chronic disease care (Boyd et al., 2014), and increased access to primary care within the
immediate community (Chen et al., 2014; Lubetkin et al., 2010) are associated with greater
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patient activation levels. These factors were also associated with improved self-management
among people living with COPD and heart failure (Dunlay et al., 2017; Van Do et al., 2015).
Increased patient activation levels and improved health outcomes among older people living in
urban, metropolitan settings were attributed to greater access to health care and less social
isolation (Chen et al., 2014). Others found conflicting results, despite increased concentration of
resources; older chronically ill adults living in inner-city settings also reported lower patient
activation levels (Maranda, Deen, Elshafey, Herrera & Gold, 2014). In contrast, other authors
described limited health care access and isolation as contributing to lower patient activation
scores among older adults living in rural settings (Young et al., 2017).
Marital status and living arrangements are relevant to the social support and health
outcomes of people with COPD and have been associated with patient activation levels. Social
support is positively correlated with maintaining daily physical activity following pulmonary
rehabilitation programing and decreased morbidity and mortality following hospitalization for
exacerbation among adults with COPD (Meshe, Claydon, Bungay & Andrew, 2017). Social
support has been positively correlated with patient activation and engagement in selfmanagement activities across chronically ill populations (Bos-Touwen et al., 2015; Fowles et al.,
2009; Hibbard & Cunningham, 2008; Hibbard et al., 2007). Living alone has been associated
with lower patient activation levels (Fowles et al., 2009; Korpershoek et al., 2016), frequent
health care utilization (Roberts et al., 2016), and increased risk of exacerbation requiring
hospitalization among people with COPD (Dhamane et al., 2015).
Biological Function
Biological function broadly reflects the dynamic processes that support life (Wilson &
Cleary, 1995). This domain includes the genetic, cellular, and whole organ system processes that
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are impacted by disease (Ferrans et al., 2005). Ferrans et al. (2005) assert that progressive
biological dysfunction can directly or indirectly affect all other domains of health, thus
optimizing biological function is integral to achieving a state of health within illness. COPD is a
multifaceted lung disease characterized by progressive obstruction within the airways and
damage to the lung parenchyma (Balkissoon et al., 2011). Spirometric measures of lung function
reflected the objective measure of biological function in this study.
Lung function and disease severity. Spirometry is a breathing test that evaluates ease
and volume of airflow through the lungs and airways. FEV1 less than 80% of predicted volume
of airflow, based on gender, race, height, weight, and age, is a diagnostic criterion of COPD
(Celli et al., 2015; GOLD, 2018). COPD severity is classified by FEV1 values in the Global
Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD, 2018). GOLD
(2018) classifies COPD by four stages of severity: (a) COPD stage 1: mild (FEV1 <80%
predicted), (b) COPD stage 2: moderate (FEV1 50-80% predicted), (c) COPD stage 3: severe
(FEV1 30-50% predicted) and (d) COPD stage 4: very severe (FEV1 <30% predicted).
Spirometry was chosen as the biological variable of interest in this study as measures of airway
obstruction are: (a) a diagnostic and staging requirement for COPD, (b) central to treatment
recommendations, and (c) integral to characterizing the sample in the COPD literature.
Celli et al. (2015) have stated that biological function, assessed by FEV1, does not fully
explain the impact of COPD on health outcomes (Celli et al., 2015). Airflow obstruction has
been poorly correlated with dyspnea, exercise tolerance, and health-related quality of life across
several studies (Benzo et al., 2010; Bucknall et al., 2012; Guyatt et al., 2007). However, Tsukino
and colleagues (1996) found FEV1 independently predicted health-related quality of life of
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people living with COPD. Severity of COPD, categorized by FEV1, was found to be a predictor
of patient activation level in people with COPD by Korpershoek et al. (2016).
Symptoms
Symptoms reflect a person’s perception of an abnormal physical, emotional, or cognitive
state (Ferrans et al., 2005; Wilson & Cleary, 1995). Symptom assessment and management are
crucial activities in self-management of COPD, shifting the focus of care from “cellular and
organism level to a (whole) person level.” (Ferrans et al, 2005, p. 339). Dyspnea and fatigue are
the two most common and progressive symptoms experienced by people with COPD (Peters et
al., 2010; Tel et al., 2012). Minimizing symptom burden is essential to maintaining quality of
life, thus a priority in COPD treatment plans (van der Molen, Miravitlles & Kocks, 2013).
Biomedical treatments are focused on controlling dyspnea caused by airway
inflammation and reactivity through use of pharmaceuticals, prevention of opportunistic
infections, and strengthening the respiratory and large muscle groups (Qaseem et al., 2011).
Research proposed the physiological mechanisms impacting the perception of dyspnea and
fatigue by people with COPD contribute to declining function and quality of life (Paes et al.,
2015). Fatigue is prevalent among people living with COPD; nevertheless, the mechanism of
fatigue is poorly understood (Walke et al., 2007). Fatigue is strongly associated with dyspnea
(Kapella et al., 2006) and low self-rated health (Nguyen et al., 2008) in this population.
Symptoms in COPD have been associated with negative outcomes across multiple
domains of the Revised Wilson Cleary Model (Ferrans et al., 2005). Liu et al. (2014) found older
adults with COPD were more likely to have difficulty with at least one instrumental activity of
daily living and less likely to engage in social activities due to dyspnea and fatigue, as compared
a healthy national sample. Further, symptoms contribute to poor general perception of health in
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COPD. Bentsen, Henriksen, Wentzel-Larsen, Hanestad, and Wahl (2008) found mood
symptoms, such as depression and anxiety, and dyspnea explained 35%-51% of the variance in
self-rated health among people with COPD, as compared to the general population. More
recently, Marvel and colleagues (2016) reported that symptoms significantly contributed to lower
self-rated health and satisfaction with role function, even when patients received the standard of
care for COPD, which included collaborative self-management support.
Symptom monitoring and activities to control or alleviate symptom burden are basic
elements of self-management in chronic disease. However, symptoms and their relationship with
patient activation have been minimally described in the literature. Kukla, Salyers and Lysaker
(2013) examined the relationship between patient activation and symptoms among adults with
schizophrenia. They found that people who experienced emotional discomfort symptoms (e.g.,
hopelessness, depression) attributed to living with chronic mental illness, reported lower patient
activation scores than counterparts with physical chronic diseases and associated physical
symptoms (Kukla et al. 2013). Dyspnea, fatigue, and pain symptoms were also found to be
related to, but not predictive of activation level, in studies of patient activation determinants
(Bos-Touwen et al., 2015; Korpershoek et al., 2016; Schmaderer et al., 2016).
Functional Status
Functional status represents a person’s ability to perform tasks in multiple domains
reflecting adequate physical, social, role, and emotional capacity (Ferrans et al., 2005).
Functional capacity describes one’s capability to perform specific physical, social, emotional, or
cognitive tasks, whereas functional performance reflects the actions performed in daily life
(Wall, 2007). The physical and role domains of functional status, as defined by Ferrans et al.
(2005), are most relevant in self-management of COPD (Reardon, Lareau & ZuWallack, 2006).
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The negative effects of COPD reach far beyond the respiratory tract, thus posing
significant threats to functional status. Comorbid cardiovascular disease, emotional vulnerability,
peripheral and respiratory muscle wasting, and sedentary, socially isolated lifestyle contribute to
impaired function as COPD progresses (Carrieri‐Kohlman et al., 2010; Monjazebi et al., 2016).
Concomitant effects of dyspnea and fatigue limit physical activity, leading to systematic
deconditioning and limited function in daily life (Kapella et al., 2006). Poor functional status is a
strong predictor of hospitalization and survival in COPD (Reardon et al., 2006). Optimization of
physical function through self-management (e.g., symptom control, reducing exacerbations, and
exercise) is critical to maintaining quality of life (Effing et al., 2016; Grodner et al., 1996; Guyatt
et al., 2007; Liu et al., 2014) and best supported through formal pulmonary rehabilitation
programming (Balkissoon et al., 2011; Bourbeau & van der Palen, 2009; Steer et al., 2010).
Pulmonary rehabilitation professionals acknowledge that adequate patient activation is a
necessary patient characteristic for regaining function through outpatient rehabilitation
programming (Stoilkova-Hartmann, Janssen, Franssen, Spruit & Wouters, 2015). Supporting this
assertion, Korpershoek et al. (2016) found that functional status was significantly correlated with
patient activation level among people with COPD in their sample.
General Perception of Health
General perceptions of health reflect the subjective synthesis of all aspects of health,
disease, the individual, and their environment (Ferrans et al., 2005; Wilson & Cleary, 1995).
Integrated physiological and psychosocial factors influence how people living with COPD
perceive and rate their health (Bentsen et al., 2008). Wilson and Cleary (1995) asserted that selfrated health was synonymous with general health perception. Thus, a single question asking,
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“How would you rate your health—excellent, very good, good, fair, or poor?” provides a simple
and global approach to assessing general perception of health (Ferrans et al., 2005).
The single question to assess general perception of health has been widely studied in
COPD. Strong correlations have been identified between symptoms (i.e., dyspnea and fatigue)
and general perception of health among adults with COPD (Mahler & Mackowiak, 1995;
Nguyen et al., 2008). Further, diminished physical function from impaired respiration imposes
negative effects on general perception of health (Nguyen et al., 2008). The global, single
question assessing self-rated health is an important measure of risk for negative health outcomes
in COPD. Self-reported health status of fair or poor was found to be an independent predictor of
hospitalization based on multiple logistic regressions in among patients involved in the medical
arm of the National Emphysema Treatment Trial (Benzo et al., 2010). The authors reported the
odds of being hospitalized for COPD were 1.6 times greater among patients who rated their
health fair or poor as compared to patients rating their health good or very good (Benzo et al.,
2010). Further, self-rated health has been found to independently predict COPD-related mortality
across diverse epidemiological samples and persists in multivariate models including potential
confounders, such as medical, behavioral, and psychological risk factors (Benzo et al., 2010;
Nguyen et al., 2008; Park and Larson, 2016; Wagner & Short, 2014).
General perceptions of health while living with COPD may influence self-management
engagement (e.g., treatment adherence and coping) and thus, directly impact health outcomes
(Lorig & Holman, 2003). Studies of determinants of patient activation revealed negative
perception of heath was associated with lower patient activation (Bos-Touwen et al., 2015;
Chubak et al., 2012; Korpershoek et al., 2016) and positive perception of health with higher
activation levels (Schmaderer et al., 2016). Rijken, Heijmans, Jansen and Rademakers (2014)
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and Hibbard et al. (2015) found through longitudinal analyses that patient activation levels and
self-rated health similarly decrease over time in the setting of chronic disease. Progressive
deterioration of health and diminishing capacity to engage in self-management activities pose
tangible risk factors for poor health outcomes for people living with COPD.
Overall Quality of Life
Per Ferrans (1990), quality of life is “a person’s sense of well-being that stems from
satisfaction or dissatisfaction with the areas of life that are important to him/her” (Ferrans, 1990,
p.15). People with COPD report higher rates of poor overall quality of life as compared to other
chronic conditions, including heart failure and chronic renal disease (Guyatt et al., 2007). The
target of COPD treatments and rehabilitation is to improve or maintain quality of life (Celli et al.,
2015).
Sexton, Munro, Chang, Woods, and Milde’s (1988) seminal work explored the
problems women experienced when diagnosed with COPD and the influence of these on overall
life satisfaction. The participants identified symptoms of: (a) breathlessness and fatigue, (b)
disease management-induced stress, (c) loss of role identity and fluctuating functional capacity,
and (d) declining health status as the most significant contributors to diminished life satisfaction
(Sexton et al., 1988). Later, Hu and Meek (2005) conducted a descriptive correlational inquiry to
examine the relationships among bio-physiological variables, symptoms status, and quality of
life in men and women with COPD. Like Sexton et al., (1988), their findings suggested
symptoms (breathlessness), impaired functional status, and negative mood (affect states)
significantly and negatively impacted quality of life (Hu & Meek, 2005). Guyatt, Ferrans, and
colleagues (2005) suggested that in the setting of COPD, all domains of the Wilson and Cleary
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Model (Wilson & Cleary, 1995) integrate to influence the individual’s perception of overall
quality of life.
The patient activation literature showed inconsistent relationships between quality of
life and level of activation. Several studies reported that patients, who indicated they had good
quality of life, also had higher patient activation scores (Dixon et al., 2009; Goodworth et al.,
2016; Hibbard et al., 2007, 2015; Mosen et al., 2007). It is unclear from the self-management
literature if better quality of life was a motivating factor for patient activation, and thus selfmanagement engagement, or if higher activation and subsequent self-management behaviors lead
to the improved quality of life (Goodworth et al., 2016). Quality of life was notably absent as a
variable of interest in Korpershoek et al.’s (2016) comprehensive examination of factors
influencing patient activation level of people with COPD. Schmaderer et al. (2016) did include
quality of life in their examination of patient activation determinants in people with
multimorbidity, including COPD. However, they did not find a relationship between quality of
life and patient activation level (Schmaderer et al., 2016). Regardless of the direction of
integration and influence, the literature suggests patient activation and quality of life are likely
related through self-management processes in chronic disease (Dixon et al., 2009).
Application and Adaptation of the Conceptual Framework
The literature provided evidence for the application and adaptation of the Wilson Cleary
Model (Wilson & Cleary, 1995) and Revised Wilson Cleary Model (Ferrans et al., 2005) to
examine health outcomes. The Wilson Cleary Model (Wilson & Cleary, 1995) has been widely
applied in COPD health outcomes research, including predictive validity testing (AdeOshifogun, 2012; Arnold, Rancor, Koeter, de Jongste & Sandeman, 2005; Bentsen et al., 2008;
Ngyen et al., 2008). Several studies used part of the model to guide correlational studies of
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general perceptions of health among people with COPD. Bentsen et al. (2008) applied the model
to identify determinants of self-rated health, while Ngyen et al. (2008) used the model to
explicate relationships between symptoms, function, and self-rated health. Additionally, Arnold,
et al. (2005) applied the model to examine health and personal factors that influenced subjective
and objective general perceptions of health in people with COPD and coronary artery disease.
Ade-Oshifogun (2012) tested the fit of the entire model to predict quality of life among people
with COPD.
The literature revealed examples of studies that adapted the Revised Wilson Cleary
Model (Ferrans et al., 2005) to study health outcomes relevant to COPD care. Zubritsky et al.
(2013) adapted and expanded the model to examine impact of cognitive function and long-term
social supports on quality of life in older adults with multimorbidity. Arbaje et al. (2008)
modified the model to describe and predict relationships among individual (socioeconomic
status) and environmental (home arrangement and living status) characteristics, and likelihood of
early hospital readmission among community-dwelling older adults with chronic disease. Two
studies tested the explanatory ability of the revised model to identify disease-specific predictors
of quality of life in adults receiving acute care for chronic conditions (Kring & Crane, 2009;
Saengsiri, Thanasilp & Preechawong, 2014). Both studies provided evidence of goodness of fit
of the Revised Wilson Cleary Model (Ferrans et al., 2005) for comprehensive examinations of
health phenomena important to the development of nursing interventions in supporting chronic
disease. A weakness of the studies that adapted or utilized only selected domains of the
conceptual models was the lack of rationale to explain why some domains were used and others
not.
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Wilson and Cleary (1995) noted the breadth of domains while Ferrans et al. (2005)
asserted the fluidity of the model, increased the utility of the conceptual framework in
examinations of relationships among health phenomena. Thus, the authors have encouraged
adaptation for application in research. However, the causal relationships implied within the
models require all domains to be included for examinations of model fit and predictive validity
involving highly integrated health outcomes (Ferrans et al., 2005). The studies that tested the
models included predictor variables from all model domains (Ade-Oshifogun, 2012; Kring &
Crane, 2009; Saengsiri et al., 2014).
Significant Gaps in Knowledge
With the high disease burden, morbidity, and growing mortality associated with COPD
in the United States, there is a significant need to understand factors that contribute to successful
engagement in self-management. Descriptions of characteristics of study responders and
assessments used to individualize interventions to meet participants’ levels of self-management
capability were missing from the self-management intervention literature. Patient activation has
emerged as a critical concept in self-management science and predictor of health outcomes in
chronic disease, yet has been minimally discussed in the COPD literature. One study described
patient activation among people with COPD (Halding & Grov, 2017), and several did so in the
context of COPD being a sub-cohort of larger chronic disease studies (Bos-Touwen et al., 2015;
Greene & Hibbard, 2012; Hibbard et al., 2015; Hibbard et al., 2007; Turner, Anderson, Wallace
& Kennedy-Williams, 2014). Notably, only one study examined COPD-related patient factors as
determinants of patient activation in Dutch people with COPD (Korpershoek et al., 2016). This
study addresses the gap by providing a comprehensive description of patient characteristics,
health outcomes, and patient activation levels experienced by people living with COPD.
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Fundamental theoretical knowledge of patient activation was missing from the literature.
A theoretical or conceptual framework describing patient activation has not yet been published.
Although Hibbard’s (2004) definition is widely accepted as the only conceptual and operational
definition of patient activation, concept analyses that examined patient activation or its use in
nursing or other disciplines have not been reported in the literature. Also missing from the
literature were theory generating, qualitative studies to explore the lived experience of
chronically ill people with varying levels of patient activation.
The second aim of this dissertation research partly addressed the theoretical gap in patient
activation literature through novel application of a health outcome conceptual model to examine
the concept. Specifically, the Revised Wilson Cleary Model (Ferrans et al., 2005) framed the
examination of relationships among patient characteristics, health outcomes, and patient
activation level of people with COPD. Further research is required to establish understanding of
the complexities of patient activation for people with specific chronic conditions.
The emerging literature that described determinants of patient activation level among
people with chronic diseases illuminated relevant health factors and patient characteristics that
could contribute to self-management risk assessment or intervention design. In the context of
COPD, the results from the Dutch studies by Bos-Touwen et al. (2015) and Korpershoek et al.
(2016) reflected predictive factors that were likely unique to the Netherlands’ health care system,
lifestyle factors, and environmental characteristics. Though informative, these findings could not
be generalized to adults in the U.S. with COPD. The diversity of determinants of patient
activation identified in the literature review was difficult to contextualize within the predominant
models of chronic disease care. Some determinants reflected modifiable targets for selfmanagement interventions, such as health literacy, self-efficacy, Body Mass Index, and self-rated
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health. Others represented non-modifiable characteristics—most applicable to self-management
risk assessment, including high comorbidity, limited social support, and negative affect states.
Without an organizing framework to provide context to these findings, it was impossible to
translate these findings to the current chronic care paradigm.
Findings from the third aim of this study begin to illuminate the independent patient and
disease-specific predictors explaining the variance in patient activation level among U.S. adults
living with COPD. These factors have not been described in the extant patient activation
literature. Further, these determinants contribute to call from the COPD self-management
research community to identify the unique patient characteristics necessary to self-manage.
Summary
This chapter provided a review and synthesis of the relevant theoretical and research
literature related to self-management of COPD and patient activation. Empirical evidence
demonstrated a positive association between patient activation, self-management, and health
outcomes in chronic disease. The significance of self-management to achievement of treatment
goals in COPD, most notably quality of life, underscores the importance of exploring patient
activation in the lives of people with COPD. Further, the research priority of the COPD
community to understand the patient characteristics necessary to effectively self-manage
supported the examination of determinants of patient activation level in people with COPD.
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CHAPTER III
METHODOLOGY
Introduction
The objective of this quantitative study was to describe and examine the relationships
among patient characteristics and health outcome factors, as conceptualized in the Revised
Wilson Cleary Model (Ferrans et al., 2005), as determinants of patient activation in adults with
chronic obstructive pulmonary disease (COPD). The specific aims of this study were to: (a)
describe the patient characteristics (individual and environmental), health outcome factors
(biological function, symptoms, functional status, general perception of health, and overall
quality of life), and patient activation experienced by a cross-sectional sample of U.S. adults with
COPD; (b) examine the unadjusted associations that patient characteristics and health outcome
factors have with patient activation in the sample; and (c) identify the independent predictors of
patient activation in the sample.
This chapter presents the research design and procedures used in this dissertation study.
A description of the participants, including the process of identification and recruitment of the
study sample is offered. The measures, data management, and statistical procedures to achieve
the study aims are presented. Finally, a discussion of ethical considerations to protect human
subjects and limitations of the study are presented.
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Research Design
This cross-sectional, descriptive correlational study was designed to explore the
determinants of patient activation level among patient characteristics and health outcome
variables experienced by people living with COPD. A cross-sectional design was chosen to
assess and describe the status of multiple phenomena experienced by people at a single point in
time (Polit & Beck, 2012). The descriptive correlational design allowed for description and
examination of the relationships among several study variables, not logistically or ethically
conducive to manipulation, within a single group (Curtis, Comisky & Dempsey, 2016; Grove et
al., 2013). Consistent with the method, measurement of variables was largely accomplished
through collection of self-reported data with a questionnaire. As causality was not the goal of this
inquiry, a non-experimental design supported the comprehensive examination of the
determinants of patient activation, yielding new insight into the relationships among patient
characteristics and the capacity to self-manage COPD.
Population and Sample
Population Description
The Centers for Disease Control and Prevention estimate the prevalence of COPD in the
United States to be between 4% and 12%, varying significantly by geographical region, race,
ethnicity, and socioeconomic status (CDC, 2017). The best current estimate of race and ethnic
distribution of the disease in the U.S. suggests multiracial and American Indian or Alaskan
Natives are mostly affected, followed by Caucasian non-Hispanics and much smaller numbers of
African Americans, Latinos, and Asian Americans or Pacific Islanders (CDC, 2017; Tilert et al.,
2013). In addition, women now outnumber men diagnosed with COPD (CDC, 2017). COPD is a
disease of middle-older adulthood, with symptoms of the condition typically presenting after 40
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years of age and diagnosis after age 65 (CDC, 2017). The main cause of COPD in the United
States continues to be tobacco smoking (NHLBI, 2013). Closely following cigarette smoking,
environmental and occupational exposures, and childhood respiratory infections and genetics,
which have been implicated as causal factors for COPD (GOLD, 2018). Recent statistics from
the Centers for Disease Control suggest that COPD prevalence, morbidity requiring
hospitalization, and death is significantly higher among people living in rural America than
among those in urban areas (Croft et al., 2018).
Sample Description
A purposeful sampling design was used to obtain participants for the study. This design
reflected a desire for a representative sample of adults living with COPD in the United States
with minimal sampling error and limited systematic bias (Grove et al., 2013). Inclusion criteria
were men and women who: (a) were 40 years of age or older, (b) had a clinical diagnosis of
COPD, chronic bronchitis, or emphysema, (c) had completed spirometry at the study site, (d)
were current or past smokers of at least 10 pack-years, (e) had a U.S. primary mailing address,
(f) could speak and read the English language, and (g) could provide informed consent for
participation in this study. Exclusion criteria included persons: (a) living in an assisted living or
skilled nursing facility, (b) enrolled in adult complex care coordination programming, (c) were
prisoners, or (d) had diagnosed cognitive disease or mental illness impairing ability to answer
questions or provide informed consent.
The inclusion and exclusion criteria defined for this study were chosen to identify a
representative sample of adults with COPD living in the United States able to engage in selfmanagement activities. Participants were not excluded based on race or ethnicity. The age
threshold of 40 years was established, as symptoms associated with COPD (e.g., dyspnea, cough,
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excess sputum production) do not typically present before the age of 40 years (NHLBI, 2013).
No upper age threshold was set for the study. Pregnant women could participate as this survey
study posed minimal risk. Finally, children were not eligible to participate because the trajectory
of exposures and impairment of lung function associated with COPD impacts only adults.
A sample of American adults who received care at one of three major Mayo Clinic
campuses in the United States was sought for the study. The Mayo Clinic provides general
medical and specialty care for a predominately U.S. patient population, though draws an
international clientele as a known healthcare leader in the world. The Mayo Clinic campuses,
located in the American Southwest, Midwest, and Southeast, offer comprehensive pulmonary
care, including pulmonary function testing and radiological testing, associated the diagnosis and
treatment of COPD.
Sampling Plan
The sample was obtained through use of Informatics for Integrating Biology and the
Bedside (i2b2) supported by Grant Number UL1 TR002377 from the National Center for
Advancing Translational Science. The i2b2 tool is a self-service, scalable informatics framework
utilizing patient-oriented clinical data for various types and stages of research
(https://www.i2b2.org). A i2b2 search query was developed based on searchable inclusion
criteria of the study. The query, which included patient demographics, vital status, diagnoses,
and spirometry procedures, yielded an adequate sample of 641 patients. After removing nonEnglish speaking and international patients, random numbers were assigned to the remaining 574
patients of the accessible sample. The i2b2 output file was sorted in ascending order, using
Microsoft Excel (Microsoft Office 365 Home 2016, Version 1804) functions to create a
randomized list of patients. Electronic medical records of the first 350 patients in the sample
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were reviewed for eligibility, including confirmation of COPD diagnosis and spirometry results,
smoking history, indication of skilled care status, care coordination participation, and
incarceration. A total of 250 eligible patients were approached via a mailed study packet.
Sample size. An a priori power analysis was conducted using G*Power 3 (G*Power 3
for Windows 8, Release 3.1.9.2) software for multiple linear regression (Faul, Erdfelder,
Buchner & Lang, 2009). With a significance level of .05, 80% power, estimate of six predictor
variables, and a conservative medium effect size of f2 = 0.15, based on the work of Korpershoek
et al. (2016), who reported a modest R2 of 0.17, 98 participants were required. To account for
attrition or incomplete data in the survey methodology, 20% was added to the power analysis
results, yielding in a desired total sample size of approximately 120 participants.
Two hundred and fifty patients identified from the i2b2 search were approached for
participation through the study mailing, described in detail later in this chapter. Eighty-eight
patients responded to the study mailing. Twenty-three patients declined participation and six
patients approached were noted to be deceased via letter, telephone, or email message from a
family member to the PI. Fifty-nine surveys were returned. Three of these surveys were not
included in the data analysis, as the participants did not accompany them with signed consent. In
addition, eight completed surveys were included from the pilot study, increasing the total sample
size to 64. The pilot study is described in detail later in this chapter.
Methods
Instrumentation
The instruments used to measure the variables in this study are presented as organized
by the domains of the Revised Wilson Cleary Model (Ferrans et al., 2005). Characteristics of the
individual, their environment, and their health outcomes (e.g., biological factors, symptoms,
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functional status, general perception of health, overall quality of life) were measured as
independent variables by tools with good validity and reliability in the population. The
dependent variable patient activation was adapted to be examined within the Revised Wilson
Cleary Model (Ferrans et al., 2005) and was measured with the Patient Activation Measure.
Characteristics of the Individual and the Environment
As defined by Ferrans et al. (2005), the collective characteristics of the individuals and
their environment reflect the psychosocial, demographic, interpersonal, developmental, setting,
and biological factors, which influence health and health outcomes of people living with chronic
disease. For this study, psychological measures, specifically positive and negative affect, were
measured by the Positive Affect Negative Affect Schedule (Watson, Clark & Tellegen, 1988).
The demographic measures of age, gender, race, ethnicity, formal education, earned income
level, and working status were assessed. Biological measures included the following selfreported variables: (a) height and weight to calculate Body Mass Index , (b) health care
utilization (i.e., number of visits to an emergency department due to breathing problems and
number of visits to a primary care provider for breathing problems in the past 12 months), (c)
smoking status and history (i.e., current or former smoker and total pack-years), and (d) time
since diagnosis of COPD. Characteristics of the environment were assessed with the following
independent variables: (a) category of residence (rural or urban), (b) marital status (single,
married/committed relationship, separated/divorced, or widowed), and (c) living status (alone or
with others).
Demographic form. Individual and environmental characteristic variables were
assessed through self-reported responses on the demographic form. Age was reported in years, at
time of questionnaire completion. Race and ethnicity were assessed using 2013 United States
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Census Bureau Questionnaire categories (U.S. Department of Commerce, United States Census
Bureau, 2013a). Marital status was identified based on six categories: married, civil
union/domestic partnership, widowed, living with significant other, single (never married), and
divorced/separated. The reported highest completed formal education program reflected
educational level. Participants chose one of the following to reflect employment status: (a)
currently working, (b) on leave of absence, (c) retired (not because of ill health), (d) disabled
and/or retired because of ill health, (e) homemaker, and (f) unemployed to assess employment
status, consistent with the 2013 United States Census Bureau Questionnaire categories (U.S.
Department of Commerce, United States Census Bureau, 2013b). Self-report of total household
income from all sources in the past year reflected their annual earned income (U.S. Department
of Commerce, United States Census Bureau, 2016). The total number of years since diagnosis of
COPD was captured through response to the choices of 0-3 years, 3-10 years, and greater than 10
years, consistent with prior studies of determinants of patient activation in COPD (Korpershoek
et al., 2016). Primary care and emergency department visits because of breathing problems in the
past 12 months were recorded. Smoking history of participants was assessed by asking if they
were: (a) current or former smokers (of cigarettes and/or pipes), (b) the average number of
cigarettes/pipes smoked per day, while smoking, and (c) the total number of years as a smoker.
These values were used to calculate smoking pack-years per the GOLD Guidelines (GOLD,
2018).
Participant response to the question, “Who do you live with—alone or with family or
friends?” reflected their current living status. The United States Census Bureau defines rural as
what is not urban (Ratcliffe, Burd, Holder & Fields, 2016). Thus, congruent with the 2010
Census categorization of residence, participants were asked to indicate if their residence was in a
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community/outlying area of less than 50,000 residents (rural) or greater than 50,000 residents
(urban) (U.S. Department of Commerce, United States Census Bureau, 2012). See Appendix E
for the demographic form.
Positive and negative affect schedule (PANAS). PANAS (Watson, Clark & Tellegen,
1988) is a 20-item self-report measure designed to evaluate the extent individuals experience a
range of positive and negative affect states. See Appendix A. Ten positive adjectives and 10
negative adjectives are presented with respondent instructions to indicate how much each of the
adjective items had been experienced, using a 5-point Likert scale (1 = very slightly, 5 = very
much). As affect can be both a mood trait (dispositional) and a state concept (situational), the
PANAS is robust in measuring both forms of affect by allowing investigators to choose the time
frame to assess either (Merz & Roesch, 2011). For this study, the mood trait or dispositional
nature of participant’s positive and negative affect was of interest and assessed by asking the
participants to respond to items with the time period of “in the past month” (Watson, et al.,
1988).
Scoring and administration. Positive and negative affect scores (interval level data)
were calculated by summing responses in each domain (Watson et al., 1988). Scores in each
domain can range from 10 to 50, with higher domain scores reflecting greater affect level.
Responding to the 20 items of the paper-and-pencil test took approximately five minutes.
PANAS is a publicly accessible tool, free for clinical and research use (Crawford & Henry,
2004).
Psychometrics. Initial reliability and validity testing by Watson, Clark and Tellegen
(1988) yielded correlation coefficients of .86 for the positive affect sub-domain and .87 negative
affect sub-domain in a general population sample. Subsequent validity and reliability
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examinations in healthy samples yielded fit indices of 0.94 and sub-domain correlation
coefficients ranging from .80 to .92 (Crawford & Henry, 2004; Merz & Roesch, 2011). Further,
Crawford and Henry (2004) reported minimal influence of demographic variables (i.e., age,
gender, income level) on PANAS sub-domain scores, suggesting stability and reliability of the
tool across demographic groups. Hu and Gruber (2008) reported excellent internal consistency
values of α = .86 and .83 for the positive and negative affect subscales, respectively, in older
adults with multiple chronic conditions, including COPD. In this dissertation study the
Cronbach’s alpha for the total tool was .761 and the positive and negative affect subscales were
.923 and .870, respectively.
PANAS is frequently cited in COPD outcomes research describing relationships
between dyspnea and mood (Carrieri‐Kohlman et al., 2010) and affect and quality of life (Benzo
et al., 2016) of those with the disease. The PANAS was appropriate for the goals of this study
because of: (a) good to excellent reliability and validity of the PANAS in chronic disease studies,
(b) established use in COPD research, and (c) simplicity of response by participants.
Biological Function
Biological function represents the molecular, cellular, and whole organ system
processes that support life and is operationalized through measures to assess and diagnose organ
function (Ferrans et al., 2005). The gold standard for COPD diagnosis is the measurement of
large and small airway obstruction in the lungs using spirometry (GOLD, 2018). Spirometry
results, specifically the most recent post-bronchodilator forced expiratory volume (FEV1) value
and ratio of forced expiratory volume (FEV1) to forced vital capacity volume (FVC), were
abstracted from the electronic medical record of participants to measure this domain.
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Spirometry. Spirometry is a physiological test to measure how an individual inhales
and exhales volumes of air over a function of time (Miller et al., 2005). The standardized
assessment yields objective measures of health or dysfunction of the lungs and airways. The
American Thoracic Society and European Respiratory Society Task Force published a
standardized spirometry guideline in 2005. The guideline outlines standards for equipment,
technical factors, and age, gender, and race norms for outcomes (Miller et al., 2005). At the study
site the guideline is used to obtain spirometric measures of forced expiratory volume (FEV1), the
volume of air in the first second of forceful exhalation, and forced vital capacity (FVC), the
largest volume of forcefully exhaled air following maximum inspiration. The ratio of these
values reflects the degree of airway obstruction. A FEV1/FVC < 0.70 and FEV1 < 80% of the
predicted value for age, gender, and race, are required elements for diagnosis of COPD (GOLD,
2018).
COPD severity was categorized based on standardized spirometry criteria established
by the Global Strategy for the Diagnosis, Management and Prevention of COPD (GOLD)
(GOLD, 2018). GOLD classifies COPD in four stages: (a) COPD stage 1: mild (FEV1/FVC<
0.70, FEV1 <80% predicted), (b) COPD stage 2: moderate (FEV1/FVC< 0.70, FEV1 50-80%
predicted), (c) COPD stage 3: severe (FEV1/FVC< 0.70, FEV1 30-50% predicted), and (d)
COPD stage 4: very severe (FEV1/FVC< 0.70, FEV1 <30% predicted) (GOLD, 2018). The FEV1
and FEV1% predicted (continuous-level data) were abstracted from the medical record. The
FEV1/FVC values of each participant were verified to meet the benchmark of < 0.70 for
calculation of categorical stage of COPD severity with the FEV1 % predicted values.
Symptoms
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Symptoms reflect the abnormal physical, emotional, or cognitive state experienced by
persons with chronic disease (Ferrans et al., 2005). Perception of symptoms is a key patient
outcome measure, as chronic diseases are managed, not cured (Redman, 2007). Dyspnea and
fatigue are pervasive symptoms experienced by people with COPD. The negative impact of these
symptoms on quality of life is the reason they are the primary foci of medical and selfmanagement interventions (Kaptein et al., 2014). The symptoms domain of the model was
measured with the Pulmonary Functional Status and Dyspnea Questionnaire-Modified (PFSDQM) dyspnea and fatigue sub-scales (Lareau, Meek & Roos, 1998). Discussion of the PFSDQ-M
psychometrics is presented in the following section, Functional Status.
Functional Status
Ferrans et al. (2005) defined the concept of functional status as a person’s ability to
perform tasks in multiple domains of his/her life, reflecting adequate physical, social, role and
emotional capacity. In both clinical and empirical literature, the gold standard criterion for
assessment of functional status in COPD is exercise capacity measured by a standardized
exercise test (Monjazebi et al., 2016). Thus, an emphasis is placed on one’s physical capacity to
carry out the task of walking, minimizing the multidimensional capacity needed to engage in the
many facets of daily life. For this study, the robust Pulmonary Functional Status and Dyspnea
Questionnaire-Modified (Lareau, Meek & Roos, 1998) was chosen to quantify the level of
overall functional status. It addresses both the physiological impact of COPD (muscle weakness,
limited energy capital, and decreased stamina) and the role-limiting effects of symptoms on
engaging the basic activities of daily life. Consistent with Ferrans’ definition, this tool measures
independent functional status while engaging in multiple domains of daily life. Further, it
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assesses walking activity and is thus congruent with the predominate emphasis on walking
function in the COPD literature.
Pulmonary functional status and dyspnea questionnaire-modified (PFSDQ-M). The
Pulmonary Functional Status and Dyspnea Questionnaire-Modified (PFSDQ-M) (Lareau et al.,
1998) is a disease specific, self-administered instrument designed to assess the change in ability
to carry out common daily activities. The activities include bathing, dressing, walking,
negotiating unlevel terrain and stairs, and preparing food, currently as compared to before the
onset of the physiological and symptom impact of chronic lung disease. See the PFSDQ-M in
Appendix B. This self-report tool of 40 questions is a modification from the original 167question Pulmonary Functional Status and Dyspnea Questionnaire (Lareau et al., 1998). This
version includes activities common to most adults with breathing difficulties and has fewer
questions, decreasing survey burden. The PFSDQ-M takes less than 10 minutes to complete and
requires reading skills at the 6th-7th-grade level, consistent with reasonable literacy standards and
time burden for questionnaire response (Creswell, 2014).
Scoring. For each component, dyspnea, fatigue, and change in activities of living since
diagnosis, ratings are noted on an 11-point Likert scale ranging from 0 to 10. For the symptom
components qualifiers of “No shortness of breath/fatigue” equal to 0 and “Very severe shortness
of breath/fatigue” equal to 10 are presented to orient responses. The change in activity
component scales also have qualifiers, for example, “As active as I have ever been” on the 0 end
of the scale to “Have omitted doing (the activity) entirely” on the 10 end of the scale. For each of
the three components scores are calculated with sums ranging between 0 and 100, lower scores
indicating better functional status or lower symptom impact. Further, sub-scale component
scores and total scores can be categorized by tertiles of 1-3 mild, 4-6 moderate, and 7-9 severe.
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The total score for the Dyspnea sub-scale and total score for the Fatigue sub-scale (ratio
level data) represented the symptom domain measure of the Revised Wilson Cleary Model
(Ferrans et al, 2005). The total score for the activity sub-scale provided a measure of overall
functional status from the model.
Psychometrics. Reliability of the PFSDQ-M was established through test-retest intraclass
correlation coefficient of .93 (Kovelis et al., 2008). Internal consistency and convergent validity
of the PFSDQ-M total score, dyspnea sub-score, fatigue sub-score, and change in activity subscore was supported by reported high Cronbach α of .93 to .95 when the instrument is tested
against the St. Georges Respiratory Questionnaire, Medical Research Council Scale (Kovelis et
al., 2008), and London Chest Activity of Daily Living Scale (Kovelis et al., 2011) in older adults
(mean age > 65 years) with stable moderate to severe COPD. Further, as a measure of dyspnea,
sensitivity of discrimination of dyspnea scores in people with mild to severe COPD was
demonstrated through significant correlations with FEV1, FEV1 (% predicted), FVC (%
predicted), FEV1/FVC and partial pressure of oxygen (Regueiro, et al., 2013). In this dissertation
study, internal consistency was similarly high for the PFSDQ-M with a Cronbach’s α for the
dyspnea sub score of .946, fatigue sub score of .940, and activity sub score of .943.
General Health Perceptions
General perception of health is a uniquely perceived, multidimensional representation
of an individual’s evaluation of their overall health status (Ferrans et al., 2005). Consistent with
the recommendations of Ferrans et al. (2005), general perception of health was operationalized
for this study by a single question from the general perception of health domain within the
Medical Outcomes Study SF-36 (Ware & Sherbourne, 1992).
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Single question from medical outcomes study SF-36. The global question from the
Medical Outcomes Study SF-36 assessed general perception of health by asking, “In general,
would you say your health is: excellent, very good, good, fair or poor?” (Ware & Sherbourne,
1992). See Appendix D. Use of the single question within clinical or research settings for
assessment of self-rated health assessment does not require license for use (Ware & Sherbourne,
1992).
Scoring. Respondents chose from one of the five levels to answer the question:
excellent (5), very good (4), good (3), fair (2), or poor (1). Responses were dichotomized
(nominal level data) and coded with 0 for those choosing “very/good” or “excellent” and 1 for
“fair” or “poor” respectively, in accordance with previous studies (Nguyen et al., 2008). The
single question is accessible in the public domain and requires only seconds to respond to when
included in survey tools (Wagner & Short, 2014).
Psychometrics. Internal consistency of this single question from the SF-36 to measure
general perception of health in people with chronic disease, including COPD, has been reported
with Cronbach’s alpha of .78-.93 (Brazier et al., 1992; Wagner & Short, 2014; Ware &
Sherbourne, 1992). Convergent validity established by correlations between this question and
other measures of general perception of health has been reported with the General Health Rating
Index r = .96 (Ware & Sherbourne, 1992) and the Nottingham Health Profile, r = .87 (Brazier et
al., 1992). Internal consistency was not calculated for this single item within this dissertation
study.
Overall Quality of Life
Overall quality of life is characterized as the subjective, multidimensional measure of
well being and satisfaction of one’s life with chronic disease (Ferrans et al., 2005). Overall
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quality of life anchors the Revised Wilson and Cleary Model of Health-related Quality of Life
(Ferrans et al., 2005) as the most complex health outcome, reflecting integration of all health
outcomes and patient characteristics preceding it. In 1990 Ferrans published a conceptual
framework of quality of life that described the domains of health and functioning, social and
economic, psychological and spiritual, and family as integral to overall quality of life. Ferrans et
al. (2005) applied these domains to clarify and expand the conceptual definitions of
characteristics of the individual and characteristics of the environment in their revision of the
Wilson and Cleary Model. The disease-specific version of the Quality of Life Index-Pulmonary
Version III (Ferrans & Powers, 1985) was chosen to provide a conceptually grounded measure of
the health outcome overall quality of life in this study. This tool presents a structure of assessing
overall quality of life congruent with Ferrans’ conceptual definition of quality of life, “a person’s
sense of well-being that stems from satisfaction or dissatisfaction with the areas of life that are
important to him/her” (Ferrans, 1990, p. 15).
Quality of life index-pulmonary version III (QLI-P). The QLI-P (Ferrans & Powers,
1985) is a self-report instrument comprised of 36-paired questions assessing personal satisfaction
and importance of various aspects of life. Importance ratings are used to weight satisfaction
responses so that the scores reflect the respondent’s satisfaction with the aspects of life they
value the most (Ferrans & Powers, 1985). This instrument assesses importance and satisfaction
within four life domains to provide an objective measure of overall quality of life. A common set
of life items form the basis of the tool, with pulmonary-specific items inquiring about symptom
(e.g., dyspnea, coughing, fatigue) impact on life. Respondents chose the degree of satisfaction
and importance for each of the presented aspects of life, measured on a 6-point Likert scale with
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1 meaning “very dissatisfied/unimportant,” and 6 meaning “very satisfied/important.” See
Appendix C for the QLI-P.
Scoring and administration. The possible range for the total quality of life score is 0 to
30, with higher scores indicating a higher overall quality of life. While sub-scale scores for each
domain could be calculated, the total score was used to operationalize overall quality of life for
analyses. The instrument is written at the fourth-grade reading level (Ferrans & Powers, 1985)
and was free to use for non-profit research (qli.org.uic.edu, n.d.).
Psychometrics. Internal consistency reliability for the QLI total score across adult age
groups (Ferrans & Powers, 1985; Nesbitt & Heidrich, 2000), healthy subjects (Ferrans &
Powers, 1985; Scott, 2000) and those with chronic diseases (Ozer & Efe, 2006; Scott et al.,
2004), has been supported by Cronbach’s alphas ranging from .89 to .93. Extensive empirical
literature review of factors related to quality of life generated the common and disease-specific
questionnaire items and established the content validity of the QLI and QLI-P (qli.org.uic.edu,
n.d.). Construct validity of the QLI is supported by strong correlations between the total score
and life satisfaction (r = .93) (Ferrans & Powers, 1985, 1992) and factor analysis of each of the
four domains explaining 91% of the total variance of quality of life (Ferrans & Powers, 1992). A
limitation of this tool was the lack of reliability and validity reporting among adults with COPD.
For this dissertation study, the Cronbach’s alpha of the QLI-P total score was high at .908.
Patient Activation Level
Patient activation is a measure of self-management capacity, operationally defined as the
belief an individual has an important role to play in their health, demonstrated through the
knowledge, skills, and confidence to maintain function, response to health changes, and access
appropriate care for their health needs (Hibbard et al., 2004). The Patient Activation Measure
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(PAM) (Hibbard, et al., 2004) objectively characterizes an individual’s activation level on a
spectrum of passive care receiver with limited self-management capacity (Level 1) to confident,
capable, and engaged self-manager (Level 4) (Hibbard et al., 2004). Patient activation was
operationalized for this study by the Patient Activation Measure-13 (Hibbard et al., 2005). Due
to copyright restrictions, the PAM-13 is not included in the appendices.
Patient activation measure-13. PAM-13 is an interval-level, unidimensional,
Guttman-like scale assessing an individual’s knowledge, skills, and confidence for selfmanagement in chronic disease. This tool was developed and tested by Hibbard and colleagues
(Hibbard, Stockard et al., 2004; Hibbard, Mahoney et al., 2005). The PAM aims to assess
cognitive and psychological variables through patient self-report of agreement or disagreement
with 13 escalating statements on confidence, skills, beliefs, and knowledge related to personal
health maintenance (Hibbard et al., 2004).
Scoring. The PAM-13 was administered as a self-report, paper-and-pencil questionnaire
and took approximately 10 minutes to complete. Responses fall on a 4-point Likert scale
(disagree strongly to agree strongly). Summation of responses generated a raw score that was
converted to a continuous activation score (ranging from 0-100) (Hibbard et al., 2004). Further,
scores were grouped into four hierarchal levels of health activation: (a) PAM level 1 (≤ 47.0,)
reflects an overwhelmed, passive recipient of care, (b) PAM level 2 (47.1 – 55.1) represents a
lack of knowledge and necessary confidence to engage in self-management, (c) PAM level 3
(55.2 – 67.0) shows an individual beginning to engage, but needs support to learn new skills and
maintain behaviors, and (d) PAM level 4 (≥ 67.1) reflects an active self-manager who may need
support in times of stress (Hibbard et al., 2004). The PAM-13 was licensed for this dissertation
study from Insignia Health, Inc. (http://www.insigniahealth.com/). See Appendix M.
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Psychometrics. Numerous research studies across diverse health populations and adult
ages have shown PAM-13to be valid and reliable (Fowles et al., 2009; Hibbard et al., 2015;
Hibbard & Tusler, 2007; Skolasky et al., 2011). In development and testing of a measure of
patient activation, Rasch person reliability was satisfactory at .85 (Grove et al., 2013; Hibbard,
Stockard et al., 2004; Hibbard, Mahoney et al., 2005). Good internal consistency of the 22-item
and 13-item versions of the PAM was reflected by a Cronbach’s alpha of .87 (Hibbard, Stockard
et al., 2004; Hibbard, Mahoney et al., 2005). Content validity of the PAM to adequately measure
the complex construct activation was established through an expert panel, reflecting diverse
utilization of health activation in human functioning, consensus followed by patient focus group
consensus for final item content and development of a conceptual activation definition (Hibbard
et al., 2004).
Skolasky et al. (2011) explored increased age and multimorbidity among communitydwelling older adults within a group health organization to examine the construct validity of
PAM for clinical use. Consistent with Hibbard et al. (Hibbard, Stockard et al., 2004; Hibbard,
Mahoney et al., 2005), Skolasky and colleagues found high internal consistency of the items on
the PAM-13 with a Cronbach’s alpha of .87 in the subgroups examined. Fowles et al. (2009)
further validated the PAM in a randomized trial of two health promotion programs within a large
midwestern health maintenance organization. The study population reflected a diverse
demographic sample of adults in two different work environments with varied health risk factors
and health status. Rasch person reliability for each group was .83 and high internal consistency
was noted with a Cronbach’s alpha of .90 (Fowles et al., 2009). Lower item reliability was noted
in the no chronic disease, age greater than 85 years, lower socio-economic status, and low selfreported health subgroups (Hibbard et al., 2005). Subsequent studies with these subgroups have
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shown the internal consistency of PAM-13 items to be valid and reliable (Hibbard & Mahoney,
2010; Skolasky et al., 2011). In this dissertation study, the Cronbach’s alpha for the PAM-13 was
.893, consistent and slightly higher than the original work of Hibbard and colleagues in 2005. A
summary table organizing the research variables as presented in the Revised Wilson Cleary
conceptual model is presented in Figure 3.
Independent Variables
Lung function

Independent Variables
Dyspnea

Fatigue

Independent Variables
Functional status

Independent Variables
General perception of health

Independent Variables
Overall quality of life
Independent Variables
Age, gender, race, ethnicity,
educational level, earned
income level, employment

Model Domain: Biological Factors
Instrument/Measure
Spirometry results (FEV1 and FEV1% Predicted)

Level of Measurement
Ratio

GOLD categorization of COPD severity
Model Domain: Symptoms
Instrument/Measure
Pulmonary Functional Status and Dyspnea
Questionnaire: Dyspnea subscale score

Ordinal

Pulmonary Functional Status and Dyspnea
Questionnaire: Fatigue subscale score
Model Domain: Functional Status
Instrument/Measure
Pulmonary Functional Status and Dyspnea
Questionnaire: Total Score
Model Domain: General Perception of Health
Instrument/Measure
Single question of self-rated health from Medical
Outcomes Study SF-36
Model Domain: Overall Quality of Life
Instrument/Measure
Quality of Life Index- Pulmonary Version III
Model Domain: Individual Characteristics
Instrument/Measure
Demographic questions

Ratio

Level of Measurement
Ratio

Level of Measurement
Ratio

Level of Measurement
Ordinal

Level of Measurement
Ratio
Level of Measurement
Nominal, Ordinal,
Interval, Ratio

Affect (Positive and Negative)

Positive and Negative Affect Scale

Health care utilization

Demographic questions

Smoking history (current or
former smoker, pack-years)

Demographic questions

Height and weight

*Body Mass Index (BMI) calculated from self-reported
height and weight

Ratio

*Duration of COPD reflected self-reported total number
of years since COPD diagnosis

Ordinal

Interval
Nominal

Duration of COPD

Nominal/Ratio

Figure 3. Research Variable Table. Adapted from the Revised Wilson Cleary Model
(Ferrans et al., 2005).
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Figure 3. cont.
Independent Variables
Living situation (alone or with
others), residence (rural vs.
urban), marital status (single,
married/committed relationship,
separated/divorced, or
widowed)
Dependent Variable
Patient Activation

Model Domain: Environmental Characteristics
Instrument/Measure
Demographic questions

Level of Measurement
Nominal

Additional Model Domain: Patient Activation Level
Measure
Patient Activation Measure-13

Level of Measurement
Ratio

Figure 3. Research Variable Table. Adapted from the Revised Wilson Cleary Model
(Ferrans et al., 2005).

Pilot Study
Prior to implementing the survey study at Mayo Clinic, a pilot study was conducted to
assess clarity of the questionnaire developed for data collection and the time needed to complete
the tool. The University of North Dakota Institutional Review Board (IRB) and the American
Lung Association Better Breather’s Clubs of the Twin Cities (ALAMN-BBC) provided ethical
and conduct approval of the pilot study. The principal investigator (PI) introduced the study at
the end of a regularly scheduled ALAMN-BBC meeting and the twelve attending members were
invited to participate in the anonymous survey. An IRB-approved Informed Consent Statement,
survey, and a postage-paid return envelope were provided to a convenience sample of nine
attendees who expressed interest in participating. The survey tool included three additional
questions to assess clarity of specific questions, format of the survey tool, and the total time
spent to complete the questionnaire. Eight people returned completed surveys. Based on their
responses, small changes were made to the format to improve readability and clarity of the
questionnaire. Most critically, the pilot study revealed that participant self-report of their
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spirometry results, specifically FEV1 and FEV1 percent predicted, was difficult and would lead to
high missingness in the data. Only three participants were able to self-report one of two
necessary spirometry values to assess degree of obstruction and disease severity. As central
variables to examine biological function within the conceptual model and common elements in
COPD research to meaningfully describe disease severity of study samples, it was necessary to
identify another way to obtain spirometry data. Therefore, the decision was made to partner with
healthcare organization for participant recruitment and data collection of spirometry values for
the study.
Data Collection
The primary data collection method was participant completion of a self-report
questionnaire. Questionnaires are a direct, cost-effective method of collecting self-report data
from a geographically dispersed sample (Waltz et al., 2010). Standardization within a
questionnaire format and ability to answer questions in the privacy of one’s own home, “supports
increased reliability of responses, facilitates comparison across respondents, and removes
interviewer bias as a threat to validity” (Waltz et al., 2010, p. 308). The study questionnaire
included the instruments described previously: (a) demographic form, (b) Pulmonary Functional
Status and Dyspnea Questionnaire-Modified, (d) single question from the Medical Outcomes
Study Short-form 36 to assess self-rated health, (e) Quality of Life Index-Pulmonary Version III,
and (f) Patient Activation Measure-13. Data from the pilot study suggested the 160-item
questionnaire took approximately 25 minutes to complete. Additionally, the most recent
spirometry results were abstracted from the medical record.
Based on the principal investigator’s prior survey research experience of older adults
with chronic disease, a preference for paper-pencil questionnaires potentially existed among
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participants. Instructions for questionnaire completion, including the option to contact the study
team for telephone administration of the questionnaire, were included in the study introduction
letter. It was expected that participants with visual impairments or low literacy requesting to
complete questions over the telephone would be a rare occurrence and represent a small
percentage of the data collected. Only one participant requested to complete the questionnaire by
telephone.
Survey Methodology
The three-phase, Dillman Total Design Method (Dillman, 1978; Dillman et al., 2014) of
survey research was employed to achieve an optimal survey return rate for this study. The
Dillman Method proposes an 80% return rate for survey research (Dillman et al., 2014). With all
factors held constant, the higher the response to a survey, the more likely the data will be
representative of the population that was sampled (Grove et al., 2013). The step-wise Dillman
Method begins with an initial mailing of a detailed introductory letter explaining the purpose of
the study, a questionnaire printed in booklet style, and a postage-paid return envelope. All
written communication to patients was formatted in a positive, appreciative tone using plain
language and was IRB approved. Please see the Ethical Considerations section below for detail
regarding the review process for the study documents. The contact letter clearly described the
purpose of the study and was signed by the principal investigator by hand, in blue ink (Dillman,
1978). The questionnaire was formatted in booklet style with an illustrated front cover, included
detailed instructions for completing the questions, and a unique respondent identifier (Dillman,
1978).
A pre-set pattern established the follow-up plan. Three weeks after the initial mailing
non-responders were sent a reminder postcard. At six weeks after the initial mailing, the entire
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study mailing was reissued to non-responders. Undeliverable paper questionnaires underwent
address recheck for transcription error. The method frames the data collection process to a twomonth period. The 250 study mailings were divided into 3 groups with the first sent in November
of 2017, second in January of 2018, and final sent in February of 2018. The pattern described by
Dillman (1978) was followed, yielding total time of data collection for each of the groups to 2
months.
Data management. Upon receipt of a completed questionnaire and signed Health
Insurance Portability and Accountability Act of 1996 (HIPAA) authorization, the medical record
was accessed for abstraction of the patient’s most recent spirometry results. Participant
questionnaire responses and spirometry data were entered into the Statistical Package for Social
Sciences (SPSS) software (SPSS for Windows, Version 25). Accuracy of the final dataset was
established through crosschecking of every fifth participant’s questionnaire and spirometry
report against the data file in SPSS.
Ethical Considerations
The study protocol was reviewed and approved by the Mayo Clinic and the University of
North Dakota Institutional Review Board. The Mayo Clinic served as IRB of Record and the
University of North Dakota served as Relying Organization for the ethical and regulatory
oversight of the study. This study posed minimal risk to participants involving the use of a
survey and abstraction of limited protected health information from the patient’s medical record.
All documents within the study mailing were Institutional Review Board approved. Please see
Appendices H-J for the study contact letter, Health Insurance Portability and Accountability Act
of 1996 (HIPAA) authorization, questionnaire, and reminder postcard. Contact letters sent to the
identified sample were considered a form of oral consent by the IRB and (a) clearly identified the
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voluntary, minimal risk nature of the study, (b) explained the expected benefits, (c) explained the
right of participants to not answer any questions in the survey that made them uncomfortable,
withdraw from the study at any time, or decline participation, (d) provided opportunity to request
to participate in the study by telephone, and (e) provided contact information for the study team
to ask questions about the research. The Health Insurance Portability and Accountability Act of
1996 authorizations (see Appendix J) were used to obtain informed consent for abstraction of
limited protected health information, specifically spirometry results, from participants’ medical
records. All study personnel completed human subject protection training prior to initiation of
the study.
Confidentiality and Data Security
All patient information and participant data were handled in a confidential manner.
Confidentiality of the electronic dataset, comprised of entered questionnaire responses and
spirometry results, was maintained using unique alphanumeric codes assigned to each study
participant. Only the PI had access to the linking file, which associated patient identifiers with
study identifiers. Further, data were secured through password protection of the electronic
dataset and i2b2 output stored on a dedicated research computer server at the study site.
Completed hard-copy questionnaires, signed HIPAA authorizations, and printed spirometry
reports were kept in a locked file cabinet at the researcher’s office at the study site, with access
limited to the researcher and her site mentor. Participant data reported in this dissertation has
been completed in aggregate to protect the anonymity of all participants involved in the study.
Data Analysis
Instrument scoring and psychometric testing was done prior to data analysis. The dataset
was screened for missingness, outliers, and normality of variable distribution to meet the
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assumptions of the univariate and multivariate analyses planned. All data analyses were
conducted using the Statistical Package for the Social Sciences (SPSS for Windows, Version 25).
Statistical significance (two-tailed) for data analysis was set at p < 0.05. The statistical consultant
for this inquiry was included throughout database development, data preparation, and statistical
analysis. Engaging the statistician throughout the research process ensured that the final data
product was appropriate for analysis (Creswell, 2014).
Missing Data
Missing data is the single greatest threat to validity in survey research design (Creswell,
2014). Participants may have purposefully or inadvertently skipped or left questions blank within
the study questionnaire. Frequencies were conducted to identify the extent of missing or
unexpected values within the dataset. The amount and pattern of missing data, type of variable
with missingness, and plan for handling the missing data is described.
One or more questions not answered within a multi-question tool were described as item
nonresponse (Patrician, 2002). All questions missed in a multi-question tool or nonresponse to a
single question variable measure was considered variable or unit nonresponse (Fox-Wasylyshyn
& El-Masri, 2005; Patrician, 2002). Variable and unit nonresponse poses greater threat to losing
statistical power through deletion of cases and introducing nonresponse bias to the data. Neither
variable or unit nonresponse was found in the dataset.
The pattern of missing data points was established to identify the best approach to
handling missing data (Shafer & Graham, 2002). Data missing at random (MAR) are values of
data dependent upon other variables in the dataset (Allison, 2000). Data missing completely at
random (MCAR) are values of data unique to the specific item and not related to other variables
in the dataset (Patrician, 2002). The plan to handle the missing data included several processes
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based on the type and pattern of missingness found, including sample mean substitution, case
mean substitution, or hot-deck imputation. These processes could be utilized to impute bestfitting values from specific items or variables within the dataset (Fox-Wasylyshyn & El-Masri,
2005). Multiple imputation was also considered as a predictive technique utilizing iterative
regression models to create “plausible imputations of missing values, to accurately reflect
uncertainty, preserving important data relationships and aspects of the data distribution”
(Patrician, 2002, p. 79). As it is difficult, if not impossible, to determine the mechanism of
nonresponse in questionnaires, the advantages of multiple imputation’s ability to reflect
uncertainty in missing data through incorporation of random error in the imputation process, may
support use of the technique in addressing missingness for this analysis (Fox-Wasylyshyn & ElMasri, 2005; Patrician, 2002).
Overall, item and variable missingness was very low in the data set. For this dataset, the
most appropriate single imputation technique to manage item missingness was case mean
substitution. This method assumes that within an individual participant, known as a case, the
item responses within a single tool or measure are closely related (Fox-Wasylyshyn & El-Masri,
2005). Item missingness was identified in responses for the PAM-13, PANAS, PFSDQ-M, and
QLI-P, though insignificant at less than 5%. Per the scoring instructions for the PAM-13 (13
single question responses), case mean substitution was used to impute the data for missing values
in among three cases for the dependent variable patient activation. Similarly, for missing case
responses in the independent variables obtained from the PANAS (20 single question responses,
10 per subscale), PFSDQ-M (30 single questions, 10 per subscale), and the QLI-P (72 single
questions), a mean for the subscale scores within each missing case was obtained and imputed
for the missing value in the subscale.
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Variable missingness was also low. Single datum was missing for the variables years of
education, visits to a primary or pulmonary doctor, emergency department visits, Body Mass
Index. Two data were missing from the variable smoking pack-years. The degree of missingness
among these variables was insignificant at less than 5%, suggesting the pattern of missingness
was random (Schafer & Graham, 2002). However, five data were missing for the key the
spirometry variable measuring biological function, FEV1, which was statistically significant (n =
5, 8%, t = -10.914, p < .001) indicating the data were missing not at random. It was important to
carefully consider how to manage the data missing not at random to avoid invalidating the results
(Fox-Wasylyshyn & El-Masri, 2005). In this study, the spirometry variable missingness was
explained through the inclusion of pilot study participants, five of which who were unable to
access their spirometry results, as described previously in the pilot study section of this chapter.
Through significant, consideration was given to the reason for missingness, desire to maintain
sample size, and likelihood that pilot participants were more similar than different to participants
identified from the study site. The decision was made to not exclude these cases and to utilize
sample mean substitution to manage the variable missingness. See Table 2 for the frequency and
handling procedures of missingness for these variables.
Table 2. Variable Missingness and Handling Procedure
Variable

% Missing

*

Handling Procedure

FEV1
Sample Mean Substitution (M = 1.30)
n = 5 (8%)
Years of Education
Sample Mean Substitution (M = 3.5)
n = 1 (3%)
Pack years (smoking)
Sample Mean Substitution (M = 46)
n = 2 (3%)
MD visits
Sample Mean Substitution (M = 2)
n = 1 (3%)
ED Visits
Sample Mean Substitution (M = 1)
n = 1 (3%)
Body Mass Index
Sample Mean Substitution (M = 31)
n = 1 (3%)
Note: N = 64
*Though statistically significant, the pattern of missingness is explained by the inclusion of pilot
study participants.
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Outliers and Normality of Distribution
The dataset was evaluated for outlier cases by examining all continuous variables as
standardized scores. Outliers are extreme scores, which can cause skewness violating the
univariate assumption of normality of a variable’s distribution (Tabachnick & Fidell, 2013).
Single outlier scores were noted in the variables of FEV1, negative affect sub score of the
PANAS, fatigue symptom sub score of the PFSDQ-M, and Body Mass Index; two outlier scores
found in the variable emergency department visits. Though the extreme cases were from the
intended population, the variability of these values led to significant skewness and kurtosis of the
variable distribution. Sample mean substitution was utilized to correct the extreme scores and
maintain sample size.
Next, attention was paid to the distribution of the variables across the normal curve. In
addition to visualizing the data in relation to their histograms, mathematical processes were
applied to assess for skewness and kurtosis. Fisher’s skewness coefficient was calculated for
each continuous variable and evaluated against the critical value for a two-tailed standardized
score. Fisher’s coefficients greater than ± 3.26 were significantly skewed or kurtosed. Physician
visits and emergency department visits demonstrated significant skewness and kurtosis. In
addition, skewness was evident in the variables FEV1, negative affect sub score, dyspnea sub
score, fatigue sub score, and activity sub score. The level of skewness in these variables seemed
to be inherent to the population, reflecting the unique impact of the disease on the individual
living with COPD. To manage the skewness and kurtosis consideration was given to log
transformation or categorization of the continuous variables. Several variables were not
amenable to log transformation as they contained zero values, but negative affect was
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successfully transformed via base-log arithmetic processes. Categorization of the skewed
variables was rejected due to concerns regarding the small sample size of the study. If these
variables were categorized and were found to be significantly associated with patient activation
in the univariate analysis, they would require dummy variable creation for the multivariate
regression. High numbers of dummy variables entered in linear regression analysis could make
the resulting models unstable, raising questions regarding validity of the results (M. El-Masri,
personal communication, April 25, 3018). Therefore, the decision was made to dichotomize the
non-normally distributed variables. This was accomplished based on conceptual cut-off points
congruent with each variable.
Data Analysis Description
Descriptive statistics were performed for each measured variable. Means, medians,
modes, ranges, standard deviations, and frequency distributions were calculated and reported in
tabular format. See Table 3. Significance for all data analyses was established by a two-tailed
alpha of .05. A three-step statistical analysis process, outlined by the three study aims, is
described below.
Specific aim #1. Describe the patient characteristics (individual and environmental),
health outcome factors (biological function, symptoms, functional status, general perception of
health, and overall quality of life), and patient activation experienced by a cross-sectional sample
of adults in the United States with COPD. To describe the patient characteristics of the sample,
means and standard deviations were calculated for the continuous variables. These included
earned income level, health care utilization, smoking pack years, Body Mass Index, positive
affect and negative affect sub scores calculated from the PANAS, PFSDQ-M dyspnea, fatigue,
and activity subscale scores, Quality of Life Index-Pulmonary Version III total score, and patient
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activation score. Frequencies and percentages were calculated for the nominal and ordinal
variables of age category, gender, race, ethnicity, educational level, working status, smoking
history, living status, community size, duration of COPD diagnosis, and the single question from
the Medical Outcomes Study SF-36assessing general perception of health. Additionally,
frequencies and percentages were calculated for the transformed variables that were
dichotomized due to being non-normally distributed or containing greater than three levels of
response.
Specific aim #2. Examine the unadjusted associations that patient characteristics and
health outcome factors have with patient activation in the sample. Univariate correlation
statistics, specifically a series of Pearson correlation coefficient (r) calculations for continuous
variables and one-way ANOVAs for categorical variables, were conducted to examine the
presence, strength, and direction of relationships among each of the patient characteristics and
the health outcomes as independent variables, and the outcome variable patient activation.
Statistical significance for these tests was set at a liberal α of 0.25 (i.e., p value of ≤ .25). Due to
concerns regarding the small sample size, any categorical candidate variables (those with p value
of ≤ .25) with greater than three categories would be dichotomized, based on their frequency
analysis, for entry into the subsequent multivariate regression analysis. One-way ANOVAs
would be repeated to assess if the dichotomized variables retained significant association with
the outcome variable.
Careful consideration was paid to two variables that raised concerns of conceptual
confounding. Positive affect and negative affect are two concepts that are inversely related and
as variables, posed risk of bivariate collinearity. If a participant had high positive affect, it would
be expected that he/she would have low negative affect, as the relationship of one explains the
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expected direction of the other. To address this concern, Kendal tau correlation coefficient was
calculated using the non-normally distributed negative affect variable with positive affect. The
result confirmed that negative affect has a non-statistically significant, negative association with
positive affect (τ = -.42, p = .636). In addition, log transformed negative affect was entered into a
Pearson correlation coefficient calculation with positive affect, similarly resulting in a nonstatistically significant, negative association (r = -.036, p = .780). Secondary to this analysis, the
decision was made to only evaluate the positive affect variable in univariate and multivariate
analysis to prevent potential confounding due to multicollinearity between positive and negative
affect with patient activation.
Specific aim #3. Identify the independent predictors of patient activation in the sample.
Stepwise linear regression analysis was performed to identify the independent predictors of
patient activation. To minimize the potential of model inflation and to ensure a parsimonious
model, only independent variables whose univariate test had a significant association with
patient activation at alpha of 0.25 were included in the multivariate regression analysis (Hosmer
& Lemeshow, 2001). The percentage of variance explained by the remaining independent
variables (R2 x 100) was calculated and reported. Higher percentages suggest the significant
relationships among the variables were true determinants of patient activation (Grove, 2007).
Several assumptions were verified to assure validity of the parametric linear regression
analyses completed to meet Aim #3. Assumptions of linearity, normal distribution, and
homoscedasticity were checked. Additionally, multivariate outliers and multicollinearity were
considered among the significant univariate patient characteristics and health outcome variables
entered into the regression model with patient activation (Grove, 2007). First, the relationships
between the significant independent variables and the dependent variable were linear. Second,
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the dependent variable patient activation, was normally distributed overall and for each of the
independent variables (Kellar & Kelvin, 2013). Third, the distribution of patient activation scores
was approximately equally distributed for each independent variable, thus meeting the
assumption of homoscedasticity (Grove, 2007).
Multicollinearity, or high intercorrelation among the independent variables, is a
significant threat in assessing complex, multidimensional health outcome variables (Curtis et al.,
2016). To meet this assumption, tolerance levels and variance inflation factors were calculated
for each independent variable to identify multicollinearity when all the variables are examined
together. The higher the tolerance value, the less likely collinearity exists among the variables
(Kellar & Kelvin, 2013). The variance inflation factor reflects how much of R2 is inflated by
multicollinearity (Mertler & Vannatta, 2002). Therefore, a tolerance value of less than .50 and a
variance inflation factor greater than ten were used to identify multicollinearity of variables that
required elimination from the regression models (Mertler & Vannatta, 2002). Condition indices
that reflect the dependency of one variable on another in regression, were examined for values
greater than 15 suggestive of collinearity and values greater than 30 indicatives of significant
collinearity (Kellar & Kelvin, 2013).
Finally, exploration for the presence and influence of multivariate outliers was
conducted. Multivariate outliers may exist between two or more variables or items among
variables that when combined can raise or lower the variance explained by the predictor
variables identified in linear regression (Kellar & Kelvin, 2013). Mahalanobis distance was
calculated for each case to identify the presence of multivariate outliers then assessed for
significance utilizing the χ2 distribution, degrees of freedom equal to the number of independent
variables in the model, and an α value of .001. Cook’s distance was calculated to show whether
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an outlier influenced the estimate variance explained by R2. A threshold of one was set for
Cook’s distance, values less than one, indicating the case was influential and should be deleted
from the analysis.
Limitations
Careful consideration was given to the design of this study, including identification of
potential challenges and limitations. The following subsections explain the limitations of selfreport measures, selection bias, and the processes undertaken to minimize impact of these on the
conduct and analysis of the study.
Self-Report
Self-reported measurement tools can pose inherent limitations on conceptual measures as
they cannot be objectively verified (Lorig & Holman, 2003; Wilson & Cleary, 1995).
Respondents may have over or under reported the significance of symptoms or perceptions of
health, suffer from recall bias, or chose answers based on perceived social desirability when
responding to the study questionnaire (Frank-Stromborg & Olsen, 2004; Grove, 2007).
Nevertheless, the health outcome factors central to this study are personally experienced
behavioral constructs (Ferrans et al., 2005). Wilson and Cleary (1995) acknowledged the
measurement challenges of these factors and asserted self-report was necessary to obtain the
lived perspective of the health outcomes within their model. The self-report measures chosen for
this study were validated in in adults with chronic disease, which contributed to the internal
validity of the study.
Selection Bias
Selection bias and representativeness of the sample are concerns with survey
methodology (Creswell, 2014). The accessible sample for this study was recruited from an
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academic medical center with clinical sites in the Midwest, Southeast, and Southwest United
States. People who received health care, specifically pulmonary care, at the study site may have
different care and self-management experiences than other people living with COPD across the
county. Survey research carries with it unique concerns regarding selection bias. Characteristics
of patients agreeing to be part of this study, as opposed to those who declined or did not respond,
are difficult to predict and may not adequately reflect the U.S. population of adults with COPD.
Participants drawn from a study site with an internationally known research reputation may have
been more interested in research in general, the study topic, or more activated than people from
the general population (Hibbard et al., 2015). The primary objective of the study was to gain
knowledge, not infer causality for generalization to the adult COPD population, thus drawing a
sample from a large, national health care organization was appropriate for sampling in this crosssectional, descriptive correlational design.
Language barrier. Inclusion of only adults who could read and speak English added an
additional limitation associated with selection bias. The resulting sample was not entirely
representative of the target population and further limits generalization of the results.
Homogeneity. Several individual characteristics and health outcome responses were
homogeneous across the study sample. The differences in these factors between participants and
patients who chose not to participate are unknown. Additionally, though the demographics of the
study sample were consistent with many adults with COPD in the U.S., the lack of racial and
ethnic diversity in the study sample further limits the generalizability of the results.
Summary
This chapter provided a detailed explanation of the methods and procedures followed to
achieve the goals of this quantitative dissertation study. First, the COPD population of interest
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and study setting were described. Next, sampling and recruitment plans described how the
accessible sample was identified and obtained within the context of the larger population of
interest. The sample size calculation to establish statistical significance in the subsequent data
analyses was presented. The validity and reliability of the measurement tools, which comprised
the study questionnaire and used to quantify the study variables derived from the Revised Wilson
Clear Model (Ferrans et al., 2005), were presented. The data collection plan, guided by the
Dillman Method (Dillman, 1978), data management processes to establish a complete,
analyzable dataset, and efforts to protect human subjects and their protected health information
were described. The chapter concluded with the data analysis plan used to address each of the
three research aims and a discussion of limitations of the study.
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CHAPTER IV
RESULTS
Introduction
The purpose of this study was to describe and examine the relationships among patient
characteristics and health outcome factors, as conceptualized in the Revised Wilson Cleary
Model (Ferrans et al., 2005), as determinants of patient activation in adults with COPD. The
specific aims of the study were to:
1. Describe the patient characteristics (individual and environmental), health outcome
factors (biological function, symptoms, functional status, general perception of health,
and overall quality of life), and patient activation experienced by a cross-sectional sample
of adults in the United States with COPD.
2. Examine the unadjusted associations that patient characteristics and health outcome
factors have with patient activation in the sample.
3. Identify the independent predictors of patient activation in the sample.
This chapter presents the results of this dissertation study including the characteristics of the
sample from which the data were derived, the descriptive and inferential statistical analyses to
achieve the aims, and a summary of the results.
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Analysis of Specific Aims
Specific Aim #1
The first aim of this dissertation study was to describe the patient characteristics, health
outcome factors, and patient activation experienced by a cross-sectional sample of adults in the
United States with COPD. Organized by the Revised Wilson Cleary Model (Ferrans et al., 2005),
the patient characteristics were examined in the context of characteristics of the individuals and
their environment. The health outcome factors were comprised of the biological function,
symptoms, functional status, general health perceptions, and overall quality of life domains. The
descriptive data representing the characteristics of the sample are presented, followed by the
health outcome factors, and finally, the patient activation experienced by the sample.
Individual characteristics. The study sample was comprised of 64 adults who met
inclusion criteria. The intervals of age for the study were set as follows: 40-50 years, 51-60
years, 61-70 years, 71-80 years, and 81 or more years of age. More than one-half (n = 36, 56%)
of the participants were between the ages of 71 and 80 years of age. Twenty-three percent of the
sample (n = 15) reported their age between 61 and 70 years, followed by 11% (n = 7) reporting
their age between 51 and 60 years. Nine percent (n = 6) were 81 years of age or older. The
distribution of ages across the sample reflects the chronicity and impact of the disease on older
adults (CDC, 2018). Though the index age for inclusion in the study was 40 years, based on the
earliest typical onset of symptoms related to COPD, none of the patients less than 51 to 60 years
of age approached to participate in the study did so. Almost two-thirds of the sample was women
(n = 39, 60.9%) compared to men (n = 25, 39.1%). The sample was predominantly Caucasian (n
= 60, 94%), not Hispanic or Latino (n = 62, 97%). Two participants (3%) reported being Black
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or African American, one participant (2%) was American Indian/Alaskan Native, and one
participant identified being more than one race (2%).
Understanding that COPD affects older adults, it was not surprising to find more than
one-half (n = 37, 58%) of the sample indicated they were retired. Twenty-two percent (n = 14) of
participants reported they were currently working outside of the home or were active
homemakers (n = 4, 6%). Only nine (14%) participants indicated they were disabled or retired
because of ill health.
The participants varied in their earned income levels. Fifty percent (n = 32) of the
sample reported incomes greater than $50,000 per year, while fourteen percent (n = 9) indicted
they preferred not to answer the question assessing income level. The majority of participants
attended or graduated from college including: completed some college or technical school
training (n = 26, 41%), graduated from college (n = 15, 23%), and completed postgraduate
degree (n = 12, 19%). Only 16% (n = 10) of the sample reported the highest level of education as
graduating from high school or completing a GED.
The adults living with COPD who participated in this study varied in the length of time
since first being diagnosed with the condition. Twelve individuals (19%) reported being newly
diagnosed in the previous three years. The majority of participants (n = 34, 53%) lived with
COPD for the past four to ten years. Almost one-third of the sample (n = 18, 28%) reported
being diagnosed for more than ten years.
Lifetime tobacco exposure is quantified by a numerical value called a pack year. One
pack year is defined as 20 cigarettes, the quantity of a package of cigarettes, smoked everyday
for one year (GOLD, 2018). Pack years were calculated from participant report of the total
number of years smoked, type of tobacco smoked (e.g., cigarettes, pipes, or cigars), and typical
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quantity smoked per day. Only one participant reported smoking cigars, while the rest of the
sample reported smoking cigarettes exclusively. The calculated pack years of the sample ranged
from 10 to 100, with the mean pack years equal to smoking an average of two packs of cigarettes
per day for 40 years (M = 46.89, SD = 21.92).
Assessment of affect was included in the domain of individual characteristics, per
Ferrans et al.’s (2005) explication of psychological factors within this domain of the model.
Participants were asked to respond to the PANAS questions in the context of the past month to
understand their dispositional mood traits of positive or negative affect, rather than assess them
on a given day to obtain a situational, more temporal response. The mean positive affect sub
score of the sample was 32 (SD = 8.86), suggesting participants had a moderate level of
dispositional positive affect. This means that they generally had a positive outlook on life. The
mean negative affect sub score was low at 17 (SD = 5.92), indicating participants in the sample
generally did not have negative dispositions. This result supports the conceptual view that one
cannot have a high positive affect and a high negative affect at the same time.
Finally, Body Mass Index (BMI) was calculated to assess an individual characteristic
with strong associations to health within illness and patient activation. Body Mass Index varied
across the sample, however the mean BMI (M = 29, SD 6.35) indicated the sample trended
toward being overweight. Excess body weight puts additional burden on the effort and sensation
of breathing. The highest BMI of the sample was 44, which categorized the individual as having
Class III Obesity (very severely obese) (WHO, 2018). On the other end of the BMI spectrum, the
lowest calculated BMI of 18 reflected an underweight participant (WHO, 2018). Significant
energy and caloric expenditure is needed to breathe with severe COPD, therefore it is not
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uncommon for people to require assistance in maintaining weight through careful attention to
nutrition (Celli et al., 2015).
Table 3. Individual Characteristics of Sample
Characteristics of the Individual

n

%

7
15
36
6

11
24
56
9

Gender
Female
Male

39
25

61
39

Ethnicity
Not Hispanic or Latino
Unknown

62
2

97
3

1
2
60
1

2
3
94
2

Marital Status
Married
Widowed
Living with a significant other
Single (never married)
Divorced/Separated

39
6
3
2
14

61
9
5
3
22

Educational Background
Graduated high school or GED
Some college or technical school
Graduated college
Postgraduate school or degree
Not college educated§
College educated§

10
26
15
12
37
27

16
41
23
19
58
42

Age
51-60
61-70
71-80
81 or more

Race
American Indian/Alaskan Native
Black or African American
White
More than one race
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Table 3. cont.
Characteristics of the Individual

n

%

Income
Less than $10,000
$10,000 to less than $30,000
$30,000 to less than $50,000
$50,000 to less than $75,000
$75,000 to less than $100,000
$100,000 or more
I prefer not to answer this question

3
12
8
14
9
9
9

5
19
13
22
14
14
14

Employment
Currently working
Retired (not because of ill health)
Disabled and/or retired because of ill health
Homemaker

14
37
9
4

22
58
14
6

Years since diagnosis of COPD
0-3 years
4-10 years
More than 10 years
0-3 Years (Newly diagnosed)§
4 or more than 10 years (Older diagnosis) §

12
34
18
12
52

19
53
28
19
81

Min

Max

Mean

PANAS: Positive Affect
14
50
32.29
□
PANAS: Negative Affect
10
32
15.64
Smoking: Pack Years
8
100
46.89
Body Mass Index
18
44
28.67
Note: N=64
§ Denotes transformed (dichotomized) variable values
□
Base-e Log transformed Negative Affect (Min 2.3, Max 3.47, M = 2.68, SD = .34)

SD
8.86
5.92
21.92
6.35

Environmental characteristics. Most participants (n = 45, 70%) reported living with
family or friends. Two-thirds of the sample were married (n = 39, 61%) or lived with a
significant other (n = 3, 5%). Thirty percent (n = 19) of the sample reported living alone. Of
these, twenty-one percent (n = 14) indicated they were divorced or separated, 9% (n = 6) were
widowed, and 3% (n = 2) reported being single, never married. The communities that
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participants lived in were almost evenly split between urban and rural. Fifty-two percent (n = 33)
of the sample indicated they lived in an urban setting of a community of more than 50,000
people while 48% (n = 31%) of the sample reported living in a rural community of less than
50,000 people.
Table 4. Environmental Characteristics of Sample
Characteristics of the Environment

n

%

Living Arrangement
Live alone
Live with others

19
45

30
70

Community Size
Rural (Community of less than 50,000 people)
Urban (Community of more than 50,000 people)

31
33

48
52

Note: N = 64
Biological function. Spirometry measures are used to assess and diagnose lung function
in COPD. The participants in this study had varying degrees of airway obstruction quantified and
categorized by their spirometry values. The mean FEV1 of the sample was 1.26 Liters/second
(SD = 0.59L/s) and the mean FEV1 percent predicted was 50.92 (SD = 21.54). The FEV1 percent
predicted values indicate how the patient’s measured value (FEV1) compares to the value the
patient should have based on their age, height, gender, and ethnicity (GOLD, 2018). These
values are used in concert with an FEV1/FVC of less than 0.70 to classify the stage of severity of
obstruction in COPD. Sixty-five percent of the sample had moderate (FEV1 = 50-80% predicted
[n = 22]) to severe (FEV1 = 30-50% predicted [n = 20]) obstruction. On the opposite end of the
distribution, 11% (n = 7) of the sample had mild (FEV1 > 80% predicted) obstruction, while 17%
(n = 11) had very severe (FEV1 < 30% predicted) obstruction. Individuals with very severe
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obstruction are often considered “end stage COPD” because of the dramatic limitation in airflow
they experience (GOLD, 2018).
Table 5. Biological Function of Sample
Spirometry Values and Severity Staging

Min

Max

Mean

SD

FEV1 (Liters/second)
FEV1 percent predicted

.32
15

2.98
119

1.26
50.92

.59
21.54

FEV1*
1.5 Liters or greater
0.3 to 1.4 Liters (Low to Very low FEV1)
Classification of COPD severity in patients with
FEV1/ FVC < 0.70**
Mild (FEV1 > 80% predicted)
Moderate (FEV1 = 50-80% predicted)
Severe (FEV1 = 30-50% predicted)
Very Severe (FEV1 < 30% predicted)

n
22
42

%
34
66

n

%

7
22
20
11

11
34
31
17

Note: N=64
*
Categorized variable
**
Classification of COPD severity based on the GOLD (2018) Criteria

Symptoms. Data for this model domain were analyzed from the PFSDQ-M Dyspnea
and Fatigue subscales. Only one participant denied experiencing dyspnea or fatigue. Participants
reported experiencing both symptoms regularly, but most indicated relatively low symptom
burden evidenced by the mean dyspnea (M = 23, SD = 19) and fatigue (M = 20, SD = 19) scores.
Scores ranged from zero indicating no dyspnea or fatigue to a high of 72 (dyspnea) and 71
(fatigue), respectively. Means, standard deviations, and ranges of each symptom were almost
identical across the sample. High symptom burden did exist; 33% (n = 21) of the sample
experienced moderate to severe dyspnea while only 23% (n = 15) experienced moderate to
severe fatigue.
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Table 6. Symptom Impact of the Sample
PFSDQ-M

Min

Max

Mean

SD

0
0

72
71

23
20

19
19

Dyspnea Sub score§
Mild dyspnea§
Moderate to severe dyspnea§

n
43
21

%
67
33

Fatigue Sub score§
Mild fatigue§
Moderate to severe fatigue§

n
49
15

%
77
23

Dyspnea Sub score
Fatigue Sub score

Note: N = 64
§ Denotes transformed (dichotomized) variable values

Functional status. The responses on the PFSDQ-M Activity subscale were similar to
those found on the Dyspnea and Fatigue subscales. Most participants (n = 48, 75%) reported a
minor change (M = 22, SD = 21) in their functional status as compared to their pre-disease state.
Participant total scores varied widely from 0 (No change in this activity) to 78 (Extreme change
in this activity). Twenty-five percent of the sample (M = 22, SD = 21) experienced major
changes in their functional status.
Table 7. Functional Status of the Sample
PFSDQ-M
Activity Sub score

Min

Max

Mean

SD

0

78

22

21

n
48
16

%
75
25

Activity Sub score§
Minor change in function§
Major change in function§
Note: N = 64
§ Denotes transformed (dichotomized) variable values
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General perception of health. The global question from the Medical Outcomes Study
SF-36 assessed general perception of health by asking, “In general, would you say your health is:
excellent, very good, good, fair or poor?” (Ware & Sherbourne, 1992). Almost 60% of this
sample chose Good (n = 26, 41%) or very good health (n = 12, 19%). The remaining 41% rated
their health as fair (n = 19, 30%) or poor (n = 7, 11%). Even though most of the sample viewed
their health positively, no participants chose “excellent” to rate their health.
Table 8. General Perception of Health of Sample
Single question from Medical Outcomes Study SF-36

n

%

Very Good
Good
Fair
Poor
Very Good or good§
Fair or poor§

12
26
19
7
38
26

19
41
30
11
59
41

Note: N = 64
§ Denotes transformed (dichotomized) variable values

Overall quality of life. Quality of life varied among the sample, as total scores ranged
from 9 to 28 with higher scores indicating better quality of life. Overall, these participants
perceived their quality of life to be moderately high as demonstrated by a mean total score of
20.56 (SD = 4.50).
Table 9. Overall Quality of Life of the Sample
QLI-P
Overall Quality of Life
Note: N = 64
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Min

Max

Mean

SD

9

28

21

4.50

Patient activation. The Patient Activation Measure-13 measured the central concept of
the study. Almost one-half of the sample was highly activated (Level 4, n = 31, 48%). Twentyfive percent (n = 16) of the sample scored in the range of Level 3, also considered activated
(Hibbard et al., 2004). The remaining 25% of the sample were almost evenly split between the
lower levels of activation. Fourteen percent (n = 9) of the sample was in Level 2 activation;
Level 1 activated participants comprised the remaining 13% of the sample (n = 8).
Table 10. Patient Activation of the Sample
PAM-13

Mean

SD

PAM-13: Patient Activation Score

66

16

Patient Activation Levels
Level 1 (PAM score ≤ 47.0)
Level 2 (PAM score 47.1 to 55.1)
Level 3 (PAM score 55.2 to 67.0)
Level 4 (PAM score ≥ 67.1)

n
8
9
16
31

%
13
14
25
48

Note: N = 64
Specific Aim #2
The second aim of this study was to examine the unadjusted associations that patient
characteristics and health outcome factors have with patient activation in the sample. The
relationships between the categorical and dichotomous variables from the model and the
outcome variable, patient activation, were explored using one-way ANOVA, while Pearson
product-moment correlations were calculated for continuous variables and patient activation.
Statistical significance for these tests was set at a liberal α of 0.25 to identify candidate variables
for inclusion in the regression analysis to address Specific Aim #3. The univariate statistical
analyses were conducted to answer the primary question underpinning the aim, ”What are the
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presence, strength, and direction of relationships among the patient characteristics and health
outcome factors with patient activation?”.
As described previously in Chapter III, categorical candidate variables (p value of ≤ .25)
with greater than three categories required dichotomization, based on their frequency analysis.
These included: (a) general perception of health (good self-rated health [very good or good] and
poor self-rated health [fair or poor]), (b) education level (college educated [completed college
degree or postgraduate degree] and not college educated [high school/GED completion or some
college or technical school)], and (c) time since diagnosis (newly diagnosed [0 to 3 years since
diagnosis] and older diagnosis [4 or more years since diagnosis]). One-way ANOVAs were
repeated and showed no change in the significance of the relationship after dichotomization of
the variables. The final F statistics and significance are reported below. Independent variables
with statistically significant relationships with patient activation are described in detail in Table
11.
Table 11. Relationships Between Independent Variables and Patient Activation Measure-13
Independent Variables

Univariate Analysis with Patient Activation

Characteristics of the Individual
Age
Gender
Race
Hispanic/Not Hispanic
Ethnicity
Marital Status
Education§
Income
Employment
Body Mass Index
PANAS: Positive Affect
Years since diagnosis of COPD§
Pack years

R

r (62) = -.221†
r (62) = .519**
r (62) = .319
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*

ANOVA
F (3, 60) = 1.033
F (1, 62) = 1.554†
F (3, 60) = .590
F (1, 62) = .236
F (1, 62) = .236
F (4, 59) = .493
F (1, 62) = 3.312†
F (5, 58) = .756
F (3, 60) = .708
F (1, 62) = 2.732†

Table 11. cont.
Independent Variables

Univariate Analysis with Patient Activation

Healthcare utilization
MD Visits§
ED Visits§

F (2, 61) = .919
F (2, 61) = 1.156

Characteristics of the Environment

R

ANOVA
F (1, 62) = 2.95†
F (1, 62) = .276

Community Size
Living Arrangement
Biological Function
FEV1 §

F (1, 62) = 0.86

Symptoms
PFSDQ-M: Dyspnea Sub score§
PFSDQ-M: Fatigue Sub score§

F (1, 62) = .207
F (1, 62) = 6.614*

Functional Status
PFSDQ-M: Activity sub score§

F (1, 62) = .708

General Perception of Health
Single question from SF-36§

F (1, 62) = 4.273*

Overall Quality of Life
QLI-P

r (62) = .422**

Note: N = 64. Variables with relationships with patient activation with p < .25 were included in
the Multiple Linear Regression.
Correlation significance (2-tailed): † p < .25 * p < .05 ** p < .01
§ Denotes transformed (dichotomized) variable values used for analysis
Characteristics of the individual. Evaluation of the variables within this domain
revealed six to be significantly related to patient activation, which included: (a) gender, (b) level
of education, (c) smoking pack years, (d) time since diagnosis of COPD, (e) Body Mass Index ,
and (f) positive affect. Calculation of Pearson correlation coefficients revealed patient activation
and smoking pack years, r (62) = .319, p = .010, and positive affect, r (62) = .519, p = .001, were
strongly positively correlated. Body Mass Index , r (62) = -.221, p = .079, was moderately
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inversely related to patient activation, indicating people with lower Body Mass Index (M =
28.67, SD = 6.35) were more activated than those with higher BMI.
One-way ANOVA showed significant direct relationships between patient activation
and gender, F (1, 62) = 1.55, p = .217, level of education, F (1, 62) = 3.31, p = .074, and years
since diagnosis of COPD, F (1, 62) = 2.73, p = .103. Women (M = 67.78, SD = 16.23) in the
sample were more activated than men (M = 62.53, SD = 16.81). College education (M = 70.06,
SD = 16.17) was directly related to higher activation, as was longer time since diagnosis of
COPD (M = 67.35, SD =16.81).
Characteristics of the environment. One characteristic of the environment was
significantly associated with patient activation. Community size, specifically urban communities
greater than 50,000 people was positively, significantly (p < .05) related to patient activation, F
(1, 62) = 2.95, p = .091. This indicated that where people with COPD reside influences their
activation. The direction of the relationship showed that people living in urban communities (M
= 69.11, SD = 17.30) were more activated than those living in rural communities (M = 62.13, SD
= 15.11).
Symptoms. The relationship between symptom burden and patient activation was
explored through one-way ANOVA calculations using the dichotomized dyspnea and fatigue sub
scores from the PFSDQ-M. Only fatigue, F (1, 62) = 6.61, p = .013, was significantly related to
patient activation. Mild fatigue (M = 68.55, SD = 16.19) was associated with greater patient
activation among the adults in the sample than was moderate to severe fatigue (M = 56.53 SD =
14.58) .
General perception of health. Dichotomized responses to the single question from the
Medical Outcomes Study SF-36 assessing general perception of health and patient activation
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were also examined for association with one-way ANOVA. A modest direct relationship
between very good or good (M = 69.18, SD = 15.36) perceived health, F (1, 62) = 4.27, p = .043,
and patient activation existed in the sample.
Overall quality of life. The total score of the QLI-P reflected participants’ perception
of their overall quality of life. Pearson correlation coefficient revealed patient activation and
overall quality of life were strongly correlated, r (62) = .422, p < .001 within the sample.
Specific Aim #3
The final aim of the study was to identify the independent predictors of patient
activation in the sample. Stepwise linear regression was calculated to predict the percentage of
variance that the candidate patient characteristics and health outcomes explained in patient
activation among the sample of adults living with COPD. Independent variables whose
univariate test had a significant association with patient activation at a liberal alpha of 0.25 were
included in the multivariate regression analysis. These variables are referred to as candidate
variables from this point forward. Ten candidate variables entered the stepwise linear regression
with patient activation. These included gender, Body Mass Index, education level, smoking pack
years, years since diagnosis of COPD, positive affect sub score, community size, fatigue sub
score, general perception of health, and overall quality of life.
Together, a statistically significant model containing four independent predictors
accounted for 45.4% of the variance in patient activation among adults with COPD. See Table.
12. Positive affect, β = .457, t (4.60) p = .001 contributed most to the explanation of variance in
patient activation, followed by smoking pack years, β = .345, t (3.693), p = .001 and overall
quality of life, β = .264, t (2.670), p = .010. The fourth independent variable to enter the model
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was gender. Female gender was significantly correlated with patient activation, β = -.192, t (2.053), p = .044.
Table 12. Multiple Linear Regression with Predictor Variables
Independent
Variables
Positive affect
Pack years
Quality of life
Gender

B

SE

β

t

p

.852
.260
.972
-6.443

.185
.070
.364
3.138

.457
.345
.264
-.192

4.600
3.693
2.670
-2.053

.001
.001
.010
.044

Note: N = 64
Constant = 0, p = .123
R2 = .488, Adjusted R2 = .454, F (4, 59) = 14.079, p < .001
Multivariate assumptions. No multicollinearity was identified among the predictors
and patient activation based on the tolerance values [.88 - 1.00] and variable inflation factors
[1.00 – 1.13]. The highest reported correlation index was 15.80, associated with gender entering
the model. This finding suggests that some collinearity may exist between gender and at least
one other predictor variable. Based on consideration of all three factors, it was determined that
multicollinearity was not a concern in the analysis.
Assumptions of normality in the regression were evidenced by a normally distributed
histogram of the regression standardized residuals and linear relationship between the observed
and expected probabilities of the residuals. Viewing the standardized residuals and predicted
values on a scatterplot assessed Homoscedasticity. The plotted residuals did not completely
mirror each other above and below the line, but were equally distributed above and below the
line. While the scatterplot did not indicate that the assumption of homoscedasticity was
completely violated, the appearance suggested that the variance noted in patient activation may
have been influence by an interaction effect between one or more of the predictor variables. An
103

interaction variable was created and the stepwise linear regression was calculated again. No
visual difference in the scatterplot was noted when including the interaction variable in the
analysis. It was concluded that normal distribution and linear relationship of the residuals
satisfactorily affirm the assumption of normality was met for the analysis.
Calculating Mahalanobis distance and Cook’s distance during the regression assessed
multivariate outliers. The highest Mahalanobis distance of 8.6916 was significantly less than the
χ2 critical value of 18.467. Cook’s distance values were all less than one, confirming the absence
of multivariate outliers impacting the regression.
Post hoc power analysis. Initial power analysis using G*Power 3 software (Faul et al.,
2009) for multiple linear regression indicated that 98 participants would be needed, assuming an
anticipated conservative medium effect size of f2 = 0.15, based on the work of Korpershoek et al.
(2016). A post hoc power analysis was conducted after the regression analysis. The actual
sample size of 64 participants, four independent predictor variables, alpha of p < .05, and
calculated effect size of f2 = .95 (based on R2 of .488) were entered into the statistical power
analysis. The post hoc analysis revealed the statistical power for the study was .99 for the overall
regression in prediction of patient activation in the sample. Substantial power and the large effect
size to detect the strength of the relationship between the predictor variables and patient
activation affirm the validity of the regression results despite the small sample size analyzed.
Summary
This dissertation study proposed to describe and examine the relationships among
patient characteristics and health outcome factors, as conceptualized in the Revised Wilson
Cleary Model (Ferrans et al., 2005), as determinants of patient activation in adults with COPD.
Apart from a single study in the Netherlands, little is known about how patient activation is
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influenced among adults experiencing the complex, multidimensional health affects of COPD.
The results of this dissertation study indicate that several patient characteristics (gender, level of
education, time since COPD diagnosis, smoking pack years, Body Mass Index, positive affect,
community size) and health outcomes (low fatigue, general perception of health, quality of life)
were significantly associated with patient activation. In multivariate analysis, positive affect,
smoking pack years, overall quality of life, and female gender independently predicted 45% of
the variation in patient activation.
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CHAPTER V
DISCUSSION
This chapter presents a summary of the study and important conclusions drawn from the
data analyses presented in Chapter IV. The results are organized by each specific aim and related
to the current body of research literature. In addition, this chapter provides a discussion of the
implications for nursing clinical practice, theory development, and recommendations for future
research.
Study Overview
Skills, confidence, and knowledge underpin the capacity of individuals with chronic
disease to self-manage (Hibbard et al., 2015). These characteristics and a sense of responsibility
for one’s own health comprise the concept of patient activation (Hibbard et al., 2004). Patient
activation has been shown to be a precursor to successful self-management and predictor of
health outcomes in chronic disease (Green et al., 2015). The concept of patient activation has
relevance in the treatment of COPD, a progressive incurable lung disease, where the onus of
treatment success lies in the capacity of the patient to engage in self-management intensive
treatment plans.
Problem and Purpose
There are two key problems noted in the COPD and patient activation research
literature. First, the COPD research community has called for further inquiry to identify and
understand the patient characteristics necessary for effective self-management. These
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characteristics may hold the key to understanding why less than one-half of all people with
COPD engage in recommended self-management. The current evidence is not only insufficient;
it is clouded by conflicting results of self-management intervention studies of the past decade.
Second, despite the emerging body of evidence suggesting patient activation is a critical
construct in chronic disease care (Coventry et al., 2014; Green, et al., 2015), determinants and
mediators of the concept are still relatively unknown (Hibbard, et al., 2015). Additionally, little
is known about how the complex, systemic nature of COPD affects patient activation
development (Evans & Morgan, 2014; Korpershoek, et al., 2016).
The purpose of this study was to describe and examine the relationships among patient
characteristics and health outcome factors as determinants of patient activation level in adults
with COPD. To guide this cross-sectional, descriptive correlational study, the Revised Wilson
Cleary Model (Ferrans et al., 2005) was adapted by adding the concept of patient activation to
the model. Patient activation was integrated as an additional outcome concept with overall
quality of life as they share similar integrated biopsychosocial complexity (Hibbard & Mahoney,
2010). The model organized a continuum of complex and integrated health outcomes and patient
characteristics integral to the experience of COPD for study (Guyatt, et al., 2007). The specific
aims to be addressed by the study were to: (a) describe the patient characteristics (individual and
environmental), health outcome factors (biological function, symptoms, functional status,
general perception of health, and overall quality of life), and patient activation experienced by a
cross-sectional sample of adults in the United States with COPD; (b) examine the unadjusted
associations that patient characteristics and health outcome factors have with patient activation in
the sample; and (c) identify the independent predictors of patient activation in the sample.
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A random sample of adults who received care for COPD at the study site were invited
to participate in a postal survey study. Data were collected from 64 participants through
completion of a questionnaire comprised of validated tools aligned with each of the domains of
the conceptual framework guiding the study. In addition, spirometry data were abstracted from
participants’ medical records. The presence, strength, and directionality of relationships between
the patient characteristics, health outcomes and patient activation were examined through
univariate correlation analyses. The patient characteristics and health outcomes significantly
associated with patient activation were then entered into stepwise linear regression models to
identify the variables that explained the greatest variance in patient activation.
Major Findings
Participants in this study were mostly older men and women in their 70s. Few
respondents lived alone as most were married or living with a significant other. The majority had
been diagnosed with COPD for several years; their most recent spirometry revealed moderate to
severe airway obstruction. They had significant smoking pack years and were overweight.
Socioeconomically, the sample was educated, living in urban communities, and had incomes
greater than $50,000 per year. The sample’s demographics were consistent with the known
demographics of the COPD population in the United States (CDC, 2017; Croft et al., 2018).
Despite having significant obstructive lung disease, the participants had few physician visits and
emergency room visits in the past year. Except for one person, all participants experienced
symptoms of fatigue and dyspnea, and noted a change in their current functional status as
compared to before being diagnosed with COPD. The degree of impact of the symptoms and
change in function was mild for most of the sample. Notably, the degree of positive affect, or an
optimistic outlook on life, and perception of good quality of life was high among the sample.
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This study found statistically significant associations between individual and
environmental characteristics, specifically gender, Body Mass Index, educational level, smoking
pack years, time since COPD diagnosis, community size, and patient activation. Additionally,
the health outcomes of fatigue, general perception of health, and overall quality of life were
positively related to patient activation in the sample. Multivariate regression analysis revealed
four determinants, positive affect, smoking pack years, overall quality of life, and gender, which
together explained 45.4% of the variance in patient activation. The next section will discuss the
major findings related to patient activation and the new knowledge emerging from this study.
Major Findings Related to Patient Activation
Patient activation is an important factor when planning care with patients diagnosed
with COPD. The goals of COPD treatment plans are to limit physical and lung functional decline
and maintain quality of life (Qaseem et al., 2011). Diligent self-management by patients is
required to achieve these goals. People with higher patient activation are more likely to
participate in recommended activities associated with collaborative self-management treatment
plans for COPD (Dixon, Hibbard & Tusler, 2009).
The mean Patient Activation Measure-13 (PAM) score of the sample was 66 (SD = 16)
(maximum score 100), which lies near the cut-off point between PAM Level 3 and 4. According
to Hibbard et al., (2005), this score indicates that the majority of participants in the sample were
activated and would be able to begin taking action toward self-management by initiating new
health behaviors. Forty-eight percent of the sample participants (n = 31) were highly activated at
PAM Level 4. At this level, it would be expected that these individuals were engaged in their
self-management and with their providers. In times of stress (e.g., COPD exacerbation) they may
need additional support to incorporate new behaviors or get back on track with established self109

management routines (Hibbard et al., 2005). Fourteen percent of the sample were in Level 2
activation, associated with early awareness of the need to do more for their health, yet having
little knowledge and sense of efficacy to make any changes on their own (Hibbard et al., 2004).
The remainder of the sample was in the lowest level of activation, Level 1. This group would
have a passive perspective toward taking responsibility to manage their health because of limited
knowledge about their condition and believing their doctor should be in charge of their health
(Hibbard et al., 2004).
The patient activation scores found in this study sample were higher than those reported
by Halding and Grov (2017) and Korpershoek et al. (2016) in their examinations of Dutch adults
with COPD. While Halding and Grov examined community dwelling adults’ activation levels,
Korpershoek et al. (2016) included patients living in skilled nursing facilities and communitydwelling adults with COPD in their examination patient activation determinants. Korpershoek et
al. (2016) did not report if there were differences in PAM scores between the communitydwelling participants and those in skilled care settings. Clinically, there should be a distinction in
patient activation scores among people who live in skilled care facilities and are not autonomous
in managing their health. As evidenced by the high capacity to self-manage (PAM Levels 3 and
4) and health outcomes reported, the findings suggest that most of the sample were selfmanaging their COPD.
Significant Relationships Among Variables and Patient Activation
Univariate statistical analyses were conducted to explore the presence, strength, and
direction of relationships between the variables described in each of the domains of the Revised
Wilson Cleary Model (Ferrans et al., 2005) and patient activation. The characteristics of people
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living with COPD significantly associated with their patient activation level provide a picture of
activation in this population that are not yet described in the literature.
Consistent with other studies of determinants of patient activation, this study found
lower BMI was associated with higher patient activation (Korpershoek et al., 2016; Liu et al.,
2014). The majority of the participants in this sample were overweight or obese (M =28.67, SD =
6.35), (WHO, 2018). Ding et al., 2017 noted that being overweight with COPD is prevalent in
the world. They found that 74% of the people with COPD in U.S. studied were overweight or
obese, compared to 60% in the European countries studied. Their study corroborates the subtle
differences noted in overweight BMI of this U.S. sample and that of Korpershoek et al., (2016)
in the Netherlands. How BMI influences activation levels has not been discussed in the literature
and warrants further study.
Lower symptom burden, specifically fatigue, was related to activation in the sample.
The fact that fatigue, not dyspnea, was associated with patient activation was an interesting
finding. Though fatigue is known to be prevalent in COPD, dyspnea is the predominant symptom
assessed clinical research. Controlling fatigue and dyspnea are self-management behaviors
considered most worthwhile by those with COPD (Chen et al., 2008) and together significantly
contribute to decreased quality of life (Guyatt et al., 2007). The processes by which fatigue and
activation were associated in this sample deserve further investigation.
Sociodemographic factors, higher levels of formal education and larger community
sizes were strongly associated with higher patient activation scores in analysis. These findings
were consistent with the Dutch sample of people living with COPD examined by Korpershoek,
et al., (2016). Acquiring and applying the necessary skills, knowledge, and confidence to selfmanage is the hallmark of patient activation (Hibbard et al., 2004). Dunlay et al. (2017) and
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others have posited that a higher level of formal education improves health literacy, positively
impacting patient activation levels over time (Green et al., 2015; Hibbard et al., 2007, 2015;
Marshall et al., 2013). Formal education develops problem solving ability and cognitive skills to
distill and apply knowledge (Heide et al., 2013). Further, education develops “soft skills” of
control, autonomy, and personal efficacy (Zimmerman et al., 2013). These skills underpin the
construct of patient activation. (Hibbard et al, 2004; Hibbard & Mahoney, 2010). In addition,
living in an urban community has been proposed to support higher activation of people with
chronic disease by having greater access to health care and less social isolation (Chen et al.,
2014). Similarly, other authors have posited limited health care resources and isolation in rural
communities as contributing to lower patient activation among older adults with COPD living
there (Croft et al., 2018).
People who had lived with the disease longer (four or more years) were more activated
in the sample of this study. There was a moderately significant association between the years
since diagnosis with COPD and patient activation. This finding is supported by Hibbard and
Mahoney’s (2010) assertion that the length of time people live with a chronic condition is
positively related to their activation. The authors rationalized that the more experience people
have managing the good and bad days common in chronic disease, the greater they develop
efficacy and knowledge, which fosters activation for self-management. This result is contrary to
the findings of Korpershoek et al., (2016) which showed lower patient activation was associated
with greater number of years living with the diagnosis of COPD. The results of this analysis
warrant further study to better understand the high levels of activation in later years of COPD.
Congruent with the conceptual model used in this study, integrated physiological and
psychosocial factors influenced how people living with COPD perceived and rated their health
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(Bentsen et al., 2008). Among the sample, a significant relationship favoring very good or good
(M = 69.18, SD = 15.36) perceived health and patient activation was found. This is corollary to
findings in other chronic disease studies of poor perception of health positively associated with
lower patient activation scores (Chubak et al., 2010; Hibbard et al., 2015). Self-rated health has
been found to independently predict COPD-related mortality across diverse epidemiological
samples (Benzo et al., 2010; Nguyen et al., 2008; Park and Larson, 2016; Wagner & Short,
2014), thus it has become an integral factor in patient assessment.
Determinants
Among the people in the sample, their high positive affect and perception of overall
quality of life, combined with the life experiences of gender and smoking, explained almost 45%
of the variance in their patient activation. How each of the independent predictors contributed to
the model provides further insight to the unique impact of COPD on activation. Positive affect
and perception of quality of life were strongly correlated with patient activation and contributed
to the regression model. The mechanisms of smoking pack years and gender on the development
of patient activation are less clear. Each of the determinants and their relationship with patient
activation in the context of the COPD population are discussed below.
Positive affect. “Emotions are key underpinnings of activation” (Hibbard & Mahoney,
2010, p. 378). In development of the Patient Activation Measure, Hibbard et al. (2004) asserted
that positive affect contributed significantly to developing an individual’s self concept as a selfmanager, the outward expression of their activation level. Positive affect was strongly positively
correlated with patient activation in the sample. This is the first time positive affect has been
identified as a predictor of activation level in the literature. The mean positive affect sub score of
the PANAS was 32 (SD = 8.9) (maximum PANAS sub score = 50), suggesting participants had a
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moderate level of dispositional positive affect. This means that they generally had a positive
outlook on life and feelings of optimism (Watson et al., 1988). The mean negative affect sub
score was low at 16 (SD = 5.9), indicating participants in the sample generally did not have
negative dispositions and pessimistic views on life. Considering most of the sample had lived
with COPD for many years, well-established positive emotions and an optimistic outlook on life
may have contributed to their activation development.
The role of positive emotions is relevant to the trajectory of COPD where in progression
of symptoms, debility, and acute exacerbations require emotional resources to adapt and problem
solve (Bentsen et al., 2008). In the context of collaborative self-management of COPD, positive
affect has been associated with better health management and engagement with the healthcare
team (Benzo et al., 2016). Further, the ratio of positive to negative affect, or positivity ratio, of
people living with COPD has been shown to mediate the relationship between patient’s
investment in self-management behavior and better overall quality of life (Benzo et al., 2016).
Identifying positive affect as a strong predictor of self-management capacity in COPD provides a
target for nursing interventions to improve self-management and activation levels of patients
with COPD.
Overall quality of life. In this study, univariate analysis revealed patient activation and
overall quality of life were strongly correlated. Therefore, adults in the sample who perceived
their quality of life as better were more activated. This finding is congruent with studies of other
chronic disease populations (Dixon et al., 2009; Goodworth et al., 2016; Hibbard et al., 2007,
2015; Mosen et al., 2007). More importantly, this study found a predictive relationship between
quality of life and patient activation, β = .264, t (2.670), p = .010, which for the first time
integrates a direct association between patient activation and overall quality of life in the self114

management capacity of people living with COPD. Examination of any measure of quality of life
was notably absent in Korpershoek et al.’s (2016) study of determinants of patient activation in
COPD. This is an important finding linking the COPD and patient activation literature related to
self-management and subsequent health outcomes. The perception of one’s quality of life is a
powerful predictor of COPD-related health behaviors, co-morbidity, mortality, and health care
utilization (Case et al., 2017; Guyatt et al., 2007). Patient activation also predicts, mediates, and
directly influences self-management engagement and health outcomes in chronic disease (Green
et al., 2015; Hibbard et al., 2015).
Improving quality of life through collaborative self-management and medical
intervention is a priority in COPD care (Qaseem et al., 2011). Though the literature has
suggested activation level and quality of life may be related through the process of selfmanagement in chronic disease (Dixon et al., 2009), the relationship between quality of life and
patient activation has not been previously studied with sufficient rigor in the COPD population.
It is unclear if better perceived quality of life supports or maintains patient activation, or if higher
activation and subsequent health outcomes lead to improved quality of life (Goodworth et al.,
2016). This important link between quality of life and patient activation must be investigated
further to understand how the relationship can be translated practically to the care of patients
with COPD.
Smoking pack years. More than 75% of all COPD diagnoses are attributed to smoking
(CDC, 2017). When diagnosed with COPD, many people express guilt that their conscious use
of cigarettes led to their diseases. The quantity of cigarettes or cigars smoked over time by
(participants in this study averaged 47 pack years. This would suggest that most participants
smoked at least a pack of cigarettes a day for approximately 40 years. The average pack years of
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the sample are indicative of the national norm of a pack-to-two-pack per day smoker of the late
1950s and 1960s (Gardner, 2011), when most of the samples were likely introduced to smoking.
The direct, predictive relationship found between smoking pack years, β = .345, t
(3.693), p = .001, and patient activation is an interesting finding. First, the correlation between
the two variables indicates that people in the sample who were heavier smokers, as quantified by
their pack years, were more activated than people who smoked less. Second, higher pack years
strongly contributed to the model explaining the variance in patient activation among the sample.
No other studies identified through literature review examined the association between smoking
pack years and patient activation. Other studies of patient activation determinants examined
smoking habits (active or former) but not quantity of tobacco smoked. Korpershoek et al. (2016)
found smoking habits were associated with patient activation level in people with COPD.
However, the variable did not explain variance in patient activation in their regression analysis.
Studies of patient activation determinants in other chronic disease populations did not find any
relationship between smoking habits with patient activation (Dunlay et al., 2017; Schmaderer et
al., 2016).
While the mechanisms are unclear why smoking pack years contributed significantly to
the model, the result cannot be ignored. To explore reasons for this result, consideration of the
theoretical underpinnings of patient activation and nature of cigarette smoking must be
considered. It can be posited that a unique sense of personal responsibility exists among people
with COPD. Many people express significant guilt regarding their smoking habits when
diagnosed with COPD (Celli et al., 2015). As most COPD is attributed directly to cigarette
smoking, patients who are current or former smokers seem to accept a degree of responsibility
for what has happened to their health related to their smoking habits. The quantity of cigarettes
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smoked is influenced by social norms, finances, and perceived effect from smoking (Benowitz,
2010). These factors contribute to many with COPD having high smoking pack years. To smoke
tobacco in an environment of social pressures and strong recommendations from healthcare
providers requires people to make conscious decisions and problem solve to maintain this
behavior, even if it is a risk to their health and socially undesirable. Responsibility and
confidence in making decisions about one’s health underpin activation (Hibbard et al., 2004).
Capability and confidence also underpin activation (Hibbard et al., 2004). The addictive
properties of nicotine in tobacco promote the long-term habituation to cigarette smoking
(Benowitz, 2010). Quitting smoking is a significant self-management success, one that builds
efficacy and can be leveraged toward other self-management behaviors in the setting of COPD.
Efficacy is central to capability and confidence to make behavioral changes to support selfmanagement (Hibbard & Mahoney, 2010). Participants with greater pack years who had
successfully quit smoking may see achieving this goal as a pivotal success in their health.
Clearly, the role of smoking within this sample of adults with COPD who were highly activated
warrants further study to explicate and understand these factors.
Gender. Gender has had inconsistent associations with patient activation and several
elements of care in COPD in the literature. In this study, even though gender was only modestly
associated with patient activation in univariate analysis, it did contribute to the overall regression
model explaining variance in patient activation score. Specifically, males were less activated
than females in all analyses. Other researchers have warned that associations between gender and
patient activation should be considered cautiously in samples with unequal gender distribution
(Green et al., 2015; Hibbard et al., 2015). Women outnumbered men by 20% in this sample.
Several studies that identified a positive relationship between female gender and patient
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activation have also had disproportionately large numbers of women in the samples (Fowles et
al., 2009; Goodworth et al., 2016; Hibbard et al., 2005, 2015, 2016). However, none of the
studies published to date have identified gender as an independent predictor of patient activation.
This is a unique finding of this study.
The process underlying greater activation among women in the sample is not entirely
clear. How women’s experiences in chronic disease, as opposed to men’s, impact activation has
not been explored in the literature. Similarly, the differences between men and women in terms
of their experiences with COPD have only recently begun to be examined and reported in the
literature. Awareness of the differences between women and men in relation to COPD only
emerged when the numbers of newly diagnosed and mortality rates began to favor women in the
early 2000s (ALA, 2017; Celli et al., 2015; Pruitt, 2014). Evidence has shown that smoking
habits, environmental exposures, genetic predisposition, symptoms and even response to
treatments vary between the sexes (Jenkins et al., 2017). Women are more likely to be diagnosed
later in the disease trajectory when symptoms and obstruction are greater (Jenkins et al., 2017).
However, once diagnosed women have more healthcare encounters and interactions with
providers than men (Jenkins et al., 2017). The timing of diagnosis, life experiences, and exposure
to providers may contribute to the skills and knowledge that predicate activation (Hibbard et al.,
2007). The relationship between gender, patient activation level, and self-management requires
further study to understand how these factors may influence outcomes for women with COPD.
Summary and Implications
This descriptive correlational study expands the limited scientific knowledge of
determinants of patient activation of adults living with COPD in the United States. Cognitivebehavioral influences appear to be at the heart of self-management capacity for those with COPD
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(Kaptein et al., 2014; Korpershoek et al., 2016). The results provide: (a) insight to the
characteristics and health outcomes experienced by a sample of people living with COPD in this
country, (b) knowledge of significant relationships and determinants among these factors and
patient activation, and (c) objective targets for future COPD self-management research. Further,
the results from this study address a gap in in the evidence base related to the patient factors
necessary to engage in self-management of COPD. Based on the findings, implications for
nursing clinical practice, theory advancement, and future research are presented.
The multidimensional Revised Wilson Cleary Model of Health-related Quality of Life
(Ferrans et al., 2005) was used to organize and examine phenomena unique to people living with
COPD as they related to patient activation. The model builds from the singular, objective
biological factors to the highly integrated, complex overall quality of life (Wilson & Cleary,
1995). Patient activation was integrated as an end-point in the model as it shares similar
biopsychosocial complexity with overall quality of life (Hibbard & Mahoney, 2010).
Unidirectional relationships between variables in each model domain, except biological function
and functional status, were revealed across the continuum of increasing complexity with patient
activation. Though the model was not tested for fit and reciprocal relationships among the
domains were not explored in this study, the domains and proposed relationships among them
contributed to the results of this study. The characteristics of the individual, explicated by
Ferrans et al. in 2005, provided most of the variables significantly associated with activation
level of people living with COPD. Adaptation to include patient activation as an end-point in the
model was supported by the strong correlation found between overall quality of life and patient
activation in the sample. Guyatt, Ferrans, and colleagues (2005) suggested that in the setting of
COPD, all domains of the Wilson and Cleary Model (Wilson & Cleary, 1995) integrate to
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influence the individual’s perception of overall quality of life. Further study of the relationships
between and among the domains of the model may reveal integration of the domains and patient
activation not identified in this study.
Implications for Nursing Clinical Practice
Findings from this study will inform nurses who care for patients with COPD what
patient activation is, how it is related to self-management outcomes, and what patient
characteristics influence it. The independent predictors of patient activation provide new targets
for self-management interventions to improve engagement and support activation development
in people with COPD. In addition, this study identified several characteristics and health
outcomes of people living with this condition significantly associated with their patient
activation level. Nurses are in a pivotal position to apply knowledge of activation predictors
toward identification of self-management capacity of patients and engage them in appropriate
behavioral interventions and care coordination services (Hibbard & Greene, 2013; Naylor et al.,
2013).
•

Patent activation is an important characteristic to assess and explore with patients as to its
potential to be modified and contribute to self-management engagement and health
outcomes. Use of the Patient Activation Measure (Hibbard et al., 2005) in the clinical
setting could contribute to improved care in this population.

•

Using the PAM to assess and evaluate patients participating in self-management, care
coordination, and pulmonary rehabilitation programs would provide objective measure of
self-management capacity to tailor the care plan and meaningfully evaluate outcomes.
Further, PAM scores can indicate how intensely to follow high-risk patients in care
transitions and to determine priorities in their care plan (Hibbard et al., 2016).
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•

Measurement of the patient activation score can augment clinical risk prediction for
emergency department visits and hospitalization rates, directly associated with all-cause
mortality in the COPD population (Dhamane et al., 2015; Hibbard et al., 2016). Patients
with PAM Level 3 and 4 are significantly less likely to have a costly emergency room
visit and subsequent hospitalization as compared to those at Level 1 (Hibbard et al.,
2016).

•

The importance of thorough psychosocial assessment of people with COPD prior to
planning interventions and supportive care for self-management cannot be understated.
Mood, affect, self-rated health, and perception of quality of lives are strongly associated
with activation level and self-management capacity of patients.

•

Positive affect and overall quality of life present modifiable targets for strengths-based
nursing interventions to improve self-management engagement and health outcomes
among people living with COPD (Gottlieb and Gottlieb, 2017).

•

Quantification of pack years should be included in assessment of smoking status of
people with COPD. Smoking history may reflect a hidden strength among people with
COPD that contributes to their activation level, and thus, capacity to self-manage.

Implications for Nursing Theory Advancement
The Revised Wilson Cleary Model of Health-related Quality of Life (Ferrans et al.,
2005) provided an adaptable, comprehensive frame to examine the unique patient characteristics
and health outcomes of people living with COPD and their relationships with patient activation.
It is recommended that the associations between and among the domains of the model and
patient activation are examined with larger sample sizes to fully explicate the relationships found
in this study and identify if others exist in the COPD population. Further, structural equation
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modeling is recommended to test the fit of the model for future exploration of causal
relationships and prediction of patient activation precursors. Advancement of this theory could
potentially identify mechanisms of patient activation development that underlie self-management
efficacy across chronic disease states. Use of the model to organize and describe the findings of
this study demonstrated the utility of the model to advance the understanding of patient
activation in COPD, filling a gap in the literature.
Recommendations for Future Research
This was the first study of its kind to describe patient characteristics and health
outcomes associated with patient activation in people living with COPD in the U.S. In addition,
this study contributed four unique determinants of patient activation, expanding knowledge of
this concept within the minimally studied COPD population. However, this study does not exist
in isolation. Further study is needed with more diverse samples to fully explicate the significant
associations, predictors, and relationships among them and patient activation. Mixed-methods
approaches are needed to explore the lived experience of adults with COPD at various levels of
patient activation. This would provide rich knowledge missing from the current literature, and
perhaps reveal other factors relevant to lend additional support for the predictors explicated in
this study.
Adoption of the Patient Activation Measure (Hibbard et al., 2004) as a core outcome
measure in COPD self-management studies is needed. Not only can the PAM provide a sensitive
evaluation measure of intervention efficacy, it can be used to tailor self-management
interventions to move patients developmentally to their optimal level of activation. Use of the
PAM would address the heterogeneity prevalent in COPD self-management outcomes and
contribute as a common data element for data sharing across nursing studies, consistent with the
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recommendations of the National Institute of Nursing Research (Grady & Daley, 2014; Moore et
al., 2016).
Recruitment of patients in exploratory and behavioral COPD research is challenging
(Benzo et al., 2017). Though response rate was low for this survey, it was encouraging to see so
many people with severe and very severe (end stage) COPD agree to participate. Few young and
less affected (mild COPD) people identified participated, consistent with other COPD studies
that identified those less affected did not believe they were sick enough or were not sure they
“had COPD” (Benzo et al., 2015). To capture the entire range of COPD severity and experiences
in this population, strategies to optimize survey design and return rate for optimal sample size
and diversity must be explored.
Additional questions should be asked of participants to gain deeper understanding of the
results of this study. First, questions to assess the relationship between current and former
smoking practices in the context of pack years are needed to explain the strong association
between smoking pack years and patient activation. Second, as patient activation is modifiable
and developmental, asking participants about prior pulmonary rehabilitation or participation in
collaborative self-management programs (i.e., nurse-led educational programming in
comprehensive pulmonary care center) is recommended. This information would shed light on
exposure to behavioral interventions that may have increased the patient activation level of the
sample.
Conclusion
Patient activation is an important construct that can contribute to the advancement of
COPD self-management science and nursing care. COPD multidimensionality affects the
individual and their ability to self-manage the condition. The relationship between self123

management engagement and positive health outcomes associated with greater activation are
important in the setting of COPD. This study revealed several mechanisms of complex health
behaviors that underlie self-management capacity in COPD. Thorough nursing assessment of
patient characteristics, including outlook on life, social history (smoking), gender, and
satisfaction with their quality of their life will provide meaningful insight to the capacity of an
individual with COPD to self-manage their disease. Use of the Patient Activation Measure
(Hibbard et al., 2004, 2005) in clinical settings and self-management research would positively
contribute to the care of this vulnerable population. Further research is needed to explicate the
modifiable and non-modifiable factors that influence patient activation in the COPD population.
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APPENDICES

Appendix A
Positive and Negative Affect Scale (PANAS)
This scale consists of several words that describe different feelings and emotions. Read each
word and then circle the choice that best describes to what extent you are feeling this way in the
past month. Remember, there are no right or wrong answers, so please give us your honest
opinion.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

Interested……......
Distressed……….
Excited………….
Upset……………
Strong…………...
Guilty…………...
Scared…………..
Hostile…………..
Enthusiastic……..
Proud……………
Irritable…………
Alert…………….
Ashamed………..
Inspired…………
Nervous………...
Determined……..
Attentive………..
Jittery…………...
Active…………..
Afraid…………..

Very
slightly or
not at all

A little

Moderately

Quite a
bit

Extremely

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

Watson, D., Clark, L. & Tellegen, A. (1988). Development and validation of brief measures of positive and negative
affect: the PANAS scales. Journal of Personality and Social Psychology, 54(6), 1063-1070.
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Appendix B
Pulmonary Functional Status and Dyspnea Questionnaire-Modified (PFSDQ-M)

DEGREE OF SHORTNESS OF BREATH ASSESSMENT
INSTRUCTIONS:
The following questions relate to your discomfort in breathing. Please
check the most accurate answer.
1. Do you ever experience shortness of breath?

Yes_____

No_____

2. How many times a month do you experience severe to very severe shortness of breath?
__________
Using the following scale, place a mark on the line between 0 (no shortness of breath) to 10
(very severe shortness of breath) in response to the following questions.
3. Indicate how you've felt on most days during the past year.
Mild

Moderate

Severe

Very severe

No shortness
of breath

0

1

2

3

4

5

6

7

8

9

10

shortness
of breath

4. Indicate how you feel today.
Mild

Moderate

Severe

Very severe

No shortness
of breath

0

1

2

3

4

5

6

7

8

9

10

shortness
of breath

5. Indicate how you feel with most day-to-day activities.
Mild

Moderate

Severe

No shortness
of breath

0 1
2
3
4
5
6
7 8 9 10
DEGREE OF SHORTNESS OF BREATH ASSESSMENT

Very severe
shortness
of breath

Lareau, S. C., Breslin, E. H., & Meek, P. M. (1996). Functional status instruments: outcome measure in the
evaluation of patients with chronic obstructive pulmonary disease. Heart & Lung: The Journal of Acute and Critical
Care, 25(3), 212-224.
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INSTRUCTIONS: Rate the following activities on a scale of 0 to 10 according to the
degree of shortness of breath each activity generally causes you.
Complete the form as follows: Place an “X” in the column under “0” if the activity
generally causes you no shortness of breath. Leave blank those activities you do not
typically perform in a normal week.

ACTIVITY

Mild

None

0

1

2

Moderate
3

4

5

6

Very
Severe

Severe
7

8

9

10

1. Brushing/combing hair
2. Putting on shirt
3. Washing hair
4. Showering
5. Raising arms overhead
6. Preparing a snack
7. Walking ten feet (3½
meters)
8. Walking on inclines
9. Walking on bumpy
terrain
10. Climbing 3 stairs

DEGREE OF TIREDNESS ASSESSMENT
INSTRUCTIONS: The following questions relate to how tired or worn out you feel. Please
check the most accurate answer.
1. Do you ever experience tiredness/feeling worn out?

Yes__ No_____

2. How many times a month do you experience severe to very severe tiredness? ________
Using the following scale, place a mark on the line between 0 (no tiredness) to 10 (very
severe tiredness) in response to the following questions.
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3. Indicate how you've felt on most days during the past year.
Mild
Moderate
Severe
No Tiredness

Very Severe

0

1

2

3

4

4. Indicate how you feel today.
Mild

5

6

7

Moderate

8

9

10

Tiredness

Severe

No Tiredness

Very Severe

0

1

2

3

4

5

6

7

5. Indicate how you feel with most day-to-day activities.
Mild
Moderate

8

9

10

Tiredness

Severe

No Tiredness

Very Severe

0

1

ACTIVITY

2

3

4

6

7

Mild

None

0

5

1

2

1. Brushing/combing
hair
2. Putting on shirt
3. Washing hair
4. Showering
5. Raising arms
overhead
6. Preparing a snack
7. Walking ten feet
(3½ meters)
8. Walking on inclines
9. Walking on bumpy
terrain
10. Climbing 3 stairs
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8

9

10

Moderate
3

4

5

6

Tiredness
Very
Severe

Severe
7

8

9

10

ACTIVITY ASSESSMENT
INSTRUCTIONS: The following is a list of activities commonly performed by adults. For
each activity listed, please place an X in the appropriate box, indicating your involvement with
the activity now as compared to before you developed breathing problems. Please respond to
every activity listed.
Complete the form as follows:
1."Has never been an Activity": Check this box near each activity in which you have never
participated.

Have Omitted
Entirely

Extreme Change

Moderate Change

Minor Change

As Active As Ive
Ever Been

ACTIVITY

Has Never Been An
Activity

2. Columns numbered 0 through 10 represent a range of activities from "As Active As I've Ever
Been" to "Have Omitted Entirely". Indicate by placing an X in the area which best reflects
your current involvement in the activity.

1. Brushing/ combing hair
0
2. Putting on a shirt
3. Washing hair
4. Showering
5. Raising arms overhead
6. Preparing a snack
7. Walking 10 feet (3.5 meters)
8. Walking on inclines
9. Walking on bumpy terrain
10. Climbing 3 stairs
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1 2 3 4 5 6 7 8 9 10

Appendix C
Quality of Life Index Pulmonary Version-III

Very Dissatisfied

Moderately Dissatisfied

Slightly Dissatisfied

Slightly Satisfied

Moderately Satisfied

Very Satisfied

Part 1. For each of the following, please choose the answer that best describes how satisfied you
are with that area of your life. Please mark your answer by circling the number. There are no
right or wrong answers.

1.

Your health?

1

2

3

4

5

6

2.

Your health care?

1

2

3

4

5

6

3.

The amount of pain you have?

1

2

3

4

5

6

4.

Your ability to breathe without shortness of breath?

1

2

3

4

5

6

5.

The amount of energy you have for everyday activities?

1

2

3

4

5

6

6.

Your ability to take care of yourself without help?

1

2

3

4

5

6

7.

The amount of control you have in your life?

1

2

3

4

5

6

8.

Your chances of living as long as you would like?

1

2

3

4

5

6

9.

Your family’s health?

1

2

3

4

5

6

10. Your children?

1

2

3

4

5

6

11. Your family’s happiness?

1

2

3

4

5

6

12. Your sex life?

1

2

3

4

5

6

13. Your spouse, lover, or partner?

1

2

3

4

5

6

14. Your friends?

1

2

3

4

5

6

15. The emotional support you get from your family?

1

2

3

4

5

6

HOW SATISFIED ARE YOU WITH?
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16. The emotional support you get from people other than your
family?

1

2

3

4

5

6

17. Your ability to take care of family responsibilities?

1

2

3

4

5

6

18. How useful you are to others?

1

2

3

4

5

6

19. The amount of worries in your life?

1

2

3

4

5

6

20. Your neighborhood?

1

2

3

4

5

6

21. Your home, apartment, or place where you live?

1

2

3

4

5

6

22. Your job (if employed)?

1

2

3

4

5

6

23. Not having a job (if unemployed, retired, or disabled)?

1

2

3

4

5

6

24. Your education?

1

2

3

4

5

6

25. How well you can take care of your financial needs?

1

2

3

4

5

6

26. The things you do for fun?

1

2

3

4

5

6

27. Your chances for a happy future?

1

2

3

4

5

6

28. Your peace of mind?

1

2

3

4

5

6

29. Your faith in a higher power?

1

2

3

4

5

6

30. Your achievement of personal goals?

1

2

3

4

5

6

31. Your happiness in general?

1

2

3

4

5

6

32. Your life in general?

1

2

3

4

5

6

33. Your personal appearance?

1

2

3

4

5

6

34. Yourself in general?

1

2

3

4

5

6

35. Your relief from coughing?

1

2

3

4

5

6

36. The changes in your life that you have had to make because
of your lung condition?

1

2

3

4

5

6
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Very Unimportant

Moderately Unimportant

Slightly Unimportant

Slightly Important

Moderately Important

Very Important

1.

Your health?

1

2

3

4

5

6

2.

Your health care?

1

2

3

4

5

6

3.

Having no pain?

1

2

3

4

5

6

4.

Having no shortness of breath?

1

2

3

4

5

6

5.

Having enough energy for everyday activities?

1

2

3

4

5

6

6.

Taking care of yourself without help?

1

2

3

4

5

6

7.

Having control over your life?

1

2

3

4

5

6

8.

Living as long as you would like?

1

2

3

4

5

6

9.

Your family’s health?

1

2

3

4

5

6

10. Your children?

1

2

3

4

5

6

11. Your family’s happiness?

1

2

3

4

5

6

12. Your sex life?

1

2

3

4

5

6

13. Your spouse, lover, or partner?

1

2

3

4

5

6

14. Your friends?

1

2

3

4

5

6

15. The emotional support you get from your family?

1

2

3

4

5

6

16. The emotional support you get from people other than your
family?

1

2

3

4

5

6

17. Taking care of family responsibilities?

1

2

3

4

5

6

18. Being useful to others?

1

2

3

4

5

6

HOW IMPORTANT TO YOU IS?
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19. Having no worries?

1

2

3

4

5

6

20. Your neighborhood?

1

2

3

4

5

6

21. Your home, apartment, or place where you live?

1

2

3

4

5

6

22. Your job (if employed)?

1

2

3

4

5

6

23. Not having a job (if unemployed, retired, or disabled)?

1

2

3

4

5

6

24. Your education?

1

2

3

4

5

6

25. Being able to take care of your financial needs?

1

2

3

4

5

6

26. Doing things for fun?

1

2

3

4

5

6

27. Having a happy future?

1

2

3

4

5

6

28. Peace of mind?

1

2

3

4

5

6

29. Your faith in a higher power?

1

2

3

4

5

6

30. Achieving your personal goals?

1

2

3

4

5

6

31. Your happiness in general?

1

2

3

4

5

6

32. Your life in general?

1

2

3

4

5

6

33. Your personal appearance?

1

2

3

4

5

6

34. You to yourself?

1

2

3

4

5

6

35. Being free from coughing?

1

2

3

4

5

6

36. The changes in your life that you have had to make because
of your lung condition?

1

2

3

4

5

6

Ferrans, C. E., & Powers, M. J. (1985). Quality of life index: development and psychometric properties. Advances in
Nursing Science, 8(1), 15-24.
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Appendix D
Global Self-rating of Health
(Adapted from Ware & Sherbourne, 1992)
Instructions: Please respond to the question by marking one box in the row.

In general,
would you
say your
health is:

Excellent

Very Good

Good

Fair

Poor

□

□

□

□

□
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Appendix E
Demographic Form
Instructions: Answer questions as they relate to you. For most answers, check the box(es) most
applicable to you or fill in the blanks.
About You
1. Your Age in Years, Today
(Select only one.)
40-50
50-60
60-70
70-80
81 or more
2. Your Gender
(Select only one.)
Female
Male
Transgender
3. Your Ethnicity
(Select only one.)
Hispanic or Latino
Not Hispanic or Latino
Unknown
4. Your Race
(Select only one.)
American Indian/Alaskan Native
Asian
Black or African American
Native Hawaiian or other Pacific Islander
White
More than one race
5. Your Marital Status
(Select only one.)
Married
Civil Union/Domestic Partnership
Widowed
Living with significant other
Single (never married)
Divorced/Separated
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6. Your Educational Background
(Select only one.)
Less than high school
Graduated high school or GED
Some college or technical school
Graduated college
Postgraduate school or degree
7. Your Employment Status
(Select only one.)
Currently working
On leave of absence
Retired (not due to ill health)
Disabled and/or retired because of ill health
Homemaker
Unemployed
8. Your Income Level
(Select only one that reflects all sources of income earned in the past year.)
Less than $10,000
$10,000 to less than $20,000
$20,000 to less than $35,000
$35,000 to less than $50,000
$50,000 to less than $75,000
$75,000 to less than $100,000
$100,000 or more
I prefer not to answer this question.
About Your Residence
9. Who do you live with?
(Select only one.)
I live alone
I live with family or friends
10. Where do you live?
(Select only one.)
In a community of < 50,000 people
In a community of > 50,000 people
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About Your Breathing
11. How long have you been diagnosed with COPD (Chronic Obstrcutive Pulmonary
Disease, Emphysema, or Chronic Bronchitis)?
(Select only one.)
0-3 years
3-10 years
More than 10 years
12. Are you a current or former smoker of cigarettes and/or pipes?
(Select only one.)
Yes
No
13. If YES, what was or is the average number of cigarettes/pipes smoked per day?
(Select only one.)
_______ cigarettes
_______ pipes
14. If YES, what was the total number of years as a smoker?
______________ Years
17. What is your current height and weight?
____ feet

____ inches

____ pounds

18. How many times have you visited your primary care provider due to breathing
problems in the past 12 months?
______ Times
19. How many times have you visited am emergency department due to breathing problems
in the past 12 months?
_______ Times
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Appendix F
Institutional Review Board Approval
Principal Investigator Notification:
From: Mayo Clinic IRB
To: Marnie Wetzstein
CC: Linda Chlan

Marnie Wetzstein
Re: IRB Application #: 17-007672
Title: Examining Determinants of Patient Activation in Chronic Obstructive Pulmonary Disease: A CrossSectional Survey Study

IRBe Protocol Version: 0.02
IRBe Version Date: 10/4/2017 2:06 PM
IRB Approval Date: 10/24/2017
IRB Expiration Date: 10/23/2018
The above referenced application is approved by expedited review procedures (45 CFR
46.110, item 5,7). This approval is valid for a period of one year. The Reviewer conducted a
risk-benefit analysis, and determined the study constitutes minimal risk research. The
Reviewer determined that this research satisfies the requirements of 45 CFR 46.111.
The Reviewer approved the accrual of 120 subjects.
The Reviewer accepts the appointment of the Mayo Clinic IRB as the IRB of Record for the
Relying Organization, University of North Dakota, and notes receipt of the fully executed IRB
Authorization Agreement.
The Reviewer noted that oral consent with HIPAA authorization is appropriate for this study.
The oral consent script was reviewed and approved as written. The written HIPAA form was
reviewed and approved as written. The Reviewer approved waiver of the requirement for the
Investigator to obtain a signed consent form in accordance with 45 CFR 46.117 as justified by
the Investigator.
AS THE PRINCIPAL INVESTIGATOR OF THIS PROJECT, YOU ARE RESPONSIBLE
FOR THE FOLLOWING RELATING TO THIS STUDY.
1) When applicable, use only IRB approved materials which are located under the documents
tab of the IRBe workspace. Materials include consent forms, HIPAA, questionnaires, contact
letters, advertisements, etc.
2) Submission to the IRB of any modifications to approved research along with any
supporting documents for review and approval prior to initiation of the changes.
3) Submission to the IRB of all Unanticipated Problems Involving Risks to Subjects or Others
(UPIRTSO) and major protocol violations/deviations within 5 working days of becoming
aware of the occurrence.
4) Compliance with applicable regulations for the protection of human subjects and with
Mayo Clinic Institutional Policies.
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Appendix I
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